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Abstract 
Vitamin K is an essential nutrient involved in the regulation of blood coagulation, 
tissue mineralization and immune response. Various types of vitamin K are 
manufactured, mainly by chemical synthesis, for use as dietary supplements and 
drugs in both humans and domestic animals. In fact, the largest single application of 
vitamin K supplements (in the form of the vitamin K analog menadione) is in 
intensive chicken farming. Vitamin K1 is the most common form found in the natural 
diets of both humans and chickens. Research in humans has shown that vitamin K1 
has additional health benefits compared to other types of vitamin K, and there is 
evidence to suggest this is also the case in chickens. However, increasing consumer 
preferences for natural and sustainable products has increased the demand for 
biosynthesized vitamin K2 in recent years. A natural vitamin K1 product has obvious 
applications in both human and animal health. Therefore, the objective of this work 
was to develop a biotechnological process for the production of vitamin K1. 
The benefits of vitamin K1 for the immune system were investigated in laying 
hens. Comprehensive blood biochemistry analyses were performed, including 
concentration of cytokines in white blood cells, concentration of cytokines in plasma 
and concentrations of different types of vitamin K in the blood. Vitamin K1 (as 
Quinaquinone®) was shown to significantly increase blood vitamin K concentrations 
to more than 20 ng mL-1, while vitamin K2 (as MenaQ7®) and the analog menadione 
(as menadione nicotinamide bisulfite) achieved concentrations of less than 5 ng mL-1. 
The range of concentrations observed was below those demonstrated to modulate 
inflammatory response. No significant differences in cytokine concentrations were 
observed. Therefore, higher concentrations and/or larger sample sizes are probably 
required to observe a difference in immune response. Nevertheless, vitamin K1 is the 
best form for improving vitamin K status in chickens. 
 The biotechnological production of vitamin K1 requires a microorganism that 
naturally contains a high concentration. Vitamin K1 is produced by photosynthetic 
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organisms, and is usually known as phylloquinone in this context. A review of the 
literature showed that algae have the highest concentrations of phylloquinone, so 
seven strains of microalgae that are commonly used for scientific and commercial 
applications were tested. The cyanobacterium Anabaena cylindrica (ANACC strain 
CS-172) was found to have the highest concentration at 200 µg g-1 on a dry-mass 
basis. This is approximately six times higher than the concentration found in rich 
dietary sources such as parsley. One gram can provide almost three times the 
Australian daily adequate intake of 70 µg per day and four times the chicken intake 
of 60 µg per day. Subsequent nutritional analysis by an independent laboratory 
confirmed this value and revealed A. cylindrica is also a rich source of protein, iron 
and vitamin B12. A mouse bioassay also demonstrated the short-term safety of diets 
including 5-15% A. cylindrica on a dry mass basis. No acute toxicity due (e.g. due to 
cyanotoxins) was observed. This strain of A. cylindrica is an excellent candidate for 
biotechnological production of vitamin K1 and other health products. 
 Maximizing the volumetric productivity of A. cylindrica in the culture system 
is essential in developing a biotechnological process, as reactor productivity is 
usually the limiting step in photoautotrophic processes. Light, nitrogen and 
phosphorus are usually the key determinants of productivity; their effects were 
tested by growing A. cylindrica in a bench-top (5 L) bubble column photo-bioreactor 
(PBR). Increasing the Photosynthetic Photon Flux Density (PPFD; from 160 to 330 
µmol m-2 s-1) and the sodium nitrate concentration (from 170 to 1700 mg L-1) led to a 
four-fold increase in phylloquinone productivity (from 4.9 to 22 µg L-1 d-1) and final 
titer (from 34 to 129 µg L-1). Unexpectedly, increasing the concentration of 
dipotassium hydrogen phosphate (from 34.8 to 348 mg L-1) did not have any main 
effect but did have a weak negative interaction with the sodium nitrate 
concentration. This may indicate that the ratio of N:P is too low in the standard 
medium used here. The phylloquinone productivity of A. cylindrica in a bench-top 
PBR was successfully boosted by manipulating light and nitrate concentration. 
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Scale-up of biotechnological processes usually entails some loss of productivity; 
however, the magnitude of this loss can be the difference between commercial 
success and failure. Irradiance and mixing are usually the limiting factors in large 
reactors for the culture of microalgae. A. cylindrica was grown in a pilot-scale (50 L) 
bubble column photo-bioreactor in order to test the efficiency of scale-up, as well as 
strategies for improving mixing and irradiance. At 2 × concentration MLA medium 
and a PPFD of ~300 µmol m-2 s-1, varying the air flow rate (superficial gas velocities 
in the range 0.62 – 6.2 cm s-1) and the sparger design (ceramic with pore size of <0.3 
mm or steel tube with 30 holes of diameter 2 mm) had no significant effect on 
phylloquinone productivity (~19 µg L-1) or final titer (~130 µg L-1). These values were 
very similar to those achieved in the bench-scale reactor, mainly due to the higher 
specific phylloquinone concentration (approximately 260 versus 150 µg g-1) induced 
by light limitation in the pilot-scale reactor. The productivity and final titer were 
doubled by increasing the duration of light from 12 to 24 hours per day. However, 
this required more concentrated medium nutrients (5 × MLA). At a medium 
concentration of 2 × MLA with continuous illumination, nitrate was depleted by day 
4 and specific phylloquinone concentration declined sharply from approximately 300 
to less than 200 µg g-1 by day 7 (the final day).  
The results of this research lay the foundations for the biotechnological 
production of vitamin K1, a world first. New applications, sources and production 
methods were presented. Future work could include studies in larger populations of 
animals, investigation of genetic influences on phylloquinone biosynthesis in 
microalgae, further optimization of microalgal culture conditions and development 
of downstream processing methods for microalgae.  
Preliminary Matter 
iv 
 
Acknowledgements 
The genesis of this research was in the long-standing collaboration between the 
University of Sydney and Agricure Scientific Organics Pty Ltd. I would like to thank 
my supervisors from the University, Prof. Fariba Dehghani and Dr. John Kavanagh, 
and my industry sponsors from Agricure, Hub Regtop and Ray Biffin, for their 
unstinting support. The knowledge, resources and good will of these four people 
were essential to the success of the project. Thank you also to the Australian 
Government for supporting this research through my scholarship and the Australian 
Research Council grant IC140100026. 
 I would like to thank Dr. Dale McClure and Dr. Peter Valtchev for their 
support with the process of actually “doing science”. An especially big thank you to 
Dale, whose discipline, expertise and good company got me through the hard times 
without too much wailing or gnashing of teeth. Dale, along with Audrey Luiz, 
helped me greatly throughout “the algae parts” of my research. Thanks to Dr. Nick 
Proschogo, from the School of Chemistry at the University of Sydney, for his expert 
assistance with the mass-spectrometric analysis of phylloquinone. Thank you to 
Prof. Aaron Schindeler and Emily Vasiljevski for their help throughout the trials and 
tribulations of planning and executing the mouse study. Aaron’s assistance in 
writing the manuscript was also invaluable. 
 Of all the staff from the School of Chemical and Biomolecular Engineering 
who assisted me, I would like especially to thank four people. Annette Karydis, with 
her unrivalled administrative skills, got me out of trouble on more than one 
occasion. Her sense of fun and willingness to help was a soothing balm against the 
chafing of University bureaucracy. Elizabeth Dobrinsky made sure we always had 
the right tools and support for the job, whether they be reagents, equipment, flights 
or hotel rooms. Alex Farago, whose ability in the workshop often goes unrecognized, 
helped us build things faster, cheaper and better than ever we could have ourselves. 
Bogumil Eichstaedt, whose expertise with all things electrical and mechanical is a 
Preliminary Matter 
v 
 
wonder, was similarly essential in the fast and cost-effective construction of our 
trusty experimental rigs. 
 To my friends and fellow researchers in the ARC Training Centre for the 
Australian Food Processing Industry in the 21st Century: Thank you so much for your 
help and good company over the past three-and-a-half years. We have endured 
failure and enjoyed success together. Failure seems like the end of the world without 
friends to laugh with. Success is a trifling thing without friends to celebrate with. 
 To the friends that I like to think of as family, thank you. Thank you to my 
partner Jess, and her parents Rick and Woon. Their generosity and enthusiasm for 
my research have been a constant source of enjoyment and optimism. Thanks to my 
good friend Dr. Edgar Wakelin, who inspired me to start (and finish!) a PhD. Thank 
you to my friend and colleague Andrea Talbot, whose friendship alone would have 
made my PhD worthwhile! 
Finally, I would like to thank my family. Again, Jess, I really can’t thank you 
enough; you have provided every kind of support imaginable. Brother Guy, we have 
had many thought-provoking and entertaining conversations during my research. 
Your own pursuits, and your interest in my project, have helped inspire and 
motivate me. Your scrutiny of the draft manuscript, honed by many hours poring 
over legal contracts, was brilliant (though at times withering). Mum and Dad, you 
have supported me come what may. When things got too much, your place was my 
one true refuge. You prepared me well for life; I hope I’ve done you proud. 
  
Preliminary Matter 
vi 
 
Student Declaration 
I declare that the work contained within this thesis is my own, unless stated 
otherwise. No part of this work has been submitted to any other institution for 
award of a degree. 
 
 
 
Thomas Tarento 
June 2018 
 
  
Preliminary Matter 
vii 
 
List of Publications and Presentations 
Journal articles 
1. Tarento, TDC, et al. "A potential biotechnological process for the sustainable 
production of vitamin K1." Critical Reviews in Biotechnology (2018): 1-19. 
2. Tarento, TDC, et al. "Microalgae as a source of vitamin K1." Algal Research 36 
(2018): 77-87. 
Conference presentations 
1. Tarento, T, et al. “Comparison of Immune Benefits of K Vitamers and a 
Vitamin K Analog for Optimization of Commercial Livestock Feed.” 
European Society of Biochemical Engineering Sciences (2016). 
2. Tarento, T and Talbot, A. “The Chicken, the Egg and Vitamin K: Benefits All 
Round.” Australasian Veterinary Poultry Association (2017). 
3. Tarento, T and Talbot, A. “Vitamin K: A disjointed narrative.” Sydney 
Musculoskeletal Health Alliance (2017). 
 
  
Preliminary Matter 
viii 
 
Table of Contents 
 
1 Introduction .................................................................................................................... 20 
1.1 The need for vitamin K ......................................................................................... 21 
1.2 Thesis Aims ............................................................................................................ 22 
2 Literature review – the benefits and industrial production methods of vitamin K24 
2.1 The vitamins ........................................................................................................... 24 
2.1 Vitamin K ................................................................................................................ 28 
2.1.1 Chemistry of K vitamers................................................................................... 29 
2.1.2 Physicochemical properties of vitamin K ...................................................... 29 
2.2 The requirement for vitamin K ............................................................................ 32 
2.2.1 Physiological functions and roles of vitamin K ............................................ 32 
2.2.2 Dietary intake of vitamin K in humans .......................................................... 36 
2.2.3 Dietary intake of vitamin K in chickens ......................................................... 39 
2.3 Production of vitamin K1 ...................................................................................... 41 
2.1.1 Global vitamin K production ........................................................................... 41 
2.3.1 Chemical synthesis of vitamin K1 .................................................................... 42 
2.3.2 Biosynthesis of vitamin K1 ............................................................................... 45 
2.3.3 Culture systems for microalgae ....................................................................... 53 
2.3.4 Recovery of vitamin K1 from biomass ............................................................ 58 
2.4 Summary ................................................................................................................. 59 
3 The immune benefits of dietary vitamin K for chickens: a comparison of 
supplements ........................................................................................................................... 61 
3.1 Background ............................................................................................................ 61 
3.2 Method and Materials ........................................................................................... 63 
3.2.1 Sample size calculation ..................................................................................... 63 
3.2.2 Animals, diet and sample collection ............................................................... 64 
3.2.3 Flow cytometric sample preparation .............................................................. 67 
Preliminary Matter 
ix 
 
3.2.4 Flow cytometric sample analysis .................................................................... 68 
3.2.5 Extracellular cytokine analysis ........................................................................ 70 
3.2.6 Blood vitamin K concentration analysis ......................................................... 70 
3.3 Results and Discussion ......................................................................................... 71 
3.3.1 Effect of vitamin K concentrations on cytokine production in vitro .......... 71 
3.3.2 Effect of different vitamin K substances on cytokine production in vivo .. 72 
3.3.3 Replication of reference method for flow cytometric immunophenotyping75 
3.3.4 Vitamin K1 supplementation boosted blood vitamin K concentration ...... 77 
3.4 Summary ................................................................................................................. 79 
4 Identification of a microalga for production of vitamin K1 ..................................... 80 
4.1 Background ............................................................................................................ 80 
4.2 Method and Materials ........................................................................................... 81 
4.2.1 Flask cultures ..................................................................................................... 81 
4.2.2 Extraction and analysis of phylloquinone ..................................................... 82 
4.2.3 Nutritional panel analysis ................................................................................ 86 
4.2.4 Animal study ...................................................................................................... 86 
4.2.5 Animal blood biochemistry and tissue histopathology ............................... 88 
4.3 Results and Discussion ......................................................................................... 89 
4.3.1 Strain screening .................................................................................................. 89 
4.3.2 Nutritional analysis ........................................................................................... 90 
4.3.3 Animal study ...................................................................................................... 94 
4.4 Summary ............................................................................................................... 100 
5 Optimizing nutrient supply for production of vitamin K1 .................................... 101 
5.1 Background .......................................................................................................... 101 
5.2 Method and materials ......................................................................................... 104 
5.2.1 Photo-bioreactor cultures ............................................................................... 104 
5.2.2 Biomass growth analysis ................................................................................ 107 
5.2.3 Statistical analyses ........................................................................................... 107 
5.3 Results and discussion ........................................................................................ 109 
Preliminary Matter 
x 
 
5.3.1 Correlations between absorbance, DCW and phylloquinone specific 
concentration ................................................................................................................ 109 
5.3.2 General trends in growth and phylloquinone productivity ..................... 111 
5.3.3 Optimal conditions .......................................................................................... 115 
5.3.4 Light intensity .................................................................................................. 116 
5.3.5 Nitrate Concentration ..................................................................................... 116 
5.3.6 Phosphate concentration ................................................................................ 117 
5.4 Conclusions .......................................................................................................... 120 
6 Scale-up of Anabaena cylindrica culture in photo-bioreactors for vitamin K1 
production ............................................................................................................................ 121 
6.1 Background .......................................................................................................... 121 
6.2 Method and materials ......................................................................................... 125 
6.2.1 Flask cultures ................................................................................................... 125 
6.2.2 Photo-bioreactor cultures ............................................................................... 125 
6.2.3 Photobioreactor set-up .................................................................................... 126 
6.2.4 Nitrate analysis ................................................................................................ 129 
6.2.5 Gas holdup and superficial velocity determination ................................... 130 
6.3 Results and discussion ........................................................................................ 131 
6.3.1 Optimal temperature and pH ........................................................................ 131 
6.3.2 Dissolved oxygen, temperature and pH ...................................................... 132 
6.3.3 Effects of air flow rate and sparger design .................................................. 134 
6.3.4 Effects of light duration versus medium concentration ............................ 143 
6.4 Conclusions .......................................................................................................... 150 
7 Conclusions and future work .................................................................................... 151 
7.1 Conclusions .......................................................................................................... 151 
7.1.1 Effectiveness of vitamin K1 for boosting vitamin K status in chickens ... 152 
7.1.2 Identification of a microorganism that is naturally rich in vitamin K1 .... 153 
7.1.3 Importance of light intensity and medium nitrogen for the production of 
vitamin K1 ..................................................................................................................... 153 
Preliminary Matter 
xi 
 
7.1.4 Robustness of vitamin K1 production in A. cylindrica against variations 
due to scale-up ............................................................................................................. 154 
7.2 Future work .......................................................................................................... 156 
7.2.1 Benefits of vitamin K1 for chicken welfare and productivity .................... 156 
7.2.2 Safety of health products from cyanobacteria for repeated long-term use156 
7.2.3 Optimization of nutrient inputs for an industrial scale process ............... 158 
7.2.4 Optimization of irradiance in a pilot-scale photo-bioreactor .................... 159 
7.2.5 Advanced tools for monitoring of microalgal culture ............................... 159 
7.2.6 Optimization of downstream processing ..................................................... 160 
7.3 Final remarks ........................................................................................................ 161 
8 References ..................................................................................................................... 162 
Appendix A: AEC approval letter for project 2015/769 ............................................. A-1 
Appendix B: AEC approval letter for project 2017/1243 ........................................... B-6 
Appendix C: Diet formulation sheet for dough premix SF14-156 ......................... C-11 
Appendix D: Reports of analysis for nutritional content of A. cylindrica .............. D-15 
 
 
  
Preliminary Matter 
xii 
 
List of Figures 
Figure 2.1: Global vitamin ingredient market split by application (a) and type (b) in 
2015 [46]–[48]. ................................................................................................................ 27 
Figure 2.2: Structural diagrams of: (a) generic K vitamers; (b) phylloquinone; and, (c) 
menaquinone-n (MK-n). .............................................................................................. 30 
Figure 2.3: Structural diagrams of: (a) menadione; (b) menadione sodium bisulfite; 
and, (c) menadione sodium diphosphate. ................................................................ 30 
Figure 2.4: The vitamin K cycle (adapted from [109]). Acronyms: vitamin K 
hydroquinone (KH2); vitamin K epoxide (KO); vitamin K epoxide reductase 
(VKOR); γ-glutamyl carboxylase (GGCX). ............................................................... 32 
Figure 2.5: Scheme of industrial synthesis of vitamin K1 [197]. Double arrows denote 
multiple steps, bold text denotes chemical compound, regular text denotes 
reagents and catalysts. ................................................................................................. 43 
Figure 2.6: Electron transport in photosystem I. Primary inputs and outputs in bold, 
electron flux in green, photon flux in red. Acronyms: Plastocyanin (PC), 
modified antenna chlorophyll (P700), modified electron transport chlorophyll 
(A0), phylloquinone (A1), iron-sulfur protein complex (Fe4S4), ferredoxin protein 
(Fd) [221]. ....................................................................................................................... 47 
Figure 2.7: The biosynthetic pathway of phylloquinone. Only structures of the key 
intermediates are shown. Double arrows denote multiple steps, bold text 
denotes chemical compound, regular text denotes biosynthetic enzymes. ......... 51 
Figure 2.8: Diagrams of the most commonly used algal culture bioreactors. The top 
and/or front views face toward the light source. ..................................................... 54 
Preliminary Matter 
xiii 
 
Figure 3.1: Gating strategy showing: elimination of cellular debris (a); selection of 
CD45+ events (b); identification of WBC (c), and; observation of IL-1β 
fluorescence (d). ............................................................................................................ 69 
Figure 3.2: Median fluorescence intensity of pro-inflammatory cytokine signals for 
WBC incubated with different vitamin K compounds at different concentrations. 
Values are the mean of 3 repeats, all repeats are mean of duplicates and error 
bars are standard deviation of repeats. ..................................................................... 71 
Figure 3.3: Fluorescence signal of (a) IL-1β and (b) IL-6 in WBC of birds fed diets 
supplemented with different vitamin K substances. Values are mean of 4 
repeats, all repeats mean of 3 biological replicates, error bars are standard 
deviation of repeats. ..................................................................................................... 73 
Figure 3.4: Pro-inflammatory extracellular cytokines in plasma of birds fed diets 
supplemented with different vitamin K substances. Values are mean of 4 
repeats, all repeats mean of 2 or 3 replicates, error bars are standard deviation of 
repeats. ........................................................................................................................... 74 
Figure 3.5: Comparison of flow cytometric phenotyping between De Boever et al. 
[317] (left) and the present study (right). Density plot of SSC-A versus FSC-A 
showing all events (a); density plot of CD45-PE versus SSC-A showing CD45+ 
events and gated WBC populations (b), and; density plot of SSC-A versus FSC-
A showing only WBC populations (c). ...................................................................... 76 
Figure 3.6: Concentration of (a) phylloquinone and (b) menaquinone-7 in blood 
plasma of birds fed diets supplemented with different vitamin K substances. 
Values are mean of 3 repeats, error bars are S.D. of repeats. Blank, QAQ and 
MenaQ7 compared using Welch’s t-test, * p < 0.05, ** p < 0.01. .............................. 78 
Preliminary Matter 
xiv 
 
Figure 4.1: Chromatograms from fluorometric analysis of: (a) phylloquinone and 
menaquinone-4 standards; (b) hexane extract of A. cylindrica, spiked with MK-4.
 ......................................................................................................................................... 84 
Figure 4.2: Mass-to-charge spectra from (a) an analytical standard and (b) a hexane 
extract of A. cylindrica. Dashed line indicates precursor ion, solid line indicates 
product ion. ................................................................................................................... 85 
Figure 4.3: Phylloquinone concentrations determined for some common microalgae. 
Phylloquinone was not detected in P. tricornutum so no value is shown. ........... 90 
Figure 4.4: Mass of mice on each diet at day 0 (initial) and day 7 (final). Values are 
mean, error bars are SD. .............................................................................................. 94 
Figure 4.5: Albumin and globulins protein concentration in plasma (indicators of 
general liver, kidney and immune function) taken from mice on four different 
diets. ............................................................................................................................... 95 
Figure 4.6: Alkaline phosphatase (ALP) and γ-glutamyl transferase (GGT) enzyme 
activity in plasma (indicators of cholestatic function) taken from mice on four 
different diets. ............................................................................................................... 95 
Figure 4.7: Aspartate transaminase (AST) and alanine transaminase (ALT) enzyme 
activity in plasma (indicators of hepatocyte integrity) taken from mice on four 
different diets. ............................................................................................................... 96 
Figure 4.8: Urea and creatinine concentration in plasma (indicators of kidney 
function) taken from mice on four different diets. .................................................. 96 
Figure 4.9: Histological micrographs of organs from mice fed control, 5% algae, 10% 
algae and 15% algae diets. ........................................................................................... 97 
Preliminary Matter 
xv 
 
Figure 4.10: Histological micrographs of organ tissues from mice fed control, 5% 
algae, 10% algae and 15% algae diets. ....................................................................... 98 
Figure 5.1: Schematic of the flat-panel PBR apparatus. ................................................ 105 
Figure 5.2: Light intensity distribution measured across the face opposite to the strip-
lights. Tanks were filled with water but no air flow was supplied. Horizontal 
lines are the geometric means of the respective quadratic fits. ........................... 106 
Figure 5.3: Dry Cell Weight (DCW) versus light Absorbance at 550 nm (A550) for all 
samples collected during the course of the experiment........................................ 109 
Figure 5.4: Phylloquinone specific concentration (based on dry mass) versus time of 
day. ............................................................................................................................... 110 
Figure 5.5: Correlation of chlorophyll-a absorbance (A664) with specific 
phylloquinone concentration. ................................................................................... 110 
Figure 5.6: Log of culture density versus time for 1× lights (a) and 2× lights (b). ..... 112 
Figure 5.7: Dry cell weight versus time for 1× lights (a) and 2× lights (b); and 
phylloquinone titers versus time for 1× lights (e) and 2× lights (f). .................... 113 
Figure 5.8: Phylloquinone titers versus time for 1× lights (a) and 2× lights (b). ........ 114 
Figure 5.9: Plot showing specific growth rates versus light intensity for the different 
growth media used. Reported results are averages while error bars denote one 
standard deviation about the mean (n = 3). ............................................................ 118 
Figure 5.10: Plot showing DCW productivities versus light intensity for the different 
growth media used. Reported results are averages while error bars denote one 
standard deviation about the mean (n = 3). ............................................................ 118 
Preliminary Matter 
xvi 
 
Figure 5.11: Plot showing mean specific phylloquinone concentrations over 10-days 
versus light intensity for the different growth media used. Reported results are 
averages while error bars denote one standard deviation about the mean (n = 3).
 ....................................................................................................................................... 119 
Figure 5.12: Plot showing phylloquinone productivities versus light intensity for the 
different growth media used. Reported results are averages while error bars 
denote one standard deviation about the mean (n = 3)......................................... 119 
Figure 6.1: Schematic of the 50 L PBR set-up used in this work. ................................. 127 
Figure 6.2: Photograph of the 50 L PBR set-up used in this work. .............................. 128 
Figure 6.3: Effect of culture temperature and initial medium pH on specific growth 
rate of A. cylindrica grown in flasks. Values are means of 2 repeats, error bars are 
SD. Comparison performed using Dunnett’s multiple comparisons test, * p < 
0.0332, ** p < 0.0021, **** p < 0.0001. .......................................................................... 131 
Figure 6.4: Variation of pH, temperature and dissolved oxygen over time for 
light:dark cycles of (a) 12:12 hours and (b) 24:00 hours. ....................................... 133 
Figure 6.5: Gas holdup versus superficial velocity for various airflow rates through 
perforated steel tube sparger. Flow regimes based upon likely values [274], 
[290], [291]. ................................................................................................................... 134 
Figure 6.6: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube 
“PST”) and air flow (0.2, 0.5, 1.0 and 2.0 vvm) over time on (a) dry cell weight 
(DCW) and (b) nitrate concentration. ...................................................................... 136 
Figure 6.7: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube 
“PST”) and air flow (0.2, 0.5, 1.0 and 2.0 vvm) over time on phylloquinone (a) 
specific concentration and (b) titer. .......................................................................... 137 
Preliminary Matter 
xvii 
 
Figure 6.8: Micrographs at 10 × magnification of A. cylindrica grown at  (a) 0.2 vvm 
and (b) 2.0 vvm aeration rates. Note long filaments of at least 400 µm (~80 cells) 
in both images. ............................................................................................................ 138 
Figure 6.9: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube 
“PST”) and air flow (0.2 and 0.5 vvm) on (a) biomass productivity and (b) 
nitrate consumption rate. Values are mean of n = 2, error bars are SD. ............. 140 
Figure 6.10: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube 
“PST”) and air flow (0.2 and 0.5 vvm) on phylloquinone final (a) specific 
concentration and (b) titer. ........................................................................................ 141 
Figure 6.11: Effect of medium concentration (MLA 2× and 5×) and light:dark cycle 
(12:12, 16:08, 20:04 and 24:00 hours) over time on (a) dry cell weight (DCW) and 
(b) nitrate concentration. ........................................................................................... 144 
Figure 6.12: Effect of medium concentration (MLA 2× and 5×) and light:dark cycle 
(12:12, 16:08, 20:04 and 24:00 hours) over time on phylloquinone (a) specific 
concentration (b) titer. ................................................................................................ 145 
Figure 6.13: Effect of medium concentration (MLA 2× and 5×) and light:dark cycle 
(12:12 and 24:00 hours) on (a) biomass productivity and (b) nitrate consumption 
rate. ............................................................................................................................... 147 
Figure 6.14: Effect of medium concentration (2× and 5× MLA) and light:dark cycle 
(12:12 and 24:00 hours) on phylloquinone final (a) specific concentration and (b) 
titer. ............................................................................................................................... 148 
Figure 6.15: Light micrographs (40x magnification) of A. cylindrica after 7 days of 
growth in: (a) 5x MLA; and, (b) 2x MLA. Note the heterocysts (enlarged cells 
induced by nitrogen limitation) indicated by arrows in (b). ................................ 149 
Preliminary Matter 
xviii 
 
List of Tables 
Table 2.1: The vitamins and their natural sources, arranged from highest to lowest 
price. ............................................................................................................................... 25 
Table 2.2: The vitamin K-dependent proteins [54], [55], [110]–[113]. ........................... 33 
Table 2.3: Dietary sources of phylloquinone (PK), menaquinone-4 (MK-4) and other 
menaquinones (MK). “n.d.” denotes that no data was available. ......................... 38 
Table 2.4: Comparison of some commercially available compounds with vitamin K 
activity [194]–[197]. ...................................................................................................... 41 
Table 2.5: Summary of research into algal culture in bubble column 
photobioreactors. When no data was available the result was denoted n.d. * 
Values estimated for linear photoautotrophic growth regions of results in 
reference. ........................................................................................................................ 56 
Table 3.1: Ingredients of complete vegetarian chicken diet. .......................................... 65 
Table 3.2: Ingredients of vitamin premix. ......................................................................... 66 
Table 4.1: Strains tested for phylloquinone content. ....................................................... 81 
Table 4.2: Proximate analysis of A. cylindrica. .................................................................. 91 
Table 4.3: Amino acid profile of A. cylindrica. .................................................................. 91 
Table 4.4: Indispensable Amino Acid (IAA) profile of A. cylindrica versus the 
FAO/WHO/UNU adult reference pattern [355]. ...................................................... 93 
Table 4.5: Vitamin & mineral analysis of A. cylindrica. ................................................... 93 
Table 5.1: Medium ingredients and concentrations used in this experiment. ........... 104 
Preliminary Matter 
xix 
 
Table 5.2: Summary of test conditions and results for the effect of light, nitrate and 
phosphate on phylloquinone productivity in 5 L PBR cultures. Aggregate daily 
mean (S.D.) values for pH and temperature: pH 7.14 (0.65); minimum 
temperature 22.2 °C (0.75 °C); maximum temperature 23.7 °C (0.67 °C). 
Optimum values highlighted in bold. ..................................................................... 115 
Table 6.1: Actual and calculated air-flow values for perforated steel tube sparger. 
Flow rate adjusted based upon a back-pressure of 30 kPa as measured at the 
rotameters. ................................................................................................................... 134 
Table 6.2: Summary of test conditions and results for effect of sparger type versus air 
flow rate. ...................................................................................................................... 135 
Table 6.3: Summary of test conditions and results for effect of daylength versus 
medium concentration. .............................................................................................. 143 
 
 
 
 
Chapter 1: Introduction 
20 
 
1 Introduction 
Vitamin deficiencies are a major contributor to chronic disease, the most costly and 
debilitating category of diseases in the modern world [1]. Diseases are termed 
“chronic” when they emerge gradually and subsequently affect patients for many 
years. The most commonly reported chronic diseases in Australia in 2011 were 
cancer (19%), cardiovascular diseases (including ischemic heart disease, 15%), 
musculoskeletal disorders (including osteoporosis and rheumatoid arthritis, 12%) 
and mental health disorders (including depression and dementia, 12%) [2], which 
cost more than AUD 12 billion to treat. This is a common trend among developed 
nations. 
The increasing incidence and severity of chronic disease has been attributed 
primarily to detrimental lifestyle behaviors, such as poor diet [1]. Research is 
beginning to reveal simple dietary choices that can help to reduce the burden of 
chronic disease. Two well-known examples are the Mediterranean and Okinawan 
diets, which can reduce the risk of morbidity and mortality due to heart disease, 
diabetes and cancer [3]–[5]. These diets are primarily made up of vegetables (leafy 
greens, roots and legumes) and are rich in plant-based chemicals [5]. 
Nutrient deficiencies and imbalances also contribute to reduced productivity 
and animal welfare in livestock systems [6]. This is a problem because the health of 
the poorest and fastest growing human populations is limited by the availability of 
nutritious animal food products, especially pork and chicken. In fact, chicken meat 
and eggs are the fastest growing and most widely consumed animal products in the 
world [6]. Optimal nutrition remains an unsolved problem in the poultry industry 
and micronutrient interventions could vastly improve animal welfare and 
productivity [7]. For example, increased vitamin levels are required when chickens 
are stressed or sick [8]. 
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1.1 The need for vitamin K 
The rationale for the research into vitamin K presented in this thesis is three-fold. 
Firstly, the most recent research suggests a much more important physiological role 
for vitamin K than has been understood since its discovery in the 1930s. If these 
findings prove true, then the potential benefits to human and animal health are 
enormous. Secondly, and as a corollary of the first point, there is very little available 
research on vitamin K (16,000 articles on Clarivate’s Web of Science as of January 
2019) compared to other vitamins, such as the fat-soluble vitamins A (approx. 
33,000), D (approx. 79,000) and E (approx. 50,000). There is considerable work 
required on the physiological roles and synthesis of vitamin K to bring our 
knowledge to a level on par with knowledge of the other vitamins. Thirdly, the K 
vitamins typically sell for several thousand USD/kg, making them some of the most 
expensive nutritional commodities in the global market. The potential economic 
value of a new vitamin K product is also enormous. 
Vitamin K refers to a family of structurally similar chemical compounds 
defined by their ability to facilitate the modification of vitamin K dependent 
proteins. True K vitamers (vitamins K1 and K2) are characterized by their ability to 
act as the enzyme cofactor in the vitamin K cycle. Natural vitamin K1 is also known 
as phylloquinone, while vitamin K2 consists of a group of compounds called the 
menaquinones (denoted MK-n). In contrast, vitamin K analogs (the menadione 
derivatives, sometimes known erroneously as vitamin K3) are pro-vitamins that 
require transformation before they become active in the vitamin K cycle [9]–[11]. 
They exhibit lower activity [12] and can be toxic [13]–[17]. In fact, menadione and its 
derivatives have been banned in human products since 1963 [18]. 
In humans, vitamin K is essential for the activity of at least 15 proteins that 
regulate diverse biochemical processes. Vitamin K has long been used to prevent 
and treat certain types of coagulation disorders [19]–[21]. There are also many 
emerging health benefits of vitamin K. Increased vitamin K intake can help prevent 
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bone fracture [22], [23] arterial calcification [24], [25], inflammatory diseases [25], 
[26], and cognitive decline [27]–[29]. Despite this, public health agencies around the 
world have so far not attempted to encourage increased vitamin K intakes. 
The most common sources of vitamin K are leafy green vegetables, which are 
a rich source of vitamin K1. Unfortunately, most people in developed nations do not 
eat enough vegetables. In Australia, only 1% of 18-34 year olds eat at least the 
recommended amount of vegetables per day [30]. Seaweed, livers, and some 
fermented soy bean foods are also very rich sources of vitamin K, however their 
consumption is not widespread. Therefore, in order to boost vitamin K intakes, food 
fortification and/or supplementation may be necessary. Vitamin K could be added to 
oil-based spreads and dairy products like the other fat soluble vitamins A, D and E. 
1.2 Thesis Aims 
A lack of availability of micronutrient-rich foods is a major impediment to the good 
health of both humans and livestock. Vitamin K has historically been ignored in 
favor of vitamins A, C, E and, more recently, B-group vitamins and vitamin D. The 
development of effective, safe and relatively cheap vitamin K products has been 
neglected as research and development focused on these other vitamins. This is 
especially evident in animal nutrition, such as in commercial chicken feed, where 
menadione derivatives are still used despite demonstrated toxicity in humans. This 
research aims to develop a natural vitamin K1 product using a biotechnological 
process. Such a product could have applications in both human and animal health. 
The literature pertaining to the benefits and production methods of vitamin K 
are reviewed in Chapter 2. Chapter 3 examines the benefits of vitamin K 
supplementation for poultry health. Domestic laying hens were fed various vitamin 
K-supplemented diets; their blood was subsequently analyzed for immune function 
and vitamin K concentration. Chapter 4 presents a novel microalgal process for the 
biosynthesis of vitamin K1. Several common microalgal strains were screened for 
vitamin K1 content, and the nutritional value and safety of the best strain was tested. 
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Chapter 5 investigates the effects of nutrients on the productivity of the selected 
microalga. Light intensity, phosphate concentration and nitrate concentration were 
varied in five liter photo-bioreactor systems, and vitamin K1 concentration and 
productivity were tested. Chapter 6 investigates the scaling-up of the microalgal 
process. Attempts to boost the productivity of cultures in a 50 liter bubble-column 
investigated effects of operating conditions such as superficial gas velocity, bubble 
flow, and day-length. Finally, Chapter 7 presents conclusions, discusses general 
trends in the present research, and proposes ideas for future research. 
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2 Literature review – the benefits and industrial 
production methods of vitamin K 
The first half of this chapter answers the questions “what is vitamin K?” and “why 
do we care about vitamin K1?” Vitamin K is defined and its characteristics are 
presented. The need for vitamin K is also reviewed in relation to known 
physiological roles and dietary sources. Subsequently, the known and putative 
benefits of vitamin K1 for human and animal health are highlighted. The second half 
of this chapter answers the questions “how do we make vitamin K1 now?” and “how 
might we make vitamin K1 in the future?” The most common process for the 
chemical synthesis of vitamin K1 is reviewed. Past, present and future efforts to 
improve the process are discussed. Alternatives to the chemical synthesis, namely 
biotechnological processes, are presented in light of the precedent for bacterial 
synthesis of vitamin K2. Criteria are proposed for the selection of organisms that are 
rich in vitamin K1, as well as methods for boosting production, processing the 
biomass and extracting the vitamin K1. Finally, the chapter concludes with a 
summary of the key points from this literature review. 
2.1 The vitamins 
The bulk of the food we eat is made up of macronutrients - fats, proteins, 
carbohydrates and fiber.  Our foods also contain micronutrients – the vitamins and 
minerals [31]. While the amounts required are small (much less than one gram per 
day), they are essential dietary ingredients as the human body cannot produce them 
[31]. Vitamins are distinguished by their organic nature (unlike minerals, which are 
inorganic) [31]. Severe vitamin deficiencies are known to cause a range of acute 
diseases such as beriberi, pellagra, scurvy and rickets. Vitamins are usually classified 
as either water or fat-soluble. The water-soluble vitamins include the B group 
vitamins and vitamin C, while the fat-soluble vitamins are A, D, E and K (Table 2.1). 
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Table 2.1: The vitamins and their natural sources, arranged from highest to lowest price. 
Vitamin (common 
chemical form) Rich dietary sources 
Typical 
method of 
production 
Indicative 
price range 
(USD/kg) 
References 
B12 
(cyanocobalamin) 
Livers, meat (red and 
white), dairy, eggs 
Biosynthesis 1,000-10,000 [32], [33] 
K 
(phytonadione) 
Leafy green vegetables, 
plant and animal fats, livers 
Chemical 
synthesis 
1,000-2,000 [33], [34] 
B7 
(biotin) 
Egg yolks, peanuts, livers, 
chicken, yeast, mushrooms 
Chemical 
synthesis 
100-1,000 [32], [33] 
B1 
(thiamin) 
Wholegrains, seeds, 
legumes, nuts, yeast 
Chemical 
synthesis 
10-100 [32], [33] 
B2 
(riboflavin) 
Dairy, wholegrains, egg 
whites, leafy green 
vegetables, meat, yeast, 
livers, kidneys 
Chemical 
synthesis OR 
biosynthesis 
10-100 [32], [33] 
B5 
(pantothenic acid) 
Livers, meat (red and 
white), kidneys, eggs, yeast, 
legumes 
Chemical 
synthesis 
10-100 [32], [33] 
B6 
(pyridoxine) 
Wholegrains, legumes, 
leafy green vegetables, nuts, 
meat (red and white), livers 
Chemical 
synthesis 
10-100 [32], [33] 
B9 
(folic acid) 
Leafy green vegetables, 
legumes, seeds, livers, 
poultry, eggs, cereals, citrus 
fruits 
Chemical 
synthesis 
10-100 [32], [33] 
A 
(retinol) 
Livers, dairy, egg yolks, 
root vegetables, stone fruits, 
leafy green vegetables 
Chemical 
synthesis 
10-100 [33], [35] 
D 
(cholecalciferol) 
None (Vitamin D is 
naturally biosynthesized in 
the human body after sun 
exposure) 
Chemical 
synthesis OR 
extraction from 
waste 
10-100 [33] 
E 
(α-tocopherol) 
Vegetable oils, nuts, leafy 
green vegetables 
Chemical 
synthesis OR 
extraction from 
waste 
10-100 [33], [36] 
B3 
(niacin) 
Meat (red and white), dairy, 
eggs, wholegrains, nuts, 
mushrooms 
Chemical 
synthesis 
1-10 [32], [33] 
C 
(ascorbic acid) 
Berries, citrus fruits, 
tomatoes, kiwifruit 
Chemical 
synthesis OR 
biosynthesis 
1-10 [33], [37] 
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Although vitamins are naturally found in foods, thousands of tons of pure vitamin 
ingredients are made every year (~45,000 tons in 2016) for a variety of applications. 
The biggest category of vitamin use is animal feed, primarily for intensively farmed 
animals such as poultry [38], [39]. In manufactured animal feed, addition or 
fortification with a range of vitamins is normal practice [33]. This is due to the low 
micronutrient levels in raw feed materials, and micronutrient losses due to 
processing and storage. In human health, vitamin ingredients find a much greater 
application in human pharmaceuticals [40], [41], with a smaller fraction in cosmetics. 
Food fortification in the human population occurs only when there is a 
demonstrated severe and widespread deficiency [42]. For example, under Australian 
law, fortification is mandatory in wheat bread flour (vitamins B1, B9 ) and in edible 
oil spreads (vitamin D) [43]. 
Vitamins that cannot be synthesized chemically, due to unfavorable reactions 
in the synthetic pathway or structural complexity, are produced by a 
biotechnological means [44]. Biotechnological processes harness living cells, often 
microorganisms, to produce these chemicals. However, in such a process, the 
product is just one dilute component of a complex “broth” composed of cells, 
metabolites and growth medium. Concentration and purification of a dilute product 
is costly – as a rule-of-thumb, improvements to a biosynthetic process that can 
increase the product concentration ten-fold will enable a ten-fold reduction in 
market price [45]. Occasionally it is economical to extract and purify vitamins from 
food processing waste (as is the case for vitamin E) [44]. Prices for natural vitamins 
vary widely depending upon purity and form, however for close to 100% purity the 
cheapest is usually vitamin C at less than 10 USD/kg, while the most expensive are 
vitamin B12 and vitamin K at more than 1000 USD/kg [33]. 
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The vitamin ingredient market is worth more than USD 5 billion annually [46]–[48]. 
By market value, the main applications for vitamin ingredients are animal feed and 
pharmaceuticals (Figure 2.1). Vitamins A, C and D account for around 50% of all 
vitamin ingredients. As the B group is comprised of 8 different vitamins, its market 
share is more than one-third. Vitamin market growth is strong at around 5% year on 
year; however, the biggest growth in demand is expected for vitamins D, K and 
some B-group. This is driven by their increasing use to improve animal welfare, fight 
chronic disease in the human population, and add value to cosmetic products [48]. 
Market price is strongly influenced by manufacturing cost, which is in turn 
influenced by manufacturing complexity [49]. Vitamin analogs (such as menadione) 
and many vitamins (such as vitamin C) can be made by cheap and simple chemical 
syntheses [44], [50]. Chemically synthesized vitamins usually cost less than 100 
USD/kg. 
 
 
Figure 2.1: Global vitamin ingredient market split by application (a) and type (b) in 2015 [46]–[48]. 
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2.1 Vitamin K 
Vitamin K refers to a family of structurally similar chemical compounds 
characterized by their ability to act as the enzyme cofactor in the γ-carboxylation of 
certain proteins. In humans, vitamin K is essential for the activity of at least 15 
proteins that regulate diverse biochemical processes. Vitamin K has been 
traditionally known for its essential role in the blood coagulation cascade [19]–[21], 
however it is also involved in maintaining bone, preventing arterial hardening, 
protecting the nervous system, and modulating inflammation [51]–[55]. 
Improved bone health has emerged in recent years as an additional benefit of 
increased vitamin K levels. Several cross-sectional studies [56]–[59] and randomized 
controlled trials [60], [61] have found that increased vitamin K intakes reduce the 
risk of bone fracture. Although some research has failed to demonstrate a 
statistically significant benefit [59], [62]–[64], the most recent systematic reviews and 
meta-analyses confirm that increased vitamin K intake reduces the risk of fracture 
[22], [23]. Whether this is due to increased bone mineral density, remodeling or some 
other mechanism is not clear [22], [23], [65], [66]. Other reviews of clinical and cross-
sectional data demonstrate a possible role for vitamin K in preventing arterial 
calcification [24], [25], mitigating inflammatory diseases [25], [26], and preventing 
cognitive decline [27]–[29]. 
More rigorous research in future years will eliminate any remaining 
uncertainty about the health benefits of vitamin K. Most of the available data on the 
health benefits of vitamin K come from cross-sectional studies, which are limited by 
self-reporting, population biases (e.g. age or gender) and inability to prove cause-
and-effect. Of the limited number of randomized controlled trials, many have been 
conducted over short durations with small samples sizes. Addressing these 
limitations will enable conclusive assessment of the health benefits of vitamin K. 
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2.1.1 Chemistry of K vitamers 
Vitamin K is comprised of a 1,4-naphthoquinone group with a methyl group at the 
2-position and an aliphatic side-chain at the 3 position (Figure 2.2(a)). The compound 
known as phylloquinone (vitamin K1) is distinguished by its “phytyl” side-chain 
[67], [68] (Figure 2.2(b)). The compounds known as the menaquinones (vitamin K2) 
consist of the same methylated naphthoquinone group [69], [70] and a 
polyunsaturated isoprenoid side-chain of varying length n [71] as in Figure 2.2(c). 
“Menaquinone-n” is usually abbreviated to MK-n. There are a number of artificial 
structural analogs of vitamin K (Figure 2.3) that exhibit vitamin K activity in vivo 
[72]–[76]. Although menadione and its derivatives are often referred to as vitamin 
K3, they are not natural components of foods and therefore do not strictly meet the 
definition of a vitamin [31]. These compounds become active as vitamin K after the 
in vivo addition of an uncharged side-chain at the 3-position [9], [10], [12], [77], and 
should properly be known as pro-vitamins. 
2.1.2 Physicochemical properties of vitamin K 
The properties of K vitamers and their analogs can be attributed either to the 1,4-
naphthoquinone moiety or the aliphatic side-chain. Generally, the 1,4-
naphthoquinone group enables vitamin K to take different oxidation states, while 
the side-chain length and saturation affects the solubility and reactivity. The 
interplay between these two distinct parts of the molecule is also important, as 
overall effectiveness of the vitamin is determined by bioavailability, transport, 
metabolism and cofactor activity. The 1,4-naphthoquinone moiety is one of a large 
family known more generally as the quinones. The quinones are known to readily 
absorb visible and ultraviolet light, due to the presence of conjugated double bonds 
and carbonyl groups, and thus appear colored [78]. Menadione and the 
menaquinones exist as pale yellow solid crystals at ambient conditions [79], [80], 
while phylloquinone exists as a yellow liquid [81]. The yellow color is due to the 
absorption of ultraviolet and near-UV light by the 1,4-naphthoquinone group [82]. 
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Figure 2.2: Structural diagrams of: (a) generic K vitamers; (b) phylloquinone; and, (c) menaquinone-n (MK-n). 
 
 
 
Figure 2.3: Structural diagrams of: (a) menadione; (b) menadione sodium bisulfite; and, (c) menadione sodium 
diphosphate. 
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Quinones are also well known for their redox cycling capability [78], which accounts 
for their existence in the electron transport chains of a wide variety of organisms 
[83]. The purpose of the electron transport chain is to transfer electrons across 
intracellular membranes, thereby creating the electrochemical gradient required for 
ATP synthesis. Phylloquinone is present in the electron transport chain of 
photosynthetic organisms [84] including plants, algae and cyanobacteria [85], while 
menaquinones are involved in the respiratory chains of many micro-organisms such 
as bacteria and archaea [86]. 
While the naphthoquinone group accounts for the redox cofactor activity of 
vitamin K, the side-chain is also essential for vitamin K activity [9], [10], [12], [77]. 
Possible reasons for this include its effects on redox potential and solubility in 
membranes. Vitamin K is usually found embedded in intracellular membranes, as 
phylloquinone and menaquinones are membrane-bound in both plants and bacteria 
[87], and probably localizes to the membrane of the endoplasmic reticulum in 
humans [88]. Molecules with longer side-chains tend to localize further towards the 
hydrophobic interior of the membrane bilayer, sometimes entirely within the 
midplane region [89], [90]. This could explain why the γ-carboxylase activity of 
menaquinones decreases as the side-chain length increases [10]. The side-chain also 
appears to prevent the generation of reactive oxygen species and depletion of 
glutathione [13], [91], harmful effects that are commonly associated with other 
naphthoquinone species [92] including menadione [13], [15], [17], [93]. The 
widespread belief that the side-chain does not contribute to vitamin K activity 
possibly originates from Henrik Dam’s 1946 Nobel Prize lecture [94].  
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2.2 The requirement for vitamin K 
2.2.1 Physiological functions and roles of vitamin K 
The main function of vitamin K is as an essential cofactor for the enzymatic gamma-
glutamate carboxylation of Vitamin K-Dependent Proteins (VKDPs) as depicted in 
Figure 2.4. The gamma-glutamyl carboxylase enzyme (GGCX) carboxylates the 
glutamate (Glu) residues of VKDPs [9], [95], [96]. The GGCX cofactor activity of 
compounds with vitamin K activity is different for all K vitamers and menadione 
derivatives [10], [12]. The protein-dependent effects of vitamin K are achieved by 
GGCX-mediated protein modification. Gamma-carboxylated glutamate (Gla) 
residues have a much higher calcium binding affinity than singly carboxylated 
glutamate (Glu) residues [97], [98], which is an important characteristic of many 
VKDPs. In fact, gamma-carboxylation is necessary for the normal function of all 
known VKDPs (Table 2.2) [99]–[108]. 
 
 
Figure 2.4: The vitamin K cycle (adapted from [109]). Acronyms: vitamin K hydroquinone (KH2); vitamin K 
epoxide (KO); vitamin K epoxide reductase (VKOR); γ-glutamyl carboxylase (GGCX). 
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Table 2.2: The vitamin K-dependent proteins [54], [55], [110]–[113]. 
Protein Name, Synonyms Known Roles Main Location of Gene Expression 
Factor II, prothrombin Procoagulant Liver 
Factor VII Procoagulant Liver 
Factor X Procoagulant Liver 
Factor IX, Christmas factor Procoagulant Liver 
Protein C Anticoagulant Liver 
Bone Gla Protein (BGP), 
osteocalcin 
Bone development, glucose 
homeostasis 
Bone 
Protein Z Antithrombotic Liver 
Protein S 
Cofactor for protein C, 
neuroprotective 
Liver, cardiovascular, 
reproductive, respiratory, 
nervous, digestive and excretory 
systems 
Matrix Gla protein (MGP) Inhibition of calcification 
Reproductive, cardiovascular 
and excretory systems 
Growth-arrest specific protein 6 
(Gas6) 
Regulation of cell cycle, 
phagocytosis and 
inflammation 
Cardiovascular, reproductive, 
respiratory, nervous, digestive 
and excretory systems 
Trans-membrane Gla protein 1 
(TMG1), Proline-rich Gla protein 1 
Unknown, possibly trans-
membrane signaling 
Nervous, cardiovascular and 
reproductive systems 
Trans-membrane Gla protein 2 
(TMG2), Proline-rich Gla protein 2 
Unknown, possibly trans-
membrane signaling 
Nervous, cardiovascular and 
reproductive systems 
Trans-membrane Gla protein 3 
(TMG3) 
Unknown, possibly trans-
membrane signaling 
Nervous, cardiovascular and 
reproductive systems 
Trans-membrane Gla protein 4 
(TMG4) 
Unknown, possibly trans-
membrane signaling 
Nervous, cardiovascular and 
reproductive systems 
Gla-rich protein (GRP) 
Fibrillogenesis, wound 
healing, strain repair 
Reproductive, cardiovascular 
and respiratory systems 
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The best-known role of vitamin K is in coagulation. Although the relationship 
between vitamin K and clotting proteins has been known since the 1930s [114], it 
was not until the 1970s that the mechanism of vitamin K-dependent activation of the 
prothrombin protein was elucidated. The work of several researchers confirmed that 
the post-translational gamma-carboxylation of prothrombin enhanced its calcium-
binding affinity [97], [115]–[119]. Another 6 vitamin K-dependent plasma proteins 
were isolated and characterized in the late 1970s [120]–[123]. Prothrombin, factor VII, 
factor IX and factor X are essential elements of the blood coagulation cascade, while 
protein C, protein S and protein Z have the ability to inhibit the cascade [112]. 
Probably the most well-known application of vitamin K is in neonatal medicine. 
Newborn babies usually have low vitamin K levels, and 5-10 in every 100,000 
newborn babies suffer from Vitamin K Deficiency Bleeding (VKDB) [124]. This 
deficiency is impossible to detect at the time of birth so Vitamin K1 is routinely given 
to newborn babies, usually by intramuscular injection, to prevent VKDB [125].  
Aside from the role of vitamin K in coagulation, vitamin K also has an 
important role in calcium homeostasis. The vitamin K-dependent proteins 
osteocalcin, Matrix Gla Protein (MGP) and Gla-rich Protein GRP are essential 
regulators of tissue mineralization. Osteocalcin, initially known as Bone Gla Protein 
(BGP) [98], [126], regulates both calcium binding and cellular activity in bone. 
Gamma-carboxylated osteocalcin has a high affinity for calcium, which is greatly 
diminished in un-carboxylated osteocalcin. Osteocalcin has also been shown to 
stimulate the activity of both osteoblasts and osteoclasts; however, this activity is not 
wholly dependent upon carboxylation status [127]. 
While MGP and GRP are also found in bone, they do not appear to bind 
calcium like osteocalcin. Rather, they behave mainly as modulators of calcification. 
This is important because MGP and GRP are found in connective and soft tissues as 
well as bone. Gamma-carboxylated MGP is essential for normal cartilage 
mineralization – insufficiency of MGP will compromise the survival of chondrocytes, 
while undercarboxylation of MGP will lead to uncontrolled calcification of cartilage. 
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The role of GRP is less clear, however it stimulates deposition of aggrecan and 
collagen type II while delaying osteoblast maturation [55]. 
Protein-dependent roles of vitamin K in innate immunity have also been 
discovered. The ability of the Gas6 protein and protein S to bind to the Tyro3, Axl, 
and Mer (TAM) family of transmembrane cell receptors was discovered in the 1990s 
[70]. When Gas6 binds to the extracellular domain of a TAM receptor, the 
intracellular protein kinase domain of the receptor is activated. The protein kinase 
phosphorylates various signaling proteins that modulate the cell’s behavior. 
Changes to the cell’s excretion of cytokines may also lead to changes in the behavior 
of other cells. This mechanism has been shown to induce a wide variety of responses 
including inhibition of inflammatory response [129], [130], stimulation of 
phagocytosis and maturation of natural killer cells [131]. 
The roles of four vitamin K-dependent proteins, the transmembrane Gla 
proteins (TMGs) [132], [133], are yet to be determined. However, TMGs are 
expressed in many different tissues throughout the body including skeletal muscle, 
kidney, lung, liver, heart, brain, pancreas, colon, prostate, trachea, spinal cord, and 
thyroid. Furthermore, TMG extracellular domains include the Gla-residues while 
cytoplasmic domains display similarities with other signal transduction proteins 
[134]. It is therefore likely that the TMGs are involved in signal transduction 
throughout the body. 
There are currently two proteins whose vitamin K-dependence is in doubt. 
Periostin and transforming growth factor-β induced protein (TGFBIp, also known as 
βig-h3 and kerato-epithelin) are closely related proteins with roles primarily in 
creation, maintenance and repair of connective tissues [135]. Their wide distribution 
in the extracellular matrix throughout the body highlights their physiological 
importance, and they have been implicated in a range of diseases, from corneal 
dystrophy to asthma. Their structural similarity with other known VKDPs has seen 
them tentatively categorized as vitamin K-dependent; however, evidence is 
conflicting [136], [137]. 
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Vitamin K can confer benefits independent of its activity as a protein 
carboxylase cofactor. The correlation between vitamin K insufficiency and cognitive 
decline has been widely studied in recent years. This effect is partially attributed to 
the importance of MK-4 in the synthesis of sphingolipids [138] [28]. Sphingolipids 
form more mechanically and chemically stable bilayers than phospholipids, which 
protect the cells of the nervous system. Unfortunately, the mechanism by which 
vitamin K promotes sphingolipid synthesis is not yet known [139]. Research has also 
shown that K vitamers can protect against intracellular oxidative stress in 
developing oligodendrocytes and neurons [140], which can also contribute to 
cognitive decline. 
There are some bone-related effects of vitamin K that are protein independent 
[22]. While the mechanisms are not conclusively known, it appears that vitamin K 
can inhibit the formation of osteoclasts and stimulate the formation of osteoblasts, 
thereby encouraging bone growth. Vitamin K is a known activator of the steroid and 
xenobiotic receptor (SXR), which is involved in both bone creation and resorption, so 
the effect of vitamin K is multi-faceted [141]. 
Finally, there is a putative role for vitamin K in mitochondrial electron 
transport chains. Vitamin K has been shown to rescue electron transport in the 
mitochondria of flies affected by knockout of the pink1 gene, which encodes the 
mitochondrial protein kinase implicated in early-onset Parkinson’s Disease [142]. 
Apart from this study, the potential role of vitamin K in human and animal electron 
transport chains has received little attention, despite the known role of 
naphthoquinones in plant and microorganism electron transport chains. 
 
2.2.2 Dietary intake of vitamin K in humans 
As for all vitamins, ensuring a healthy dietary intake of vitamin K is essential. Leafy 
green vegetables are the richest dietary sources of phylloquinone, while fermented 
foods (e.g. natto) are rich sources of menaquinones (Table 2.3). There is evidence 
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from studies in mice that phylloquinone (which is the primary dietary source of 
vitamin K) is converted into MK-4 [143] by the prenylation of menadione [11]. 
Gastrointestinal bacteria are another possible source of menaquinones, though their 
contribution to total intake remains unknown. Studies of the gastrointestinal tract 
have demonstrated the presence of menaquinone-producing bacteria in the large 
intestine [144]–[146], as well as the absorption of menaquinones in the intestines 
[147]–[151]. The prevailing opinion among medical professionals is therefore that 
gastrointestinal menaquinones are an important source of vitamin K. However, it is 
not clear if the menaquinones of gastrointestinal origin are efficiently absorbed by 
the host, mainly because vitamin K is thought to be poorly absorbed in the large 
intestine compared to the small intestine [146], [150], [152]. The contribution of 
gastrointestinal menaquinones to vitamin K status has been reviewed and is 
generally considered insignificant [153], [154]. 
Guidelines in the US [155], EU [156], and many other regions provide an 
“adequate intake” (AI) figure for phylloquinone, which is approximately 1 µg 
phylloquinone per kg bodyweight per day. These are based upon typical 
population-wide phylloquinone intakes (such as in the US) or the requirement of 
phylloquinone for normal coagulation (such as in the EU). The extremely low 
prevalence of vitamin K deficiency bleeding, which is the only accepted clinical sign 
of vitamin K deficiency, implies that typical intakes are adequate. Nevertheless, 
these guidelines recognize that there is insufficient evidence to publish a “dietary 
reference value” (DRV) for vitamin K intake based upon optimal protein 
carboxylation. Furthermore, the guidelines recognize that there is insufficient 
evidence to determine an AI or DRV for any menaquinones.  
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Table 2.3: Dietary sources of phylloquinone (PK), menaquinone-4 (MK-4) and other menaquinones (MK). 
“n.d.” denotes that no data was available. 
Food 
Vitamin K content (ng g-1) 
References 
PK MK-4 Other MK 
Vegetables     
Wakame (seaweed)  12,930 n.d. n.d. [157] 
Kale  6,180-8,170 n.d. n.d. [34], [158] 
Parsley 3,600-5,480 n.d. n.d. [34], [159] 
Spinach  2,700-5,750 n.d. n.d. [34], [157]–[161] 
Laver (seaweed)  4,130 n.d. n.d. [157] 
Cabbage 1,270-3,390 0-10 n.d. [34], [157] 
Broccoli, boiled  1,100-3,070 n.d. n.d. [34], [157]–[161] 
Brussels sprouts  1,220-2,890 n.d. n.d. [34], [159]–[161] 
Plant oils and fats     
Soybean oil  1,310-2,340 n.d. n.d. [34], [157], [161]–[163] 
Vegetable oil, mixed  1,340-1,640 n.d. 10 (MK-7) [157], [161] 
Rapeseed oil, refined  920-1,500 n.d. 0-30 (MK-7) [34], [157], [161]–[163] 
Margarine  120-1,100 0-3 0-1 
[157], [158], [160]–
[162] 
Olive oil  300-800 0-4 n.d. 
[34], [157], [158], 
[161]–[163] 
Fruits     
Kiwi fruit  343 n.d. n.d. [159] 
Black currant  300 n.d. n.d. [159] 
Avocado  10-200 n.d. n.d. [34], [159], [160] 
Grapes, green  83-190 n.d. n.d. [34], [159]–[161] 
Fermented products    [157], [158], [164], 
[165] 
Natto 200-450 0-10 9,000-12,300 (MK-7)  
Cheese, Jarlsberg  60 84 652 (MK-9 (4H)) [166] 
Cheese, Edam  19 33 442 [167] 
Cheese, Emmental  52 84 269 (MK-9 (4H)) [166] 
Animal products     
Chicken meat  0-20 89-600 0-0.1 
[157], [158], [167]–
[169] 
Chicken liver  0-25 40-141 0-2 [168], [169] 
Egg, whole  3-25 56-250 n.d. [157], [164], [169] 
Egg yolk  7-70 
155-
640 
0-7 [157], [158], [169] 
Egg white  n.d. 4-10 n.d. [157], [158], [169] 
Beef liver  18-58 7-8 73-1148 [167], [168] 
Beef meat  3-7 11-150 0-6 
[157], [158], [167], 
[168] 
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Requirements for vitamin K are strongly influenced by bioavailability, especially 
from plant-based foods. Humans cannot efficiently extract nutrients from plant 
matter [170] as they do not produce the cellulase enzymes required to digest tough 
plant material, nor do they harbor microorganisms that produce these enzymes 
[171]–[173]. The typical plant cell is surrounded by a tough cell wall, comprised of a 
strong cellulose fabric embedded within a cross-linked matrix of hemicelluloses, 
pectins, glycoproteins and, sometimes, lignins [174]. Complex polysaccharides are 
almost impossible to digest due to high resistance to hydrolysis by mammalian 
enzymes [175]. Therefore, only a small fraction of total phylloquinone content is 
extracted from plant foods in the human gut. 
In comparisons of vitamin K preparations, the bioavailability of MK-4 from 
fat was 40-80%, while bioavailability of phylloquinone from boiled spinach was only 
4-18%  [176], [177]. Food preparation methods that improve digestibility may help to 
release vitamin K [178]. Eating organisms with weak or absent cell walls (e.g. 
cyanobacteria) and/or processing of the material to break down the walls (e.g. by 
milling and enzymatic treatment) would also improve bioavailability [170]. 
Problems with the secretion of bile salts or a lack of dietary lipids can also cause a 
reduction in the amount of vitamin K absorbed [149], [176], [179], [180]. In fact, oily 
foods have been shown to approximately double the absorption of phylloquinone 
from plant-based foods [176], [179]. 
2.2.3 Dietary intake of vitamin K in chickens 
Animal nutrition is a 20 billion USD global industry, and vitamin K is extensively 
added to the diets of poultry, swine and companion animals [181]. Despite this, 
Gallus gallus domesticus (the domestic chicken) is the only animal species for which 
vitamin K requirements have been extensively investigated. This research stemmed 
from the discovery in the 1930s of a hemorrhagic disorder in chicks [94], [114], [182], 
[183]. Unsurprisingly, the largest single use of fat-soluble vitamin supplements, 
including vitamin K, is in fortification of chicken feed [184]. 
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Modern manufactured chicken rations typically use menadione derivatives 
such as menadione nicotinamide bisulfite (MNB). Addition of these vitamin K 
analogs stems from research in the 1950s and 60s studying the prevention of vitamin 
K deficiency bleeding in chicks [185]–[190]. This research found that 0.5 mg 
menadione (or equimolar equivalent of menadione derivatives) per kg of finished 
diet was adequate to prevent vitamin K deficiency bleeding. This addition rate 
remains in use today [39]. However, menadione is not a natural ingredient in the 
diet of wild birds and this addition rate does not reflect the normal intake. Prior to 
the adoption of menadione, vitamin K came primarily from cheap leafy crops, such 
as alfalfa, that were included in the feed mix [39]. 
The diets of the Red Jungle Fowl (Gallus gallus) and its domestic cousin (Gallus 
gallus domesticus, aka the chicken) are omnivorous and considerably varied in the 
wild. A study of a feral population of Gallus gallus domesticus on Northwest Island 
off the coast of Gladstone in Queensland, Australia, observed that the birds ate 
leaves, figs, berries, seeds, grass, insects, slugs, isopods, and even the remains of 
other wild birds [191]. A British study attempted to replicate the conditions of these 
observations by releasing domestic fowl into the wild on an Island off the west coast 
of Scotland [192]. They observed that during summer, grass leaves made up over 
80% of the diet with 5-10% made up of invertebrates. In contrast, the lack of grass 
available during the winter forced the birds to eat more roots, stems and leaves. This 
seasonal cycle was observed in chicks as well. 
A more recent, much more detailed study of wild Gallus gallus (Red Jungle 
Fowl) in Malaysia found that the birds commonly ate a range of invertebrates 
(notably ants, termites, beetles, leeches), vertebrates (snakes, other birds) and plants 
(seeds, leaves, oil palm fruit) [193]. From the available diet studies it can be inferred 
that chickens, in the absence of dietary restrictions, will consume vitamin K 
primarily as phylloquinone. A bird eating a wild diet consisting of 20-80% grass or 
leaves with a phylloquinone concentration of 250-500 µg per 100 g, would have a 
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phylloquinone intake of 50-400 mg per kg feed. Plant-eating gastropods such as 
slugs and snails may also be a rich source of phylloquinone for Gallus gallus.  
The vitamin K intake of a natural diet is vastly different to the manufactured 
diet. Not only does a wild diet provide vitamin K mainly as phylloquinone, the 
concentration is at least 4 times higher on a molar basis compared to the menadione 
in manufactured diets. Given that phylloquinone is known to be safer and more 
effective than menadione, it is likely that birds on the wild diet may experience some 
additional health benefits over their domesticated cousins. However, no 
comparisons of natural and manufactured diets were found in the open literature. 
2.3 Production of vitamin K1 
2.1.1 Global vitamin K production 
Vitamin K makes up approximately 5% of the current value of the global vitamin 
ingredients market [47]. This market was worth USD 5.36 billion in 2016 and is 
forecast to reach USD 8.19 billion by 2025 [46]. Animal feed (44%), pharmaceuticals 
(38%) and cosmetics (12%) are the primary end uses [48]. Applications, production 
methods and prices differ for each of the K vitamers and analogs (Table 2.4). The 
vitamin K analogs (salts of menadione bisulfite and menadiol diphosphate) are 
chemically synthesized. They are widely used in livestock and pet food (especially 
for poultry), which is surprising considering that they have been banned from 
human products for more than 50 years. Chemically synthesized vitamin K1 (known 
as phytomenadione or phytonadione) is used for a wide range of human nutrition, 
pharmaceutical and cosmetic products. There is no commercial biosynthetic process 
for vitamin K1. Vitamin K2 may be chemically synthesized or biosynthesized, 
however it is expensive and not widely used. Chemically synthesized MK-4 is 
usually known as menatetrenone rather than menaquinone-4. 
 
 
Table 2.4: Comparison of some commercially available compounds with vitamin K activity [194]–[197]. 
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Compound Primary application Method of production Price range 
(USD/kg) 
Menadione 
sodium bisulfite 
Animal food VK 
replacement 
Reaction of sodium bisulfite salt 
with menadione 
10-20 
Menadiol 
sodium 
diphosphate 
Animal food VK 
replacement 
Reduction and phosphorylation 
of menadione 
50-100 
Phytonadione 
(vitamin K1) 
Human supplements,  
pharmaceuticals & 
infant formula 
Friedel-Crafts alkylation of 
menadione with phytol 
1,000-2,000 
Menatetrenone 
(vitamin K2/MK-
4) 
Human supplements 
Friedel-Crafts alkylation of 
menadione with geranylgeraniol 
2,000-3,000 
Menaquinone-7 
(vitamin K2/MK-
7) 
Human supplements 
Fermentation of plant-based 
substrate using B. subtilis OR 
Friedel-Crafts alkylation 
200,000-300,000 
 
2.3.1 Chemical synthesis of vitamin K1 
For pharmaceutical and food products, a synthetic version of vitamin K1 is 
manufactured by condensing naphthoquinoid and isoprenoid precursors [195], 
[198]. Chemical synthesis begins with menadione, which is itself synthesized by 
oxidation of 2-methylnaphthalene [197]. The most widely known method was 
developed by Roche [199] (Figure 2.5) and entails condensation of menadione with 
isophytol [200]. First, to prevent undesirable reactions during the condensation step, 
the menadione is reduced under acidic conditions and esterified at C1 [201] 
(commonly with benzoate [197]). The condensation of the menadiol monoester with 
phytol is then catalyzed with heat and acid (commonly a Lewis acid such as boron 
trifluoride etherate) [197], [200]. The product is then de-protected by saponification 
(traditionally with potassium hydroxide and methanol [200]) and oxidized (with a 
catalyst such as silver oxide [199] or in air [197]) to form vitamin K1. 
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Figure 2.5: Scheme of industrial synthesis of vitamin K1 [197]. Double arrows denote multiple steps, bold text 
denotes chemical compound, regular text denotes reagents and catalysts. 
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The commercial process for the chemical synthesis of vitamin K1 has remained 
mostly unchanged since it was published in 1939 [68]. This is primarily due to the 
low cost and ready availability of raw materials and reagents. This process has two 
notable drawbacks. The first is that the condensation of menadione with phytol 
results in formation of 10-20% of the inactive Z-isomer [195]. Chemically synthesized 
vitamin K1 is therefore a racemic mixture, and is often referred to as phytonadione or 
phytomenadione. The second drawback is that the catalysts and solvents are 
hazardous to both humans and the environment, necessitating costly treatment [50]. 
Research on chemical synthesis of vitamin K1 has traditionally focused on 
improving the stereoselectivity of the phytylation step, as formation of the inactive 
Z-isomer reduces yields and the activity of the final product. Efforts from the 70s, 
80s and 90s have been reviewed [195], and there has been little research into 
chemical synthesis of vitamin K1 since then. These efforts can be summarized into 
three main categories: (1) condensation of protected naphthoquinone with phytyl 
where one moiety is organometallic (organocuprates, organolithiums or Grignard 
reagents) and the other a halide; (2) condensation of menadione directly with phytyl 
where one moiety is a silane or stannane and the other a halide; (3) condensation of 
menadione or protected naphthoquinone with a short-chain isoprenoid, followed by 
a secondary side-chain alkylation, using methods from category (1) or (2). 
There is limited evidence of successful attempts to reduce or eliminate the use 
of toxic chemicals in vitamin K1 synthesis. The method of Coman et al. (2010) 
employed heterogeneous, nanoscopic metal fluoride catalysts to reduce the amount 
of catalyst required to 1 g per 6.5 g vitamin K1 [198]. A 2016 patent, by Tien et al. of 
Sunny Pharmatec Inc., claims that the replacement of metal catalysts with amines 
can reduce the environmental and health dangers of vitamin K1 synthesis [202]. 
However, the proposed amine catalysts include 4-dimethylaminopyridine (DMAP), 
triethylamine (TEA) and pyridine, which are all hazardous chemicals. Processes 
based on enzymatic reactions are a “greener” alternative, as they are highly selective 
and proceed under mild conditions with reduced consumption of organic solvents 
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and other toxic reagents [50]. Although the biosynthetic pathway of phylloquinone is 
known, enzymatic chemical synthesis of vitamin K1 has not yet been investigated. 
2.3.2 Biosynthesis of vitamin K1 
No biotechnological process for vitamin K1 has been proposed or commercialized, 
however bacterial biosynthesis of vitamin K2 is already a commercial reality [203], 
[204].  Some bacteria of genus Flavobacterium synthesize menaquinones with side-
chains as short as 5 isoprene units (MK-5), while strains of Bacteroides oralis and 
Bacteroides ruminicola produce side-chains of up to 14 isoprene units (MK-14) [205]. 
The production of menaquinones by liquid and solid state fermentation has been 
previously reviewed in detail [196]. The lack of interest in biotechnological 
production of vitamin K1 could be due to the fact that phylloquinone is regarded as 
the least abundant of the terpenoid quinones [206] based on research from higher 
plants. Nevertheless, it is possible that there are higher phylloquinone 
concentrations in other photosynthetic organisms, such as algae. 
Aquatic species are an attractive prospect for biosynthesis of vitamin K as 
many have been reported to have much higher phylloquinone concentrations than 
terrestrial plants. The phylloquinone content of macroalgae (seaweed) varies 
considerably, from 24.4 µg/100g dry mass in kelp [207] to the incredible figure of 
75,000 µg/100g dry matter in Sargassum muticum [208]. The best candidates for 
biosynthesis of phylloquinone are microalgae because they have many industrially 
useful characteristics: high surface area to volume-ratio; high growth rates; diverse 
metabolic pathways; environmental adaptability, and; simplicity of screening and 
genetic manipulation [209]. Reported phylloquinone concentrations in microalgae 
also vary, from undetectable levels in the diatom Chaetoceros calcitrans to 
2,800 µg/100 g in the green microalga Tetraselmis suecica [208]. 
The microalgal production of carotenoids has been successful for over 30 
years, and provides some clues as to how production of phylloquinone might be 
achieved [210]. Carotenoids, such as β-carotene and astaxanthin, are a diverse group 
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of isoprenoids which are produced industrially using halotolerant microalgae [210], 
[211]. Establishment of the industry began with identification of the most carotenoid 
rich species [210]. Growth conditions, including climate and nutrients, were 
optimized to maximize productivity and process robustness. More recently, research 
has aimed to further improve the productivity of these “cellular factories” by genetic 
modifications [212], [213]. 
When formulating a potential biosynthetic process, it is important to 
understand why plants and algae contain vitamin K1 (phylloquinone). As shown in 
Figure 2.6, phylloquinone is intimately associated with the photosynthetic 
apparatus; specifically photosystem I (PSI) [214]. Along with photosystem II (PSII), 
PSI is responsible for harvesting energy from light to facilitate electron transport. It 
is the reducing power of these electrons that enable all photosynthetic processes, 
including carbon fixation and oxygen evolution. Phylloquinone functions primarily 
as an electron acceptor from chlorophyll-a (chl-a) in Photosystem I (PSI) [85], [215], 
[216]. However, phylloquinone can also act as an electron acceptor during the 
formation of protein disulfide bonds in the thylakoid membrane [217], [218]. 
There are many strategies that can be used to increase the productivity of a 
biotechnological system. Selection of a highly productive organism (strain screening) 
is the simplest and usually the first step. Optimization of environmental conditions 
(such as light and nutrition) is more difficult but nevertheless essential for 
maximizing productivity. Metabolic (genetic) engineering is a much more complex 
strategy for increasing productivity. In many jurisdictions, the legal framework 
makes it difficult or impossible to engage in any genetic manipulation of 
microorganisms; however, it can be incredibly effective [219]. 
Strain screening 
The simplest method of achieving a high phylloquinone yield is strain screening. 
The field of likely candidates can be narrowed by understanding phylogenetic 
differences in photosynthesis. Organisms that have a high PSI content can be used as 
a starting point for screening; other desirable traits may include a high growth rate, 
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salt or pH tolerance (favorable for preventing contamination) and a weak cell wall 
(which may be favorable for the extraction of the phylloquinone). 
Light 
Light is widely acknowledged as the most important factor affecting microalgal 
growth [220] and the productivity of an industrial microalgal system [170]. During 
light harvesting, electrons from PSII are transferred to PSI. It is important that the 
flux of electrons from PSII matches the demand from PSI to prevent harmful 
accumulation of reductants [221]. Regulation of this electron flux is primarily 
achieved by changing the amount of PSI or the size of the PSII light harvesting 
antenna [221]. 
 
 
Figure 2.6: Electron transport in photosystem I. Primary inputs and outputs in bold, electron flux in green, 
photon flux in red. Acronyms: Plastocyanin (PC), modified antenna chlorophyll (P700), modified electron 
transport chlorophyll (A0), phylloquinone (A1), iron-sulfur protein complex (Fe4S4), ferredoxin protein (Fd) 
[221]. 
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Photosynthetically Active Radiation (PAR) includes electromagnetic wavelengths 
from 400 to 700 nm (violet to red). The PAR intensity is usually expressed as 
irradiance in W m-2. Total solar irradiance averages 1000 W m-2 at sea level, however 
only around 45% of this is in the wavelength range 400-700 nm, and irradiance 
depends upon atmospheric attenuation and latitude [222]. On average over the year, 
tropical PAR is steady at around 400 W m-2, while it ranges between 0 and 550 W m-2 
with an average less than 200 W m-2 inside the Arctic and Antarctic circles. The 
intensity of photosynthetically active light can also be expressed as the 
Photosynthetic Photon Flux Density (PPFD) in photon µmol m-2 s-1, where 1 W m-2 is 
approximately 4.57 µmol m-2 s-1 [222]. 
At low light intensities (PPFD < 100 µmol m-2 s-1), light-dependent chemical 
reactions (driven mainly by reductants from PSII) are the rate limiting step in 
photosynthesis. An increase in the rate of light-dependent reactions in response to 
higher light intensity necessitates an increase in PSII/PSI ratio [220]. In a long term 
process (hours to days) known as photoacclimation [223], cells will reduce the 
number of PSI to ensure that electron flux is balanced [221]. At very high light 
intensities (typically PPFD 500-1000 µmol m-2 s-1 [220], [223], [224]), PSII functionality 
is impaired and protective pigments are produced to prevent harmful photo-
oxidation [224], [225]. This protective response is accompanied by a decrease in 
photosynthesis, a phenomenon known as photoinhibition. Low light intensity is 
favorable for PSI (and thus phylloquinone) synthesis. 
Plants and algae harvest light at different wavelengths using different 
pigments, so the spectral power distribution also affects the light response in a 
phenomenon known as chromatic adaptation [223]. Cyanobacteria and rhodophytes 
contain light harvesting phycobilins, which are sensitive to spectral intensity 
distribution. Phycocyanin and phycoerythrin harvest in the green-red and blue-
green portions of the visible spectrum, respectively. Shifting the spectral distribution 
towards shorter wavelengths will favor an increase in phycocyanin, while shifting 
toward longer wavelengths will favor phycoerythrin [224]. Of special relevance is 
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the fact that most photosynthetic organisms are sensitive to changes in the red 
portion of the spectrum. Specifically, the PSII red light absorption maximum is at a 
wavelength of approximately 680 nm, while the PSI maximum is at around 700 nm. 
Shifting the spectral distribution towards shorter wavelengths will induce an 
increase in number of PSI during photoacclimation [220], [221], favoring 
phylloquinone synthesis. 
Temperature 
Temperature also has an important role in microalgal growth. Temperatures below 
the optimum reduce the ability of the organism to photosynthesize, and therefore 
induce a response similar to high light [226]. Temperatures above the optimum 
induce a similar response to low light [226]. Generally, a 10 °C increase in 
temperature will double the rate of photosynthesis (though each organism has an 
optimum temperature, above which growth declines) [226]. Furthermore, 
photosynthesis proceeds optimally at a higher temperature and lower light 
compared to cell growth [223], [226]. Data on microalgal species commonly used in 
research and industry reveal that marine microalgae grow fastest between 20 and 25 
°C [227], [228], while freshwater species typically grow fastest between 25 and 35 °C 
[229], [230]. 
Nutrient supply 
Nutrient optimization is another strategy that can be employed to maximize 
productivity of microalgal systems. Photosystem I, which includes phylloquinone, 
ultimately transfers electrons to ferredoxin; reduced ferredoxin in turn drives many 
processes including NADPH generation, nitrate fixation, and fatty acid desaturation 
[221]. The most important nutrients for photosynthesis are nitrogen, phosphorus, 
and iron [170]. Nitrogen is an essential ingredient in all proteins, including 
biosynthetic enzymes, and accounts for 7-10% of algal dry cell weight (DCW). 
Phosphorus is required for many components of the cell, including DNA and 
thylakoid membrane phospholipids, and makes up around 1% of DCW. Iron is 
found only at trace levels in algal cells (0.2-34 mg/g DCW) [231] however it is 
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involved in electron transport and chlorophyll synthesis [231], [232]. Limitation of 
any one of these three nutrients will inhibit photosynthetic activity and growth rate 
[232]–[236] in most algae. Many cyanobacteria are able to overcome nitrogen 
limitation by fixing atmospheric nitrogen [237], however this activity is iron-
dependent [232]. Ample supply of nitrogen, phosphorus and iron are required for an 
optimal yield of phylloquinone. 
Metabolic engineering 
Metabolic engineering could be used to increase the output of the phylloquinone 
biosynthetic pathway. Engineering efforts usually begin by identifying rate-
influencing steps in the synthetic pathway [238]. The biosynthetic pathway of 
phylloquinone, as shown in Figure 2.7, is similar to that of menaquinones in bacteria 
[239] and has recently been reviewed in detail [214]. In this process, synthesis of the 
phytyl side-chain begins with isopentenyl pyrophosphate (IPP) from the 
methylerythritol (MEP) pathway [240]–[242], which is converted to dimethylallyl 
pyrophosphate (DMAPP) by the isopentenyl pyrophosphate isomerase (IPPI) 
enzyme [243]. Production of geranylgeranyl pyrophosphate (GGPP) from 3 IPP 
molecules and DMAPP is achieved in one step by geranylgeranyl pyrophosphate 
synthase (GGPPS) or in two sequential steps by geranyl pyrophosphate synthase 
(GPPS) [243]. Finally, three consecutive double bonds are reduced by geranyl 
pyrophosphate reductase (GGPR) in three sequential steps to yield phytyl 
pyrophosphate (phytyl-PP) [244]. 
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Figure 2.7: The biosynthetic pathway of phylloquinone. Only structures of the key intermediates are shown. 
Double arrows denote multiple steps, bold text denotes chemical compound, regular text denotes biosynthetic 
enzymes. 
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Synthesis of the naphthoquinone backbone begins with chorismate from the 
shikimate pathway in a process analogous to the bacterial process of menaquinone 
synthesis [245]–[247]. Chorismate is converted to o-succinyl-benzoate (OSB) via 
intermediates isochorismate (ISC), 2-succinyl-5-enolpyruvyl-6-hydroxy-3-
cyclohexene-1-carboxylic-acid (SEPHCHC) [248] and 2-succinyl-6-hydroxy-2,4-
cyclohexadiene-1-carboxylate (SHCHC) [249]. The OSB molecule is converted to 1,4-
dihydroxynaphthoate (DHNA) by esterification with coenzyme A (CoA), cyclization 
to produce DHNA-CoA and hydrolysis to remove CoA [250]. The DHNA and 
phytyl-PP are condensed to yield 2-phytyl-1,4-naphthoquinone (PNQ) [246]. The 
PNQ molecule is reduced by NADPH Dehydrogenase C1 (NDC1) [251] and 
methylated [252] to yield phylloquinol, which spontaneously oxidizes to yield 
phylloquinone [251]. 
Gene knockout or overexpression are powerful tools for identifying rate 
influencing genes, however simpler methods such as identifying mutants or 
supplementation with key precursor compounds [238] could also be used to 
determine the rate-limiting steps in the phylloquinone biosynthetic pathway. While 
there is relatively little literature specifically related to phylloquinone, many authors 
have examined genetic modification for the production of similar compounds such 
as ubiquinones [253], [254] and menaquinones [255]. 
Genetic manipulation can increase the synthesis of precursors, divert 
precursors to preferred biosynthetic pathways, prevent expression of genes 
encoding inhibitory enzymes and increase the storage capacity for the target 
compounds. Reviews of the topic suggest that targeting the genes of the biosynthetic 
pathway, especially the committing enzyme gene, is the most reliable method for 
boosting yield [213], [256], [257]. Typical approaches involve increasing the flux 
through the MEP pathway by overexpressing genes such as DXS and also diverting 
chorismate towards quinone pathways by overexpressing genes encoding 
biosynthetic enzymes [253].   
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Tools for the genetic modification of cyanobacteria and algae are not yet as well 
developed as those for other microorganisms (e.g. Escherichia coli or Saccharomyces 
cerevisiae). However, there have been many recent advances in this area (as reviewed 
elsewhere [258]–[260]). Cyanobacteria may be favorable hosts compared to 
eukaryotic species as their (relatively) simpler structure may mean the metabolic 
engineering process is less complex. Indeed, many authors have examined the use of 
engineered cyanobacteria for the production of a range of isoprenoids [256], [261], 
[262]. Metabolic engineering and synthetic biology offer promising approaches to the 
biosynthetic production of phylloquinone. 
2.3.3 Culture systems for microalgae 
In order to produce phylloquinone commercially using microalgae, an efficient 
culture system is required. Microalgal cultures are extremely diffuse, usually less 
than 10 g of solids per liter of liquid, so large culture volumes are required. 
Microalgal culture systems are designed to optimize the availability of light, carbon 
dioxide and dissolved inorganic compounds (such as nitrate and phosphate) that are 
essential for the rapid growth of microalgae. Ponds are simple to construct though 
they achieve very low culture densities (approximately 0.5 g per liter), sub-optimal 
irradiance, and are prone to contamination [263]–[265]. Most of the global supply of 
microalgal biomass is produced in open ponds, however closed Photo-Bioreactors 
(PBRs) are also used [263], [266]. Closed PBRs eliminate the problem of 
contamination, achieve culture densities of 2-10 g per liter, and use land much more 
efficiently. The extra expense of bioreactors is justified if the product is sufficiently 
valuable [263]–[265]. 
There are many types of photo-bioreactors and they are usually distinguished 
by their geometry. Common shapes include flat plate, tubular and bag reactors [263]. 
Reactors can also be distinguished by their mode of mixing, such as stirred, paddle-
wheel or airlift [263]. The most commonly used photobioreactors in industry are the 
bubble column, raceway pond, flat panel and tubular (Figure 2.8) [170], [267]. Each 
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reactor has its advantages and disadvantages, meaning that each is used in specific 
circumstances. Most of the world’s algal biomass is grown in raceway ponds (Figure 
2.8(b)), which are simply long narrow ponds of algae culture mixed by paddle 
wheels [268]. At much less than 1000 USD per cubic meter of culture volume, 
raceways are by far the cheapest reactors on a volumetric basis [269], [270]. 
However, open ponds are inappropriate for many algal species and applications 
where more controlled conditions and/or a high degree of cleanliness is required. 
 
 
Figure 2.8: Diagrams of the most commonly used algal culture bioreactors. The top and/or front views face 
toward the light source. 
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The flat panel (Figure 2.8(c)) and tubular (Figure 2.8(d)) closed photobioreactors are 
the most commonly used types where cleanliness and the highest possible 
volumetric productivities are required [271]. The light path length through the algae 
culture in these reactors is seldom more than 5 cm, which minimizes shading. A flat 
panel reactor consists of a large, rectangular prism enclosing a narrow space [272]. 
The algae culture is grown within this space and mixing is provided by air bubbles, 
which also ensure that appropriate dissolved oxygen and carbon dioxide levels are 
maintained [272]. A tubular photobioreactor consists of tubes that are tens of meters 
long but only around 5 cm in diameter [273]. The algae culture is pumped from a gas 
exchanger through these tube manifold to maximize light exposure, then back to the 
gas exchanger where excess oxygen is removed and carbon dioxide is injected [273]. 
Flat panel and tubular reactors typically cost 5,000 to 10,000 USD per cubic meter of 
reactor volume [270], [273]. 
Bubble column reactors 
Bubble columns (Figure 2.8(a)) are much cheaper and simpler closed alternatives to 
flat panels and tubular reactors [170]. A bubble column consists of a tall, usually 
cylindrical, vessel of 20 to 50 cm in diameter in which the algae is grown [274]. Like 
the flat panel, mixing and gas exchange is provided by air bubbles [274]. The 
simplest bubble column vessels are single-use sterile plastic bags that can be hung 
from a rack or installed in a mesh enclosure [170]. For this reason, bubble columns 
are the best closed reactors when low cost and flexibility of scale are more important 
than volumetric productivity. Nevertheless, the volumetric productivities of bubble 
columns are much closer to flat panel and tubular reactors than raceway ponds 
[275], and there is ample evidence of this from the last 20 years (Table 2.5). Bubble 
columns are therefore the most appropriate closed photobioreactors for the kind of 
prospective research proposed here. 
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Bubble-column reactors are used in many chemical processes, primarily because of 
their excellent heat and mass transfer coefficients, minimal maintenance 
requirement, and low operating cost [274], [290], [291]. The main design 
considerations for bubble column reactors are the column aspect ratio (usually 
height >5 × diameter) and the sparger geometry (perforated plate, ring, arm) [274], 
[290], [291]. It is also important to consider at what gas flow, pressure, and 
temperature the column will be operated [274], [290], [291]. The primary parameters 
used to characterize the hydrodynamic state of the column are superficial gas 
velocity and column diameter, from which the bubble flow regime can be estimated 
[13]–[15]. Bubble flow regime is important because it affects the mixing, heat and 
mass transfer behavior of the system. Gas holdup and bubble size are also important 
for predicting mass transfer based upon the gas-liquid interfacial area [13]–[15]. 
The key considerations in BC-PBRs are slightly different to typical industrial 
BCRs because the bubble flow and column diameter greatly affects the irradiance of 
the algal culture. Specifically, high mixing rates between the walls and centre of the 
column are important to prevent light limitation of the culture, while bubbles can 
also reduce the transmission of light when the source is at an oblique angle to the 
reactor surface [275], [292]. High shear stress due to high air flow rates can also 
damage or destroy algal cells, however the shear tolerance is different for every 
species [27], [28]. On the other hand, gas-liquid mass transfer is just as important in 
bubble column PBRs as in conventional bubble column reactors because oxygen 
build-up and carbon dioxide deficiency can severely limit growth [275], [292]. 
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2.3.4 Recovery of vitamin K1 from biomass 
Break-down or disruption of the cell wall 
The first step in recovery of chemicals from biomass is usually to break down the 
microstructure of the raw material. This is necessary to reduce the particle size and 
to degrade the tough cell wall that surrounds the cells of most photosynthetic 
organisms [170]. The breakdown is most commonly achieved by mechanical 
treatment (grinding and milling), hydrolysis with chemicals (enzymes, acids and 
bases) or with high pressure saturated steam [293]. Other methods that have been 
tested for the disruption of microalgal cell wall include high pressure 
homogenization (HPH), high speed homogenization (HSH), ultrasound, microwave, 
pulsed electric field (PEF) [294]. Due to the instability of phylloquinone in acidic and 
alkaline solutions, digestion using acid or base is not likely to be a viable approach. 
Ultrasound, microwave, PEF and HSH have high specific energy consumption, 
which is a drawback for scale-up [294]. The high temperatures required for 
pressurized saturated steam treatment may not affect the phylloquinone yield [163], 
[295] but they will degrade other valuable bioactive molecules. This processing step 
may be eliminated or simplified by selecting an organism with weak or absent cell 
walls, such as a cyanobacterium [170]. 
Extraction of the intracellular components 
The second step is extraction from the processed biomass. A search of the 
scientific literature and patent databases revealed few examples of industrial 
phylloquinone extraction processes. Patents filed in the 80s and 90s describe the 
extraction of phylloquinone from vegetable oil processing waste (the deodorizing 
distillate fraction) by esterification of fatty acids, followed by anion exchange resin 
separation [296], [297], molecular distillation [297] or solid-phase extraction on 
activated carbon [298]. These methods are useful for concentrating and purifying 
phylloquinone from oily or alcoholic solutions; however they are not designed for 
direct extraction from biomass. 
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It is important that new extraction processes should be designed to be 
sustainable, encompassing ideas from green chemistry including reducing waste 
generation, eliminating hazardous materials and minimizing energy consumption 
[299]. A comparison of “green” extraction solvents reveals that carbon dioxide (CO2) 
has the best combination of properties for extraction of vitamin K – it readily 
dissolves non-polar compounds and is less hazardous than the alternatives [300]. 
The main drawbacks are the technical complexity of the processing equipment and 
the associated cost. The most promising “green” extraction methods are supercritical 
fluid extraction (SFE), pressurized liquid extraction (PLE), microwave-assisted 
extraction (MAE), and ultrasound-assisted extraction (UAE) [301]. Carbon dioxide 
can be used in SFE and PLE methods, making them preferable to microwave and 
ultrasound methods. Methods like SFE and MAE typically utilize organic solvents, 
are difficult to scale up and are, as previously stated, energy inefficient. Pressurized 
carbon dioxide can be used to extract lipophilic compounds from a range of 
biomasses, including plants and algae [301], [302]. 
A good example of CO2-SFE is the recovery of vitamin E (RRR-α-tocopherol) 
from plants and algae. Phylloquinone and RRR-α-tocopherol have similar molecular 
weights, are lipophilic terpenoid compounds found in the chloroplasts of plants 
[303], and both exist as pale yellow viscous liquids at ambient temperature and 
pressure [197], [304]. A number of papers have been published on recovery of 
vitamin E from oil and solid biomass using SC-CO2 [305]–[308] and these methods 
have been shown to work equally well for extraction of vitamin K (unpublished 
data). 
2.4 Summary 
Vitamin K is an essential nutrient involved in a range of physiological processes 
including ensuring proper function of blood coagulation, improving bone density 
and reducing arterial calcification, among others. Of the K vitamers, phylloquinone 
(Vitamin K1) is the most common dietary source for humans and animals such as 
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chickens; additionally it is the only form used therapeutically. Although the benefits 
of K vitamers have been demonstrated in humans, it is unclear what benefits they 
confer in animals, especially in comparison to the industry standard menadione 
derivatives MNB and MDP. It is possible that natural K vitamers may be superior to 
menadione, with important benefits for animal welfare and consumer health. 
Biotechnological production of vitamin K offers several advantages over the 
chemical synthesis: improved stereoselectivity; a ‘natural’ product preferred by 
consumers; the benign synthesis conditions; and, the use of renewable feedstocks. 
Biotechnological processes for menaquinones have been demonstrated, and 
industrial biosynthesis of menaquinones-7 is common. However, no such process 
has been demonstrated for phylloquinone. Phylloquinone is a key part of the 
electron transport chain in photosynthetic organisms. Hence it may be possible to 
produce phylloquinone via extraction from green waste or growth of photosynthetic 
microorganisms. The biotechnological production of phylloquinone offers a 
promising route to reducing the environmental costs of including vitamin K1 in 
supplements and fortified foods. 
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3 The immune benefits of dietary vitamin K for 
chickens: a comparison of supplements 
This chapter investigates the effects of different forms of vitamin K on the avian 
immune system. Some background is provided on the potential effects of vitamin K 
on white blood cells in chickens. The experimental methods for testing the effects of 
menadione, vitamin K1 and vitamin K2 on chicken white blood cells are presented. 
The results from both in vitro and in vivo experiments are discussed. Finally, the key 
points of the chapter are summarized. 
3.1 Background 
Commercial chicken feed is one of the single largest uses of vitamin K supplements. 
Despite evidence of toxicity in humans, menadione derivatives such as MNB are the 
industry standard in commercial chicken feed. Vitamin K is known to beneficially 
modulate the cell-mediated immune response by protein-dependent mechanisms 
[108], [130], [131], while menadione derivatives have been shown to directly 
suppress the inflammatory response [309], [310]. It is possible that menadione 
derivatives are detrimental for the immune system. Numerous papers have 
examined the behavior of menadione in protein thiol oxidation, impairment of 
calcium homeostasis and alteration of cell surface morphology [14]–[16]. This 
sparked interest in the use of menadione derivatives as redox-dependent tumor 
suppressants [311], [312], as they were found to suppress proliferation and up-
regulate apoptosis. 
Commercial chicken flocks are frequently exposed to factors that stress the 
immune system, from climatic and weather conditions (free-range birds) to 
frustration and behavioral restrictions (cage- and barn-raised birds) [313]. During 
these times, vitamin requirements are elevated [7], [8]. Numerous studies have 
observed marked immune responses in stressed birds [314], [315]. The primary 
immune cells found in avian blood are lymphocytes, thrombocytes, monocytes and 
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heterophils [316]. An elevated heterophil to lymphocyte ratio is the most obvious 
indicator of an immune response. Latimer et al. reported that the heterophil count, 
followed by the monocyte count, increased 3-4 times after an inflammatory injury 
[315]. In contrast, lymphocyte counts decreased immediately following the injury. In 
recent years, more specific markers of immune response, such as pro-inflammatory 
cytokines, have been preferred for probing the immune system [309], [310], [317]. 
The immune effects of different K vitamers and menadione derivatives have never 
been compared in the same experiment. Such a comparison could reveal great 
differences in the relative benefits of these supplements. Optimizing vitamin K 
supplementation has the potential to improve flock welfare and reduce the use of 
antibiotics. The aim of this experiment was therefore to examine the effects of 
menadione, phylloquinone and menaquinone-7 on inflammatory response in 
chickens. Specifically, to determine the effects of these compounds upon production 
of pro-inflammatory cytokines IL-1β and IL-6 by the WBCs. 
Flow cytometry offers a quick and powerful method for analysis of cell 
suspensions, including blood samples. It can be used to distinguish between and 
assay characteristics of white blood cells (WBC), the immune cells found in blood. It 
can also be used to assay pro-inflammatory markers (such as the cytokines IL-1β and 
IL-6) using fluorescent staining. A paper published in 2010 by De Boever et al. 
describes a robust method for flow cytometric immunophenotyping of avian WBC 
[317]. Other research, such as in Bohls et al. from 2006 [318], provide additional 
information on flow cytometric analysis of avian leukocytes. 
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3.2 Method and Materials 
3.2.1 Sample size calculation 
The Z-statistic was calculated to test the difference between predicted means and 
standard deviations of the values of the control and test treatments. This test was 
used to determine the number of animals required to observe a statistically 
significant difference between treatments. If we assume that the number of birds in 
each group (n) and the standard deviations of the values in each group (σ) are equal 
then the required number of animals in each group is given by the following 
equation [319]: 
 
 𝑛𝑛 = 2𝜎𝜎2(𝑧𝑧𝛼𝛼/2 + 𝑧𝑧𝛽𝛽)2(𝜇𝜇𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 − 𝜇𝜇𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡.)2  (3.1) 
 
Where α is the false positive (type I error) rate and β is the false negative (type II 
error) rate. The Z-statistic for the type I error (zα/2) is set at 1.96 for a 5% level of 
significance and the Z-statistic for the type II error (zβ) is set at 0.84 at a power level 
of 80%: 
 
 𝑛𝑛 = 2𝜎𝜎2(1.96 + 0.84)2(𝜇𝜇𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 − 𝜇𝜇𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡.)2 = 15.68 � 𝜎𝜎𝜇𝜇𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 − 𝜇𝜇𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡.�2 (3.2) 
 
From Checker et al. [309], we can predict a mean difference in IL-6 concentration of 
over 40% in response to menadione at 1 µmol L-1:  
 
 
𝜇𝜇𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 − 𝜇𝜇𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡.
𝜇𝜇𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡. ≥ 0.4 (3.3) 
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Coefficients of variation were less than 20% in Checker et al. [309]: 
 
 
𝜎𝜎
𝜇𝜇𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡. ≤ 0.2 (3.4) 
 
Substituting equations (3.3) and (3.4) into equation (3.2), we have: 
 
 𝑛𝑛 ≥ 15.68 �0.20.4�2 = 3.92 (3.5) 
 
Therefore at least 4 birds per treatment group are required to observe a significant 
difference in inflammatory response with the control group. Allowing for potential 
attrition, 6 birds were assigned to each treatment group. 
3.2.2 Animals, diet and sample collection 
The project was approved by the University of Sydney Animal Ethics Committee 
(AEC). The project number was 2015/769 (see approval letter in Appendix A). 
Twenty-four Rhode Island Red x Australorp hens were separated into 4 groups 
during the 6-week in vivo diet study. Each group was kept in a separate 
compartment of a large cage for the duration of the experiment. The cage was 
constructed of galvanized mesh (25 mm × 25 mm × 4 mm for the floor and 35 mm × 
35 mm × 4 mm for the walls). Half of the cage walls and the entire roof were covered 
with galvanized roofing sheets. Each compartment was 2 m (h) x 2.4 m (l) x 1.4 m 
(w), and included food and water vessels, a roosting perch, and a nesting box 
containing hay or straw. 
Group 1 (control group) was fed the basal diet (Table 3.1 and Table 3.2), while 
groups 2-4 were fed the basal diet supplemented with equimolar amounts of 
menadione, vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-n). Group 2 
was fed the basal diet supplemented with 2 mg menadione nicotinamide bisulfite 
(MNB, DSM N.V., Heerlen, Netherlands) per kg feed, group 3 was fed the basal diet 
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supplemented with 3.45 mg menaquinone-7 (as MenaQ7 powder, NattoPharma 
ASA, Oslo, Norway) per kg feed, and group 4 was fed the basal diet supplemented 
with 2.40 mg phylloquinone (as Quinaquinone, “QAQ”, Agricure Scientific Organics 
Pty Ltd, Braemar, NSW, Australia) per kg feed. Blood samples were collected after 
the 1st, 2nd, 4th and 6th weeks of the diet study. Blood was taken from the brachial 
artery of birds using hypodermic syringes (SUR-VET®, Terumo Corporation, Tokyo, 
Japan) with 23 gauge needles. Approximately 1 mL was transferred to a blood 
sample tube (Greiner Bio-One International GmbH, Kremsmünster, Austria) 
preloaded with 25 IU of sodium heparin. The anticoagulated whole blood samples 
were maintained at around 23 oC for the 2 hour duration of transport to the 
laboratory. 
 
Table 3.1: Ingredients of complete vegetarian chicken diet. 
Ingredient Fraction (% w/w) 
Ground wheat bulk 60.59 
Soybean meal 10.00 
Calcium carbonate (lime) 9.00 
Wilpromil R soy protein conc. 5.00 
Coconut meal 5.00 
Mill run (wheat husk) bulk 3.00 
Vitamin premix 2.50 
Process water 1.85 
Canola oil - crude 1.50 
Dicalcium phosphate powder 1.50 
Mastercube pellet binder 0.07 
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Table 3.2: Ingredients of vitamin premix. 
Ingredient Fraction (% w/w) 
Mill run (wheat husk) bulk 61.30 
Sodium bicarbonate 9.20 
Sodium chloride 8.00 
Nisso DL-methionine 99% 6.92 
L-lysine HCl 6.28 
Choline chloride 60% 3.33 
L-threonine 1.72 
Nicotinamide 0.99 
Vitamin E 250 IU natural 0.80 
Ferrous sulfate 30% 0.66 
Manganous oxide 62% 0.48 
Oxistat dry antioxidant 0.48 
Zinc oxide 72% 0.30 
Selenium premix 0.5% + ROVIMIX vitamin E50 0.12 
Copper sulfate 25% Cu 0.10 
Calcium pantothenate 98% 0.06 
Vitamin A 1000 IU + vitamin D 3200 IU 0.04 
Riboflavin (B2) 80% 0.03 
Pyridoxine HCl (B6) 0.02 
Potassium iodide 76% fat sol 0.01 
Sodium molybdate 40% 0.01 
Vitamin B12 FG 1% 0.01 
Thiamine mononitrate 0.01 
Folic acid 97% 0.01 
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3.2.3 Flow cytometric sample preparation 
Flow cytometry samples were prepared as per the method of De Boever et al. [317].  
Blood (500 µL) was transferred to a centrifuge tube. In order to trigger an immune 
response, 50 µL LPS (LPS from Escherichia coli 0127:B8, Sigma-Aldrich, St. Louis, MO, 
USA) solution was added to the blood, which was incubated for a further 3 hours. 
Prior to the diet study, an in vitro experiment was performed where the blood 
samples were pre-treated with a solution of each vitamin K compound. Solutions (50 
µL) of menadione (analytical standard, 47775, Sigma-Aldrich), phylloquinone 
(V3501) or menaquinone-7 (analytical standard, ASB-00022822, Chromadex Inc., 
Irvine, CA, USA) in ethanol (for molecular biology, Sigma-Aldrich) were added to 
each sample and the tube placed on a rocker in an incubator for 1 hour at 37oC. The 
control was pure ethanol. The lower treatment concentration for each solution was 
set at 0.01 µmol L-1 because this corresponds to a physiological plasma baseline 
concentration of phylloquinone (4.51 ng/mL) [320]. Ten- and 100-times 
concentrations were also tested.  
Red blood cells (RBC) were lysed by adding 4.5 mL BD FACS Lysing Solution 
(Becton, Dickinson and Company, Franklin Lakes, NJ, USA) to the tube, which was 
incubated at room temperature on a rocker for 10 minutes. The RBC debris was 
removed by centrifugation at 500 RCF and washing with stain buffer – 1% BSA 
(lyophilized powder BioReagent bovine serum albumin, Sigma-Aldrich) in 
RPMI1640 (RPMI1640 without phenol red or L-glutamine, Sigma-Aldrich). The 
pellet was resuspended in 50 µL of CD45 MAb conjugated with R-PE (Mouse anti-
chicken CD45 MAb conjugated with R-phycoerythrin, AbD Serotec, Kidlington, UK ) 
at 50 µg/mL in stain buffer. The pellet was incubated for 30 minutes at 4 °C in the 
dark. After washing, the pellet was resuspended in 500 µL permeabilizing reagent 
(BD FACS Permeabilizing Solution 2, Becton, Dickinson and Company) and 
incubated for 10 minutes at room temperature in the dark. The cells were again 
washed and the pellet resuspended in 50 µL of IL-1β or IL-6 antibody (rabbit anti-
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chicken polyclonal antibody, AbD Serotec) at 50 µg/mL in RPMI, which was 
incubated for 30 minutes at room temperature in the dark.  
After washing, blocking was performed by resuspending the pellet in 500 µL 
of 20% goat serum (Life Technologies, Carlsbad, CA, USA) in stain buffer. This was 
incubated for 30 minutes at room temperature in the dark. The cells were washed 
again and the pellet resuspended in 50 µL of secondary antibody (F(ab')2 fragment of 
goat anti-Rabbit IgG conjugate with CF™488A, Sigma-Aldrich) at 5 µg/mL in stain 
buffer. This was incubated for 30 minutes at 4 °C in the dark. The cells were washed 
in DPBS (without Ca or Mg) then resuspended in 250 µL BD CytoFIX for 10 minutes 
at 4 °C. Finally, the cells were washed twice in DPBS and stored at 4 °C until analysis 
(within 24 hours). Immediately before analysis, the cell suspension was passed 
through a 40 µm filter and vortexed. 
3.2.4 Flow cytometric sample analysis 
A BD Accuri C6 flow cytometer (Becton, Dickinson and Company) was used to 
analyze the samples. Flow rate was set at 13 µL/second and samples were diluted if 
the event count exceeded 2,500 per second. Data acquisition continued until at least 
10,000 CD45+ events were recorded. All values for forward scatter, side scatter and 
fluorescence intensity were output in arbitrary units. These values could be reported 
as peak intensity (H) or time integral of intensity (A) for each cell counted. The 
gating strategy was adapted from the study by De Boever et al. [317]. Debris was 
eliminated by removing all events with a peak forward-scatter value (FSC-H) below 
500,000, as shown in Figure 3.1a. This value is recommended by the Accuri C6 user 
manual [321] and proved to be a good threshold in preliminary studies. 
The CD45 antibody (specific for WBC) was conjugated with the fluorescent 
dye PE so that white blood cell events were gated based on plots of CD45-PE 
fluorescence signal. The histogram of cell count versus CD45-PE signal in Figure 3.1b 
shows the distinction between CD45-negative and CD45-positive cells (debris shown 
in red). The CD45+ and CD45– cells are shown in green and blue, respectively, on the 
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CD45-PE versus SSC plot in Figure 3.1c. The IL-1β and IL-6 antibodies were 
conjugated with the fluorescent dye CF488, and the CD45-PE signal was plotted 
against the IL-CF488 signals (Figure 3.1d). When the WBC contained more of the 
pro-inflammatory cytokines IL-1β or IL-6, the IL-CF488 signal increased and the 
WBC population shifted to the right. 
 
 
Figure 3.1: Gating strategy showing: elimination of cellular debris (a); selection of CD45+ events (b); 
identification of WBC (c), and; observation of IL-1β fluorescence (d). 
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3.2.5 Extracellular cytokine analysis 
Extracellular pro-inflammatory cytokines were analyzed by Cardinal Bioresearch 
Pty. Ltd. (New Farm, QLD, Australia) using ELISA kits purchased from CUSABio 
(CUSABIO TECHNOLOGY LLC, Houston, TX, USA). Chicken IL-1β, (ELISA kit 
CSB-E11230Ch), IL-6 (ELISA kit CSB-E08549Ch) and TNF-α (ELISA kit CSB-
E11231Chken) were assayed. All data were plotted and statistical analysis was 
performed using GraphPad Prism 7 for Windows (GraphPad Software, Inc.). 
3.2.6 Blood vitamin K concentration analysis 
The plasma (0.5 mL) was transferred to a centrifuge tube. Ethanol (1 mL) was then 
added to denature the protein and 3 mL of hexane was added. After shaking for 5 
min, the solution was centrifuged at 3000 RCF for 5 min. The upper layer was 
aspirated and transferred to an amber glass vial. This solution was evaporated to 
dryness under a constant stream of nitrogen. The dried sample was reconstituted in 
1 mL of methanol and sonicated for 10 minutes. The solutions were transferred to 
microvials and capped to await analysis. Analysis of samples was performed using 
an Agilent 1100 series system with fluorometric detection (Santa Clara, CA, USA). 
Flow  was isocratic at a rate of 1 mL/min, injection volume was 50 µL, mobile phase 
was 90% methanol, 10% isopropanol with 1.37 g/L zinc chloride, 0.41 g/L anhydrous 
sodium acetate and 0.30 g/L glacial acetic acid. The column assembly consisted of a 
C18 guard column, C18 analytical column (150 mm x i.d. 4.6 mm) and empty column 
(50 mm x i.d. 4.6 mm) packed with zinc dust (particle size < 63 µm). The zinc 
stationary phase is preferentially oxidized as the mobile phase, including the vitamin 
K, is reduced. Reduced vitamin K (the hydroquinone oxidation state) excited at 243 
nm produced fluorescence that was detected at 430 nm. All data were plotted and 
statistical analysis was performed using GraphPad Prism 7 for Windows (GraphPad 
Software, Inc.). 
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3.3 Results and Discussion 
3.3.1 Effect of vitamin K concentrations on cytokine production in 
vitro 
The concentrations of vitamin K substances necessary to suppress the synthesis of 
pro-inflammatory cytokines were assayed in vitro. Pure solutions of menadione, 
phylloquinone and menaquinone-7 in ethanol were tested. All treatment groups 
were expected to suppress inflammation, and therefore have lower fluorescence 
intensity, compared to the control group. However, no significant difference in 
intensity was observed for any treatment (Figure 3.2). 
 
 
 
Figure 3.2: Median fluorescence intensity of pro-inflammatory cytokine signals for WBC incubated with 
different vitamin K compounds at different concentrations. Values are the mean of 3 repeats, all repeats are 
mean of duplicates and error bars are standard deviation of repeats. 
 
The failure to observe any significant differences between the treatment groups may 
be due to the short incubation time used. It is possible that the WBC need to incubate 
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for longer than 1 hour before the vitamin K substances can take effect. It is also 
highly likely that the carboxylation of the Gas-6 protein, which is responsible for the 
vitamin K-mediated suppression of the innate pro-inflammatory response, cannot 
occur in an isolated blood sample [54], [131]. Furthermore, menadione has been 
shown to suppress cytokine expression at 10 µmol L-1 (4,510 ng/mL) and above [310], 
[311] so concentrations in excess of the physiological norm may be required to 
modulate immune response. 
3.3.2 Effect of different vitamin K substances on cytokine production 
in vivo 
The in vivo assay attempted to determine the effect of dietary supplementation on 
the intra- and extra-cellular pro-inflammatory cytokine concentrations in avian 
blood. Menadione was added as MNB, phylloquinone as QAQ®, and menaquinone-
7 as MenaQ7®. Comparisons of the results between sample time points yielded no 
differences so they are presented here as repeats. Again, no significant difference 
was observed between the supplemented diets and the control diet. Both the 
intracellular cytokine fluorescence (Figure 3.3) and the plasma cytokine 
concentration (Figure 3.4) demonstrate that pro-inflammatory response on all diets 
was broadly the same. Recently published research has revealed that RBCs are a 
large reservoir of cytokines [322], [323]. Removal of the RBC fraction in the sample 
processing step possibly masked the true inflammatory response. 
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Figure 3.3: Fluorescence signal of (a) IL-1β and (b) IL-6 in WBC of birds fed diets supplemented with different 
vitamin K substances. Values are mean of 4 repeats, all repeats mean of 3 biological replicates, error bars are 
standard deviation of repeats. 
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Figure 3.4: Pro-inflammatory extracellular cytokines in plasma of birds fed diets supplemented with different 
vitamin K substances. Values are mean of 4 repeats, all repeats mean of 2 or 3 replicates, error bars are 
standard deviation of repeats. 
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3.3.3 Replication of reference method for flow cytometric 
immunophenotyping 
De Boever et al. used the CD45-PE versus SSC plot to distinguish between the CD45+ 
populations of lymphocytes, thrombocytes, monocytes and heterophils. However, as 
shown in Figure 3.5, only the heterophils could be identified. Consequently only 
aggregate data for all WBC were used in our analysis of intracellular pro-
inflammatory cytokines. It is possible that the inability to distinguish the WBC 
populations is due to the lower resolution of the BD Accuri C6 compared to more 
sophisticated machines, such as the FACSCanto used by De Boever et al. It is also 
likely that excessive cellular debris and un-lyzed erythrocytes contributed to 
increased non-specific binding as well as accounting for a large proportion of the 
recorded events [324]. The primary innate immune cells of avian blood are 
thrombocytes and monocytes [316]. They are more prolific producers of pro-
inflammatory cytokines, as well as being more likely to respond to the vitamin K-
mediated anti-inflammatory mechanism. An inability to distinguish between the 
WBC may be the reason that no differences between treatment groups were 
observed, as discussed later. 
Another relevant difference in our study was the use of CF488A, rather than 
APC, conjugated secondary antibody. The CF488A fluorophore is fluorescein-based 
[325], which means that it has higher spectral overlap with the R-PE. Another 
possible source of error peculiar to the fluorescein-based fluorophores is cytoplasmic 
granule staining of the heterophils [326]. This phenomenon, where the fluorescein 
binds with the granules in the cytoplasm of avian heterophils, may lead to false 
positives and increased background for the IL-1β and IL-6 antibodies.  
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Figure 3.5: Comparison of flow cytometric phenotyping between De Boever et al. [317] (left) and the present 
study (right). Density plot of SSC-A versus FSC-A showing all events (a); density plot of CD45-PE versus 
SSC-A showing CD45+ events and gated WBC populations (b), and; density plot of SSC-A versus FSC-A 
showing only WBC populations (c). 
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However, the staining of heterophil granules was probably insignificant: firstly, the 
CF488A (molar mass ~910 g/mol) is a much larger molecule than fluorescein (molar 
mass 332 g/mol); and secondly, the CF488A fluorophore is minimally charged, 
unlike FITC and other fluorescein-based dyes, which have multiple negative 
charges. A longer incubation period could negate any concerns about granular 
staining, as LPS stimulation has been shown to cause almost complete degranulation 
after 16 hours [326]. 
3.3.4 Vitamin K1 supplementation boosted blood vitamin K 
concentration 
Despite the failure of the diet experiments to demonstrate an anti-inflammatory 
effect of vitamin K substances, there were some interesting and useful observations. 
Supplementation with QAQ produced a much higher blood concentration of 
phylloquinone (almost 20 ng mL-1), compared to other diets (less than 10 ng mL-1), as 
shown in Figure 3.6. Menaquinone-7 was detected only in the blood of the birds 
supplemented with MenaQ7, however the concentration was less than 5 ng mL-1. 
Menadione did not appear in the blood from any diet supplement. These differences 
could be explained by the lower absorption of menaquinone-7 and the higher 
excretion rate of menadione compared to phylloquinone. 
All four diets led to the appearance of some phylloquinone in the blood. This is 
unsurprising as the chicken feed is made with vegetable oils, which are known to 
contain appreciable amounts of phylloquinone [163]. The higher phylloquinone 
concentration in the control diet compared to the MNB and MenaQ7 diets is 
probably due to the intake of grass. Increased serum vitamin K concentrations are 
known to correspond to increased concentrations in tissues such as liver [320], [327], 
[328], so phylloquinone is likely to be the most effective treatment for improving 
vitamin K status. 
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Figure 3.6: Concentration of (a) phylloquinone and (b) menaquinone-7 in blood plasma of birds fed diets 
supplemented with different vitamin K substances. Values are mean of 3 repeats, error bars are S.D. of 
repeats. Blank, QAQ and MenaQ7 compared using Welch’s t-test, * p < 0.05, ** p < 0.01. 
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Research comparing the immune benefits of dietary vitamin K1 and menadione in 
greenlip abalone (Haliotis laevigata) was also published recently [329]. Vitamin K was 
added as K1 (QAQ®) or menadione at 0.5 mg kg-1 to the feed. Hemocyte count and 
phagocytic activity were measured as indicators of immune response. Viscera and 
muscle concentrations of menadione, vitamin K1 and vitamin K2 were measured as 
indicators of vitamin K status. No significant differences in hemocyte count or 
phagocytic activity were observed between the vitamin K1 and menadione 
treatments at an addition rate of at 0.5 mg kg-1. However, visceral and muscle 
vitamin K content in abalone fed vitamin K1 was approximately double the 
concentration compared to those fed menadione. No menadione was detected in the 
viscera or muscle tissue. The effects of vitamin K1 on tissue vitamin K concentrations 
were also tested at addition rates of 0, 1.0 and 5.0 mg kg-1. The visceral vitamin K1 
concentration was approximately proportional to the vitamin K1 feed rate. These 
results support the conclusion that, although it is difficult to detect immune benefits 
due to vitamin K1, it is still the best form for boosting vitamin K status. 
3.4 Summary 
The effect of three different K vitamers (menadione, phylloquinone and 
menaquinone-7) on the inflammatory response of avian white blood cells was 
examined. No difference in pro-inflammatory cytokine levels was observed between 
the control and the three test groups; such results suggest that further work is 
needed to examine the mechanism by which vitamin K has an anti-inflammatory 
effect. Alternatively, a large observational study examining the effect of different 
vitamin K supplements on avian health and other metrics (e.g. egg production) may 
also be a useful approach. This study observed that supplementation of the diet with 
phylloquinone led to a significant increase in blood concentrations of phylloquinone. 
Such results suggest that future work should focus on the development of a vitamin 
K1 product for incorporation into chicken feed.  
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4 Identification of a microalga for production of 
vitamin K1 
This chapter presents original research into microorganisms that could potentially be 
used to produce vitamin K1. Some background is provided on organisms that are 
already known to contain high levels of vitamin K1. Microalgae are identified as a 
suitable category of microorganisms and some examples of existing microalgal 
bioprocesses are given. Methods are specified for the analysis of vitamin K1 content 
of different microalgal species, as well as for nutrition and toxicity testing. The 
results, identifying and characterizing an ideal microorganism, are discussed. 
Finally, the key points of the research presented in this chapter are summarized. 
4.1 Background 
Vitamin K1 (phylloquinone) is found in a wide range of photosynthetic organisms 
including terrestrial plants [157], [330], [331], seaweed [157], [208] and microalgae 
[206], [208], [246], [332]. However, concentrations are highly variable [157], [208] and 
some photoautotrophs contain no vitamin K1 whatsoever [86], [333], [334]. For the 
biosynthesis of vitamin K1, microalgae may be favored over other photosynthetic 
organisms due to their higher growth rates, relative ease of screening, and genetic 
simplicity [209]. In comparison to the current chemical process, microalgal 
biosynthesis uses no organic solvents, requires little energy, and operates at ambient 
temperatures and pressures. Additional advantages of the biosynthesis are the fact 
that it only produces the active E-isomer of phylloquinone [195], [197], [199] and if a 
photoautotrophic process is used the primary feedstocks are light and CO2. While 
there are no specific examples for the biotechnological production of phylloquinone, 
microalgae have been widely used for producing a range of compounds including 
carotenoid pigments [210], [264], [335]. Hence the aim of this chapter was to identify 
a suitable microalgal strain for biotechnological production of vitamin K1. 
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4.2 Method and Materials 
4.2.1 Flask cultures 
Seven commonly used microalgal strains representing various phyla (summarized in 
Table 4.1) were grown in flasks and screened for phylloquinone content. All strains 
were obtained from the Australian National Algal Culture Collection (ANACC). 
Modified ASM-1 medium (MLA) was prepared as per Bolch and Blackburn [336], 
however B vitamins and selenium were omitted as they are not required by most 
strains [337], [338]. Guillard’s and Ryther’s f medium [339] was prepared at half 
strength (f/2) as per the ANACC modification [340]. A commercially available 
marine salts mixture was added at 35 g L-1 to the f/2 medium. Cultures were 
maintained in 50 mL Erlenmeyer flasks on a light pad at room temperature and 
passaged under aseptic conditions every 2-4 weeks. 
To prepare experimental cultures, fresh medium (100 mL) was added to 250 
mL Erlenmeyer flasks, then autoclaved and allowed to cool for 24 hours. The flasks 
were inoculated with 10 mL of culture in the exponential growth phase. The algae 
were grown on a LED light pad of 6000 K color temperature, with a 12-hour light to 
12-hour dark cycle. 
 
Table 4.1: Strains tested for phylloquinone content. 
Phylum 
(common name) Species 
ANACC 
Strain Growth medium 
Cyanobacteria 
(blue-green algae) 
Spirulina sp. CS-785 50% MLA + 50% f/2 
Anabaena cylindrica CS-172 MLA 
    
Chlorophyta 
(green algae) 
Chlorella vulgaris CS-41 MLA 
Desmodesmus asymmetricus CS-905 MLA 
Dunaliella salina CS-265 f/2 
    
Ochrophyta 
Nannochloropsis oculata CS-192 f/2 
Phaeodactylum tricornutum CS-29 f/2 
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A Walz ULM-500 series light meter equipped with a US-SQS/L spherical sensor was 
used to measure the light intensity at 9 points over the light pad (corners, midpoints 
of each side, and center point), and the mean Photosynthetic Photon Flux Density 
(PPFD) was 70 ± 10 µmol m-2 s-1. The optical density of the culture was measured 
daily. After two weeks, the remaining culture was harvested for vitamin K1 analysis. 
Cultures were grown in triplicate; each replicate was analyzed once and the mean 
was calculated. Experiments were performed twice (n = 2). 
4.2.2 Extraction and analysis of phylloquinone 
Sample preparation was based upon the method of Breuer et al [341]. Culture (50 
mL) was centrifuged (3000 RCF for 5 minutes), and the supernatant discarded. The 
residue was resuspended in deionized water, centrifuged and the supernatant 
discarded. This step was performed twice for strains grown in f/2 medium to ensure 
complete removal of the salts. The residue remaining after washing and 
centrifugation was freeze-dried. Approximately 10 mg of dry powder was weighed 
into a 1.8 mL bead-beater tube, pre-loaded with 0.5 mm diameter zirconia beads. 
Menaquinone-4 (Sigma-Aldrich) was prepared at 10 µg mL-1 in n-hexane and 
100 µL was added to each tube as an internal standard. Chromatography grade n-
hexane was added to the tube (1.0 mL), which was subsequently beaten at 4000 rpm 
for 1 minute, followed by centrifugation and transfer of the supernatant to an amber 
glass vial. This step was performed three times such that the total volume of n-
hexane extract in the amber vial was 3 mL. The n-hexane extract was diluted 10 
times in mobile phase and syringe filtered (PTFE filter, 0.45 µm pore size) before 
analysis using HPLC. 
Sample analysis was performed based upon the Association of Official 
Analytical Chemists (AOAC) method 999.15 [342] using a Shimadzu Prominence-i 
HPLC system. The mobile phase consisted of  1.37 g L-1 anhydrous zinc chloride (LR 
grade, Chem-Supply, Gillman, SA, Australia), 0.41 g L-1 anhydrous sodium acetate 
(AR grade, Sigma-Aldrich, St. Louis, MO, USA) and 0.30 g L-1 glacial acetic acid (AR 
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grade, Merck) dissolved in a solution of 90% (v/v) methanol and 10% (v/v) 
dichloromethane (both LiChrosolv for liquid chromatography, Merck). 
The flow rate was 0.3 mL min-1 with a sample injection volume of 10 µL. The 
column assembly was maintained at 40 °C and consisted of three parts: C18 guard 
column (YMC-Guardpack ODS-AM, particle size 3 µm, pore size 120 Å, ID 4.0 mm × 
10 mm); C18 analytical column (YMC-Pack ODS-AM, particle size 3 µm, pore size 120 
Å, ID 2.0 mm × 150 mm), and; reducing column (YMC original empty column, ID 4.6 
mm × 30 mm) packed with zinc dust (EMPLURA®, particle size < 63 µm). 
Fluorometric detection (FLD) of the reduced phylloquinone and menaquinone-4 was 
achieved using a Shimadzu RF-20Axs detector with excitation wavelength at 243 nm, 
emission wavelength at 430 nm and flow-cell temperature set to 37 °C. The retention 
times were approximately 5.8 minutes and 7.8 minutes for menaquinone-4 and 
phylloquinone, respectively (Figure 4.1).  
To confirm the HPLC-FLD result of A. cylindrica, LC-ACPI-MS/MS analysis 
was performed based upon the method of Suhara et al. [343] using an Agilent 1100 
HPLC system and a Bruker AmaZon SL with atmospheric-pressure chemical 
ionization (APCI). The mobile phase consisted of 9:1 methanol:2-propanol (both 
LiChrosolv grade for liquid chromatography, Merck). The flow rate was 0.3 mL min-1 
with a sample injection volume of 50 µL. The analytical column (Sunfire C18 
column, particle size 3.5 µm, pore size 100 Å, ID 2.1 mm × L 100 mm) was 
maintained at 25 °C. The APCI source temperature was 400 °C and the corona 
current was 5 µA. The scan range was 150-1000 m/z and all data were collected in 
positive ion mode. The precursor ion (m/z = 451.33) and product ion (m/z = 187.03) 
match the values found by Suhara et al. [343], corresponding to protonated 
phylloquinone and 2,3-dimethyl-1,4-naphthoquinone, respectively (Figure 4.2). The 
extract from A. cylindrica had the same retention time and mass-to-charge spectrum 
as the analytical standard (Figure 4.1), which confirmed beyond reasonable doubt 
that the compound from A. cylindrica was phylloquinone. 
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Figure 4.1: Chromatograms from fluorometric analysis of: (a) phylloquinone and menaquinone-4 standards; 
(b) hexane extract of A. cylindrica, spiked with MK-4. 
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Figure 4.2: Mass-to-charge spectra from (a) an analytical standard and (b) a hexane extract of A. cylindrica. 
Dashed line indicates precursor ion, solid line indicates product ion. 
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4.2.3 Nutritional panel analysis 
The cyanobacterium A. cylindrica was grown in a 50 L bubble-column PBR, with 2× 
MLA medium concentration at a constant temperature of 28 °C. Illumination was 
provided by LED lights of 6000 K color temperature and PPFD of approximately 300 
µmol m-2 s-1 on a 12 hour:12 hour light:dark cycle. The culture was harvested at a 
density of approximately 0.8 g L-1 DCW, and dewatered using a WVO Raw Power 
centrifuge with power booster (WVO Designs, North Charleston, SC USA) running 
at maximum speed. The resultant slurry of approximately 100 g L-1 DCW was 
transferred to a sealed container, packed in ice and shipped overnight to the 
National Measurement Institute Food Analysis Laboratory (Port Melbourne, VIC 
Australia).  Proximates, amino acids, fatty acids, vitamins (β-carotene, thiamin, 
riboflavin, niacin, pantothenic acid, pyridoxine, folate, cobalamin, ergocalciferol, α-
tocopherol, phylloquinone and biotin) and minerals (calcium, iron, magnesium, 
potassium, sodium and zinc) were analyzed. 
4.2.4 Animal study 
The cyanobacterium A. cylindrica has not been used for food and is not Generally 
Recognized as Safe (GRAS). As many cyanobacteria are known to produce potent 
toxins (cyanotoxins) [344], an animal bioassay was used to demonstrate safety and a 
lack of cyanotoxins. The AOAC Official Method 959.08 for paralytic shellfish 
poisoning [345] has been used to determine the food safety of novel cyanobacterial 
species [346], however the method only tests for water soluble toxins. Here, the 
AOAC method has been adapted to administer whole biomass by the oral route, 
rather than a water soluble extract by the intraperitoneal route. Most cyanotoxins 
produce biological effects after a matter of hours at concentrations in the range of 
several hundred µg per kg bodyweight [344], [347]. 
Intracellular cyanotoxin concentrations are usually in the order of several 
thousand µg per g dry mass [348], which means that 1 g dry mass per kg 
bodyweight should produce a severe, acute response within one day. A 20 g mouse 
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will consume approximately 4 g of food per day, which equates to 200 g dry mass of 
food per kg bodyweight per day. To ensure that all diets would elicit a response in 
the event that A. cylindrica was acutely toxic, ten times the calculated toxic dose (10 g 
dry mass per kg bodyweight per day) was set as the minimum daily intake. This 
equated to a 5% (10/200) addition rate. On the other hand, feed studies have shown 
that non-toxic algae have detrimental effects at addition rates above 10-20% [349]–
[351], so the inclusion rates of 10% and 15% were tested in order to estimate the 
detrimental addition rate. 
Animal experiments were approved by the University of Sydney Animal 
Ethics Committee under protocol 2017/1243 (see approval letter in Appendix B). 
Twelve female mice of strain C57BL/6JAusb (Australian BioResources, Moss Vale, 
NSW Australia) were divided into 4 cages (3 mice per cage) at 8 weeks of age. The 
mice were coded with an ID number (#1, #2 and #3) for each diet group (control, 5%, 
10% and 15%).  Feeding of the experimental diets was begun at 10 weeks of age. The 
diets incorporated 0% (control), 5%, 10% and 15% A. cylindrica respectively. Every 
morning for 7 days, food residue from the previous day was removed and replaced 
with fresh food. Approximately 20 g of each diet was weighed onto a petri dish and 
placed in the bottom of the cage. The mice were also weighed daily. 
The diet base was supplied as a powder (SF14-156, Specialty Feeds, Glen 
Forrest, WA Australia; see Appendix C), to which the freeze-dried A. cylindrica was 
added. The powder-algae mix was autoclaved with a 15 minute sterilization (121 °C 
and 1.1 bar) and 30 minute vacuum-drying (−0.9 bar) cycle. The autoclaved diets 
were mixed with water (5 parts diet to 2 parts water by mass) to make a dough 
mixture. The dough was rolled into ~20 g balls and stored at −30°C until needed. 
Frozen dough balls were thawed over night at 4°C before use. 
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4.2.5 Animal blood biochemistry and tissue histopathology 
After 7 days, the mice were anesthetized with isoflurane and blood was taken by 
cardiac puncture. The mice were then euthanized by cervical dislocation and the 
brain, heart, lungs, kidneys, liver, and spleen were harvested. Blood samples were 
centrifuged at 10,000 RCF for 10 minutes. The serum was transferred to a clean 1.5 
mL tube and frozen at −80 °C until time of analysis. Organs were fixed in neutral 
buffered formalin solution (cat. # HT5012, Sigma-Aldrich) and refrigerated at 4 °C 
for approximately 24 hours. Organs were then transferred to 70% ethanol solution 
and refrigerated at 4 °C until the time of tissue processing.  
Serum biochemistry was analyzed by Veterinary Pathology Diagnostic 
Services (VPDS, University of Sydney, NSW Australia). Serum biochemistry tests 
included: serum total protein, albumin and globulins for general liver, kidney and 
immune function; aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT) for hepatocyte integrity; alkaline phosphatase (ALP) and γ-glutamyl 
transpeptidase (GGT) for cholestatic function, and; urea and creatinine for kidney 
function [352]. 
Tissue histology was performed by the histology department at the 
Westmead Institute for Medical Research (Westmead, NSW Australia). After 
processing, embedding and sectioning, the specimens were stained with 
hematoxylin and eosin. Tissues were examined from n = 3 mice. The tissues 
examined included heart, kidney, lung liver, spleen, and stomach. The slides were 
scanned at high resolution (40 × objective) using an Aperio ScanScope CS slide 
scanner (Aperio, Vista, CA, USA). 
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4.3 Results and Discussion 
4.3.1 Strain screening 
The concentrations of phylloquinone showed great variability, from undetectable 
levels in P. tricornutum to around 200 µg g-1 in A. cylindrica on a dry weight basis (as 
shown in Figure 4.3). Fresh parsley, which is known to be a rich dietary source of 
phylloquinone [34], [159], was analyzed for comparison. The value plotted for 
parsley in Figure 4.3 is the mean of our wet-weight value (7.6 µg g-1) and previously 
reported values (3.6 µg g-1 [159] and 5.5 µg g-1 [34]), where dry weight was 
determined to be 15% of the wet weight. The concentration of phylloquinone in A. 
cylindrica is almost six times higher than the 37 µg g-1 found in parsley. The 
concentration of phylloquinone found in A. cylindrica is higher than any previously 
recorded dietary source of phylloquinone [34], [157]–[161], as well as the other 
species of microalgae examined. A. cylindrica is therefore the most promising strain 
for the biotechnological production of phylloquinone. 
The cyanobacteria tested here were observed to have higher concentrations of 
phylloquinone than strains from the other phyla. As previously discussed, the role of 
phylloquinone in these organisms is electron transport in photosystem I. While it is 
well known that the ratio of PSII/PSI in photosynthetic organisms is highly variable 
[353], generally speaking cyanobacteria have a much higher relative concentration 
(PSII/PSI < 0.5) of PSI compared to terrestrial plants and other eukaryotic 
photoautotrophs (PSII/PSI > 2) [353], [354]. This may explain our observations 
regarding the phylloquinone content of the species examined. No phylloquinone 
was detected in the diatom P. tricornutum; previous studies have shown that some 
species of diatom from genus Chaetoceros also do not contain phylloquinone [208], 
[355]. Overall the results from this screening analysis indicate that cyanobacteria, 
particularly A. cylindrica, have the highest potential for production of phylloquinone. 
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Figure 4.3: Phylloquinone concentrations determined for some common microalgae. Phylloquinone was not 
detected in P. tricornutum so no value is shown. 
 
4.3.2 Nutritional analysis 
The nutritional data for A. cylindrica were provided by NMI in reports RN1190636 
and RN1193054 (see Appendix D). The values were reported on an “as-received” 
(wet-weight) basis and subsequently converted to a dry-weight basis. Typical 
nutrient values for Spirulina, taken from the USDA food database [356], are also 
reported here for the purpose of comparison. The proximate analysis revealed that 
A. cylindrica is primarily composed of protein with appreciable amounts of 
carbohydrates and fiber (Table 4.2). The quantity of fat is extremely low (3.5%) so the 
fatty acid profile is not reproduced here. 
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Table 4.2: Proximate analysis of A. cylindrica. 
Proximate 
Dry mass fraction % (w/w ) 
A. cylindrica Spirulina [356] 
Protein 68.6 57.5 
Carbohydrates 11.6 23.9 
Total dietary fiber 10.5 3.6 
Ash 5.8 6.2 
Fat 3.5 7.7 
 
 
Table 4.3: Amino acid profile of A. cylindrica. 
Amino acid 
Concentration in dry mass (mg g-1) 
A. cylindrica Spirulina [356] 
Glutamic acid 88.4 83.9 
Aspartic acid 81.4 57.9 
Leucine 60.5 49.5 
Alanine 55.8 45.2 
Arginine 48.8 41.5 
Threonine 45.3 29.7 
Glycine 41.9 31.0 
Serine 39.5 30.0 
Valine 38.4 35.1 
Tyrosine 34.9 25.8 
Isoleucine 33.7 32.1 
Phenylalanine 30.2 27.8 
Proline 24.4 23.8 
Lysine 17.4 30.3 
Methionine 14.0 11.5 
Histidine 11.2 10.9 
Tryptophan 7.4 9.3 
Cysteine 3.6 6.6 
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Generally speaking, the Kjeldahl method and adjustment factor used to determine 
the protein content overestimates the true protein content by around 10% in 
microalgae [170]. Nevertheless, this means that around two-thirds of the dry mass of 
A. cylindrica is composed of protein. Approximately half of the protein content is 
composed the amino acids glutamic acid, aspartic acid, leucine, alanine and arginine 
(Table 4.3). Compared to the FAO/WHO/UNU reference pattern for essential amino 
acids, A. cylindrica exceeds the amino acids content for all but lysine (Table 4.4), and 
is therefore a good quality protein source. The calculated Essential Amino Acid 
Index (EAAI) [357] is 1.58, which is much higher than the reference pattern. 
However, the commonly used Protein Digestibility Corrected Amino Acid Score 
(PDCAAS) [358], [359] only considers the limiting amino acid (in this case lysine). 
Assuming a digestibility of 80% [360], A. cylindrica has a PDCAAS of 0.46, which is 
far below the reference score of 1.00. 
The concentrations of the most nutritionally relevant minerals, as well as 
some vitamins, are shown in Table 4.5. The mineral content of microalgae usually 
reflects the concentration in the growth medium, which explains why Spirulina 
(grown in brackish, alkaline water) is almost five times higher in sodium than A. 
cylindrica. Nevertheless, 10 grams of A. cylindrica grown in 2× concentration MLA 
medium contains almost 600 µg g-1 of iron. This is around 33% of the adult female 
iron requirement, according to the Australian guidelines [361]. The vitamin content 
of microalgae is less influenced by medium mineral content. Ten grams of A. 
cylindrica contains more than 30% of the adult iron requirement, 118% of the adult 
vitamin A requirement (as β-carotene), 640% of the adult vitamin B12 requirement 
and 3300% of the adult vitamin K1 requirement [361]. 
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Table 4.4: Indispensable Amino Acid (IAA) profile of A. cylindrica versus the FAO/WHO/UNU adult 
reference pattern [355]. 
Amino acid Reference Pattern A. cylindrica Ratio 
Leucine 55 89.3 1.62 
Lysine 45 25.8 0.57 
Valine 39 56.7 1.45 
Phenylalanine + Tyrosine 38 96.2 2.53 
Isoleucine 30 49.8 1.66 
Threonine 23 67.0 2.91 
Methionine + Cysteine 22 25.9 1.18 
Histidine 15 16.5 1.10 
Tryptophan 6 11.0 1.83 
  
 
Table 4.5: Vitamin & mineral analysis of A. cylindrica. 
Micronutrient 
Concentration in dry mass  (µg g-1) 
A. cylindrica Spirulina [356] 
Minerals   
Potassium 9,530 13,630 
Magnesium 3,840 1,950 
Calcium 3,140 1,200 
Sodium 2,330 10,480 
Iron 593 285 
Zinc 16.3 20.0 
Vitamins   
Β-carotene 1,279 1,400 
Phylloquinone (K1) 233 0.3 
Riboflavin (B2) 11.6 36.7 
Thiamine (B1) 5.8 23.8 
Cobalamin (B12) 1.5 6.6 
Biotin 0.18 - 
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4.3.3 Animal study 
The mass of the mice on each diet increased by 1-2% over the course of the 
experiment (Figure 4.4). No significant differences were found between initial mass, 
final mass or mass change when comparing test groups to the control group using 
unpaired t-tests (all p ≫ 0.05). Blood biochemistry values for alkaline phosphatase 
(ALP) (Figure 4.6), alanine aminotransferase (ALT), aspartate aminotransferase 
(AST) (Figure 4.7), total protein, albumin, globulin (Figure 4.5), creatinine and urea 
(Figure 4.8) were within the normal ranges for female C57BL6 mice at around 2 
months of age [362]–[365]. Values for γ-glutamyl transpeptidase (GGT) (Figure 4.6) 
were lower than the reference values [363], however this is not cause for alarm as 
only elevated levels are associated with liver or kidney disease [366]. Data for each 
biochemical marker were analyzed by Kruskal-Wallis one-way ANOVA on ranks 
and Dunn’s post test. No significant difference was observed between any test group 
and the control group. 
 
Figure 4.4: Mass of mice on each diet at day 0 (initial) and day 7 (final). Values are mean, error bars are SD. 
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Figure 4.5: Albumin and globulins protein concentration in plasma (indicators of general liver, kidney and 
immune function) taken from mice on four different diets. 
 
 
Figure 4.6: Alkaline phosphatase (ALP) and γ-glutamyl transferase (GGT) enzyme activity in plasma 
(indicators of cholestatic function) taken from mice on four different diets. 
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Figure 4.7: Aspartate transaminase (AST) and alanine transaminase (ALT) enzyme activity in plasma 
(indicators of hepatocyte integrity) taken from mice on four different diets. 
 
 
Figure 4.8: Urea and creatinine concentration in plasma (indicators of kidney function) taken from mice on 
four different diets. 
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Figure 4.9: Histological micrographs of organs from mice fed control, 5% algae, 10% algae and 15% algae diets. 
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Figure 4.10: Histological micrographs of organ tissues from mice fed control, 5% algae, 10% algae and 15% 
algae diets. 
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Histopathological examination revealed no abnormalities in diet-fed mouse tissues. 
Representative slides from each tissue and diet group are presented for whole organ 
(Figure 4.9) and cellular (Figure 4.10) analyses. In the hearts, there was no evidence 
of cardiomyopathy or abnormal cardiac muscle tissue in any group. In the kidneys, 
there were no abnormalities in the renal capsule or in the renal cortex, and cell 
structures appear normal in all groups. In the lungs, alveoli appear normal in all 
groups. In the liver, there were no signs of liver damage or toxicity, and cell 
appearance is normal in all groups. In the spleen, no change in white/red matter and 
no overall enlargement of the spleen were observed in any group. In the stomach, no 
signs of damage to the villi of the stomach lining were observed. Notably, there are 
regions of imperfect histology thus there may be small ulcerations that remain 
undetected. However, based on the n = 3 sections which contain the majority of the 
stomach this was deemed to be unlikely. 
 Due to the acute toxicity of very low concentrations (parts per million) of 
cyanotoxins, even the mice on the 5% algae diet probably would have experienced 
toxic effects after only one day. It is unlikely that the diet processing and preparation 
method eliminated these toxins prior to feeding, as neither freeze-drying [367], [368] 
nor boiling [369]–[372] have been demonstrated to eliminate cyanotoxins. There 
were no differences in weight gain, blood biochemistry and tissue histology between 
the treatment and control groups. Therefore, these results demonstrate the absence 
of cyanotoxins in this strain of A. cylindrica beyond reasonable doubt. Both whole cell 
and cell extracts could potentially be used in human and animal health products. 
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4.4 Summary 
The aim of this Chapter was to identify a suitable species of microalgae for the 
biotechnological production of phylloquinone. A range of microalgal strains were 
screened for phylloquinone content. The cyanobacterium A. cylindrica (ANACC 
strain CS-172) was identified as an extremely rich source of phylloquinone at 200 µg 
g-1 on a dry mass basis, which is approximately three times the Australian guideline 
for adult daily intake and six times higher than rich dietary sources such as parsley. 
Further detailed analysis of the biomass composition revealed that this strain was 
also a rich source of protein, iron and vitamin B12.  
One potential concern with the use of cyanobacteria in food products is the 
presence of cyanotoxins. To evaluate this, a preliminary study was performed using 
nine mice fed diets supplemented with A. cylindrica. No signs of acute toxicity were 
observed in any of the mice examined. Demonstrating the safety of the whole 
biomass is important because it means that purified extracts would also be safe. 
A. cylindrica is a suitable organism for biotechnological production of 
phylloquinone. The biomass of A. cylindrica may also be used directly as a nutritional 
supplement. These results demonstrate the promise of whole-cell and cell-extract 
products from A. cylindrica for human and animal health products. Chapters 5 and 6 
will focus on optimal culture conditions for A. cylindrica to maximize phylloquinone 
productivity as well as process scale-up. 
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5 Optimizing nutrient supply for production of 
vitamin K1  
In this chapter, original research is presented on the optimization of nutrient supply 
to A. cylindrica for the purpose of maximizing vitamin K1 productivity. Some 
background information is provided on the key nutrients influencing microalgal 
growth. Methods are specified for the analysis of vitamin K1 productivity in A. 
cylindrica. The results of the analyses are discussed in light of the key nutrients 
identified in the background. The optimal nutrient parameters are determined on the 
basis of main and interaction effects. Finally, the key points from the chapter are 
summarized and ideas for subsequent work are proposed. 
5.1 Background 
Microalgae are traditionally grown photoautotrophically – they use light to produce 
energy storage chemicals that power their metabolism and growth. Both the 
intensity and spectral distribution of light affect the uptake of nutrients and the rate 
at which metabolic processes occur [170]. Changes in light intensity and spectral 
distribution also induce specific metabolic and structural responses [220]. Therefore 
light is usually the most important input to the photoautotrophic microalgal 
biosynthesis of chemicals. Other limiting nutrients are usually carbon (primarily 
from the carbon dioxide-carbonate buffer system), nitrogen (from a variety of 
sources including atmospheric nitrogen, nitrates, ammonium and urea) and 
phosphorus (primarily as phosphate salts) [170]. Hence the aim of this chapter was 
to identify the influence of nutrient levels on the biotechnological production of 
phylloquinone using A. cylindrica. This is information is essential for maximizing the 
volumetric productivity of the culture vessel, which is normally the limiting step in 
microalgal biotechnological processes [170]. 
The primary role of phylloquinone is to transfer electrons from modified 
chlorophyll-a to the iron-sulfur complexes in photosystem I (PSI) [85], [216]. A role 
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has also been demonstrated for phylloquinone in the formation of protein disulfide 
bonds in the thylakoid lumen [218], [373]. Nevertheless, phylloquinone synthesis is 
primarily linked to PSI synthesis [246], [252], [374], [375]. There are exactly two 
phylloquinone molecules in every PSI [85], [216], so phylloquinone synthesis is 
proportional to PSI synthesis. The main controller of PSI number is light: decreasing 
the light intensity and/or shifting the spectrum towards blue wavelengths induces 
PSI synthesis [376]–[379]. In cyanobacteria, the de novo synthesis of chlorophyll is 
directed mainly towards PSI [380], [381]. This process appears to be regulated by 
possibly the most important gene in PSI biogenesis, pmgA [221], [376], [382]. 
Spectrophotometric analysis of cyanobacterial cultures has been used to probe 
changes in the PSI-related chlorophyll concentration in response to light intensity 
[383]. 
As PSI numbers cannot increase infinitely [354], [384], de novo synthesis of 
phylloquinone will occur mainly in new cells. Maximizing biomass growth is 
therefore also very important for phylloquinone production. Nitrogen and 
phosphorus are most frequently identified as the elemental nutrients that limit 
microalgal growth [235], [236], [385]. Besides carbon, they are the most abundant 
elements in microalgal cells at around 5-10% and 0.5-1% of dry mass, respectively 
[170]. Unlike carbon, which comes from atmospheric CO2, nitrogen and phosphorus 
are usually required in the medium. 
Nitrogen uptake and utilization is complicated, as photosynthetic organisms 
have the ability to degrade proteins and redistribute amino acids during nitrogen 
limitation [386], [387]. Although there is evidence that PSI is retained while PSII is 
degraded during nitrogen limitation [386], [388], ample nitrogen is required to 
maximize rate of photosynthesis [387]. Furthermore, utilization of nitrogen from the 
medium [389], [390] or atmosphere [237], [391] is governed by various feedback 
mechanisms from photosynthesis. Nitrogen utilization rate is also linked to carbon 
fixation rate [392]. The level of nitrogen in the medium would likely have significant 
effects on growth rate and interactions with light intensity. 
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Phosphorus is required at only 5-10% of the molar concentration of nitrogen 
[391], [393], [394]. However, phosphorus is an indispensable input to all cellular 
processes, including photosynthesis and carbon fixation. During photosynthesis, 
phosphate is incorporated into adenosine triphosphate (ATP) and nicotinamide 
adenine dinucleotide phosphate (NADPH) [221]. During carbon fixation, the energy 
released by dephosphorylation of ATP and oxidation of NADPH is used to convert 
CO2 into simple sugars [395]. The molecules ATP and NADPH are used to power 
nitrogen uptake [237], [389], [390], [396]. Phosphorus is also an essential element of 
DNA and phospholipids membranes [397]. Phosphorus level in the medium should 
also greatly impact the growth behavior. 
Light, nitrogen and phosphorous supply have been identified as the nutrients 
that are most likely to impact phylloquinone productivity. From a practical 
perspective, intensity is the best aspect of light to vary as frequency and duration are 
normally dependent upon day:night cycles. In most microalgal culture media, 
nitrogen is supplied as nitrate and phosphorus as phosphate. Hence, the effects of 
light intensity, nitrate concentration and phosphate concentration were selected for 
testing. 
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5.2 Method and materials 
5.2.1 Photo-bioreactor cultures 
The effect of light intensity, nitrate and phosphate concentrations on phylloquinone 
productivity were investigated in A. cylindrica. The cyanobacterium was grown in 
custom-made flat panel PBRs, adapted from a design used previously [398] and 
constructed from clear acrylic sheet as shown in Figure 5.1. Deionized water, MLA 
nutrient concentrate and inoculum were added such that the liquid volume was 5 L, 
medium concentration was 1 × MLA, and the initial optical density (at a wavelength 
of 550 nm) was approximately 0.1. Sodium nitrate and/or dipotassium hydrogen 
phosphate were added at 10 × concentration in some experiments (see Table 5.1 for 
details). Light was provided by two or four cool white (6000 K) LED linkable 
aluminium strip lights (Jaycar). The light intensity was measured at 9 points across 
the front face of the reactor (Figure 5.2) and the mean PPFD was approximately 170 
µmol m-2 s-2 for two strip-lights (1 × light) and 330 µmol m-2 s-2 for four strip-lights (2 
× light). Measurements of light intensity were made with the PBRs full of water but 
without aeration. 
 
Table 5.1: Medium ingredients and concentrations used in this experiment. 
Ingredient 
Concentration (mg L-1) 
Normal 10 × N 10 × P 10 × N, 10 × P 
NaNO3 170 1700 170 1700 
MgSO4.7H2O 49.2 49.2 49.2 49.2 
K2HPO4 34.8 34.8 348 348 
CaCl2.2H2O 29.4 29.4 29.4 29.4 
NaHCO3 16.8 16.8 16.8 16.8 
H3BO3 2.40 2.40 2.40 2.40 
Na2EDTA 4.56 4.56 4.56 4.56 
FeCl3.6H2O 1.58 1.58 1.58 1.58 
MnCl2.4H2O 0.360 0.360 0.360 0.360 
ZnSO4.7H2O 0.022 0.022 0.022 0.022 
CoCl2.6H2O 0.010 0.010 0.010 0.010 
CuSO4.5H2O 0.010 0.010 0.010 0.010 
Na2MoO4.2H2O 0.006 0.006 0.006 0.006 
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Figure 5.1: Schematic of the flat-panel PBR apparatus. 
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Figure 5.2: Light intensity distribution measured across the face opposite to the strip-lights. Tanks were filled 
with water but no air flow was supplied. Horizontal lines are the geometric means of the respective quadratic 
fits. 
 
The temperature was regulated by 23 °C water passing through a 6 mm diameter U-
shaped stainless-steel tube with an approximate surface area of 0.02 m2. Air enriched 
with 1% CO2 (food-grade, Coregas, Yennora, NSW, Australia) was introduced into 
the base of the PBR at 1 vvm (5 L min-1) from a perforated, 150 mm-long, 6 mm 
diameter stainless-steel tube. Flow rates for both air and carbon dioxide were 
measured using RM series rotameters (Dwyer Instruments, Michigan City, IN). The 
optical density of the culture was measured daily. Minimum and maximum 
temperatures were measured daily using an inside/outside digital thermometer 
(Jaycar Electronics, Rydalmere, NSW, Australia). The pH was measured daily using 
MColorpHast™ pH test strips (Merck KGaA, Darmstadt, Germany). Samples were 
retained for Dry Cell Weight (DCW) and vitamin K1 analysis. The total volume of 
medium was kept constant by the addition of deionized water into the PBR before 
sampling.  Samples were retained for vitamin K1 concentration and DCW analysis.  
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All photo-bioreactor experiments were performed 3 times (i.e. n = 3) to ensure 
reproducibility. Extraction and analysis of phylloquinone was conducted as per the 
method in Chapter 4. Sample preparation was based upon the method of Breuer et al 
[341], while the analysis method was adapted from AOAC method 999.15 [342]. 
5.2.2 Biomass growth analysis 
Optical density of all cultures was measured by absorbance at 550 nm for estimation 
of biomass, as recommended by Myers et al. [399], using a Varian Cary 50 UV-vis 
spectrophotometer. Absorbance in the red portion of the spectrum was also 
measured as a potential proxy for phylloquinone content: 680 nm (typical algal red-
absorption maximum [400]); 664 nm (chlorphyll-a absorption maximum [401]); and, 
647 nm (chlorophyll-b absorption maximum [401]). The initial A550 was 
approximately 0.1 in all experiments. The method used to determine DCW was 
based upon that of Zhu and Lee [402]. Quantitative-grade glass filter papers (GA-55, 
Advantec Toyo Roshi Kaisha Ltd., Tokyo, Japan), were placed on a watch-glass and 
weighed using an analytical balance. Samples of culture of known volume (10-50 
mL) were vacuum filtered through the filter papers and washed with 100 mL of 0.5 
M ammonium bicarbonate solution. The filter papers were returned to the watch 
glass and dried overnight at 105 °C, allowed to cool in a desiccator, then weighed 
again. The DCW was calculated as the difference in final and initial weights divided 
by the volume of filtered culture. 
5.2.3 Statistical analyses 
Productivity metrics were determined for each of the 24 PBR test runs (8 test 
conditions, 3 repeats for each condition). These included specific growth rate (µ), 
DCW productivity, mean specific phylloquinone content and phylloquinone 
volumetric productivity. Statistical analyses were performed using GraphPad Prism 
7 for Windows (GraphPad Software, Inc., La Jolla, CA, USA). Linear regression of 
the A550 and DCW results pooled from all 24 samples (184 data points) revealed a 
strong positive correlation (Figure 5.3, R2 = 0.97). Values of A550, which exhibited less 
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variation than values of DCW, were therefore used to calculate the specific growth 
rates (µ) over days 2-7 according to the exponential growth equation: 
 
 Specific growth rate, µ = 𝑙𝑙𝑛𝑛 �𝑋𝑋𝑡𝑡𝑋𝑋0�
𝑡𝑡
 (5.1) 
 
DCW productivity was determined from the slope of the linear fit of DCW versus 
time over days 2-10: 
 
 Biomass productivity = 𝐷𝐷𝐷𝐷𝐷𝐷
𝑡𝑡
 (5.2) 
 
Phylloquinone productivity was determined from the slope of the linear fit of DCW 
× phylloquinone concentration versus time over days 2-10: 
 
 Phylloquinone productivity = 𝐷𝐷𝐷𝐷𝐷𝐷 × [𝑃𝑃𝑃𝑃]
𝑡𝑡
 (5.3) 
 
Three-way analysis of variance (ANOVA) was run on values of µ, biomass 
productivity, phylloquinone concentration and phylloquinone productivity to 
examine the effect of light intensity, nitrate and phosphate concentration.  
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5.3 Results and discussion 
5.3.1 Correlations between absorbance, DCW and phylloquinone 
specific concentration 
Spectrophotometric analysis is known to be useful for rapid estimation of 
parameters such as chlorophyll content [403], DCW and more [399]. Dry cell weight 
(DCW) was plotted against A550, and a strong correlation found; DCW was 
approximately equal to 4 × A550. Based upon the strong relationship between DCW 
and A550 (Figure 5.3, R2 = 0.971), A550 is an appropriate proxy for DCW in the 
calculation of growth rate. 
 
 
 
Figure 5.3: Dry Cell Weight (DCW) versus light Absorbance at 550 nm (A550) for all samples collected during 
the course of the experiment. 
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Figure 5.4: Phylloquinone specific concentration (based on dry mass) versus time of day. 
 
 
Figure 5.5: Correlation of chlorophyll-a absorbance (A664) with specific phylloquinone concentration. 
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Prior to any calculation of correlations with phylloquinone, the phylloquinone 
specific concentration was plotted against time of day (Figure 5.4). No linear 
correlation was observed (R2 = 0.029), so the time of sampling did not affect the 
results. This is consistent with the fact that PSI numbers change slowly over a period 
of days in the process of photoacclimation [223], [384], [404]. The variation in specific 
phylloquinone concentration therefore cannot be attributed to time of day effects. 
Absorbance of light at 647, 664 and 680 nm (normalized by the absorbance at 
550 nm due to cell density) was plotted against specific phylloquinone 
concentration. The ratio A664/A550 had the strongest linear relationship (Figure 5.5, R2 
= 0.834), followed by A647/A550 (R2 = 0.822). The linear fit of A680/A550 (R2 = 0.578) was 
poor. These results suggest that chlorophyll-a absorbance is a good proxy for 
phylloquinone concentration. In this case, phylloquinone specific concentration 
increased 103 µg g-1 for every 0.1 unit increase in A664/A550. 
5.3.2 General trends in growth and phylloquinone productivity 
The exponential growth phase and specific growth rates were determined from the 
data plotted in Figure 5.6. The slope (~0.5 d-1), exponential growth phase (days 2-7) 
and linear growth phase (days 7-10) are especially clear in Figure 5.6b. The biomass 
productivity was determined from the data plotted in Figure 5.7. The day-on-day 
increase in DCW is clearly greater with 2 × light intensity (Figure 5.7b), though the 
effects of nitrate and phosphate are not so obvious. The phylloquinone volumetric 
productivity was determined from the data plotted in Figure 5.8. The effects of the 
nutrients are obvious, where 10 × nitrate is associated with the greatest day-on-day 
increase in both 1 × and 2 × light cases. 
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Figure 5.6: Log of culture density versus time for 1× lights (a) and 2× lights (b). 
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Figure 5.7: Dry cell weight versus time for 1× lights (a) and 2× lights (b); and phylloquinone titers versus time 
for 1× lights (e) and 2× lights (f). 
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Figure 5.8: Phylloquinone titers versus time for 1× lights (a) and 2× lights (b). 
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5.3.3 Optimal conditions 
The effects of light intensity, nitrate and phosphate concentrations on growth and 
phylloquinone productivity in A. cylindrica are summarized in Table 5.2. No 
significant three-way interaction effects were observed. Generally, increased light 
intensity was correlated with faster growth rate and lower phylloquinone specific 
concentration. Increased nitrate concentration was correlated with higher 
phylloquinone specific concentration. Overall, increased light intensity and nitrate 
concentration were correlated with increased biomass and phylloquinone 
productivity. 
The highest growth rate (0.56 d-1) and phylloquinone productivity (22 µg L-1 
d-1) were at 2 × light (PPFD 330 µmol m-2 s-1), 10 × nitrate and 1 × phosphate. The 
specific growth rates observed here were in the range 0.4 - 0.6 day-1, which is typical 
for cyanobacteria at room temperature [405]–[407]. Biomass productivity was in the 
range 0.05 – 0.1 g L-1 d-1, such values being comparable with previously reported 
values for the batch culture of cyanobacteria [407]. 
 
Table 5.2: Summary of test conditions and results for the effect of light, nitrate and phosphate on 
phylloquinone productivity in 5 L PBR cultures. Aggregate daily mean (S.D.) values for pH and temperature: 
pH 7.14 (0.65); minimum temperature 22.2 °C (0.75 °C); maximum temperature 23.7 °C (0.67 °C). Optimum 
values highlighted in bold. 
PPFD 
(µmol m-2 
s-1) 
NaNO3 
(mg L-1) 
K2HP
O4 
(mg L-
1) 
Specific growth 
rate, µ (d-1) 
DCW at day 
10 (g L-1) 
Productivity 
(µg L-1 d-1) 
Titer at day 
10 (µg L-1) 
170 170 34.8 0.44 (0.02) 0.34 (0.01) 4.9 (1.5) 34 (1.4) 
170 170 348.0 0.39 (0.07) 0.46 (0.01) 5.7 (1.1) 41 (8.1) 
170 1,700 34.8 0.45 (0.06) 0.39 (0.08) 15.0 (2.9) 95 (3.3) 
170 1,700 348.0 0.44 (0.01) 0.33 (0.00) 12.1 (3.9) 68 (5.6) 
330 170 34.8 0.52 (0.07) 0.56 (0.06) 5.0 (0.4) 47 (6.2) 
330 170 348.0 0.52 (0.02) 0.61 (0.13) 11.8 (2.9) 101 (34.2) 
330 1,700 34.8 0.56 (0.03) 0.65 (0.05) 22.0 (2.8) 161 (35.9) 
330 1,700 348.0 0.44 (0.06) 0.73 (0.00) 16.0 (2.6) 129 (26.4) 
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5.3.4 Light intensity 
The 3-way ANOVA of specific growth rates showed a significant main effect of light 
intensity (F(1, 16) = 15.04, p = 0.0013). The mean growth rate for 1 × light (i.e. an 
intensity of 170 µmol m-2 s-2 ) was 0.43 day-1 while for 2 × light (an intensity of 330 
µmol m-2 s-2 ) it was 0.51 day-1, indicating that the 1 × light cultures were mildly light-
limited during the exponential growth phase (as shown in Figure 5.6). Such results 
are in line with the literature, where cyanobacteria were reported to generally grow 
fastest at light intensities > 200 µmol.m-2.s-1 [406], [408]. 
There was a significant main effect of light intensity on DCW (F(1, 16) = 266.8, 
p < 0.0001). Values for DCW productivity at 2 × light (mean 0.103 g L-1 d-1) were 
approximately double those at 1 × light (mean 0.052 g L-1 d-1). These results support 
the conclusion that light was the growth limiting factor in these experiments. 
Interestingly, it was observed that increased light intensity led to a decrease in the 
specific phylloquinone concentration (Figure 5.11). We hypothesize that this is due 
to a reduction in the PSI/PSII ratio with increased light intensity [220], [376]. Both the 
phylloquinone titer and productivity were observed to be significantly greater at 
higher light intensity, with the increase in cell growth more than compensating for 
the reduced concentration of phylloquinone.  
5.3.5 Nitrate Concentration 
The 3-way ANOVA of phylloquinone concentration showed that there was a 
significant main effect of nitrate concentration, F(1, 16) = 40.15, p < 0.0001. As shown 
in Figure 5.11, the addition of nitrate to the medium had a significant effect on the 
mean specific phylloquinone concentration (134 µg g-1 for 1× nitrate and 180 µg g-1 
for 10 × nitrate). Volumetric productivity (Figure 5.12) also showed a significant 
interaction (F(1, 16) = 83.73, p < 0.0001), which can be explained by the increase in the 
specific phylloquinone concentration as the DCW (Figure 5.10) and specific growth 
rate (Figure 5.9) were comparable for experiments with both low and high levels of 
Chapter 5: Optimizing nutrient supply for production of vitamin K1 
117 
 
nitrate. PSI is required for the photoreduction of nitrate and nitrite, and is therefore 
involved in the utilization of nitrate [389], [390], [409]–[411]. Nitrogen is an essential 
and often limiting ingredient for synthesis of proteins [387] in both PSI [221], [386], 
[387] and the phylloquinone biosynthetic pathway [412], [413]. It is possible that 
increased nitrogen leads to increased protein synthesis. Alternatively, it could be 
that nitrogen limitation is occurring in the 1 × nitrate cultures, and that this is 
limiting PSI and phylloquinone concentrations. It may be that both of these 
phenomena contribute to increased specific phylloquinone concentrations. 
5.3.6 Phosphate concentration 
Addition of phosphate to the medium did not lead to significant increases in the 
DCW productivity (Figure 5.10) or phylloquinone concentration (Figure 5.11). There 
was a significant two-way interaction of nitrate and phosphate on phylloquinone 
volumetric productivity (F(1,16) = 16.18, P = 0.0010). Addition of phosphate led to a 
decrease in the mean volumetric productivity from 18.48 µg L-1 d-1 (for medium with 
10 × nitrate and 1 × phosphate) to 8.76 µg L-1 d-1 (for medium with 1 × nitrate 10 × 
phosphate). 
Optimal atomic N:P ratios from the literature can range from 7:1 to 45:1 based 
upon genetic differences and growth stage, with a typical value being 15:1 [393], 
[414]. The standard ratio in 1 × MLA is 10:1 with 2 mmol L-1 nitrogen (28 mg L-1) and 
0.2 mmol L-1 phosphorus (6.2 mg L-1). Although lower than average, a N:P ratio of 
10:1 has been found to favor cyanobacterial growth [391], [393]. In freshwater, 
typical growth limiting values of phosphorus are 0.1 mg L-1 (5 µmol L-1) or less [394], 
[415], and increasing the N:P ratio does not appear to negatively affect growth when 
phosphorus is adequate [394]. However, addition of large amounts of phosphorus 
alone at low N:P ratios does not improve the growth rate [236], [385], [394], and may 
even be inhibitory [281]. 
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Figure 5.9: Plot showing specific growth rates versus light intensity for the different growth media used. 
Reported results are averages while error bars denote one standard deviation about the mean (n = 3). 
 
 
Figure 5.10: Plot showing DCW productivities versus light intensity for the different growth media used. 
Reported results are averages while error bars denote one standard deviation about the mean (n = 3). 
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Figure 5.11: Plot showing mean specific phylloquinone concentrations over 10-days versus light intensity for 
the different growth media used. Reported results are averages while error bars denote one standard 
deviation about the mean (n = 3). 
 
Figure 5.12: Plot showing phylloquinone productivities versus light intensity for the different growth media 
used. Reported results are averages while error bars denote one standard deviation about the mean (n = 3). 
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5.4 Conclusions 
The aim of this work was to determine the effect of key nutrient levels on the 
biotechnological production of phylloquinone by A. cylindrica. The effects of light, 
and the concentrations of nitrogen and phosphorus, were examined. These variables 
were chosen because they are widely regarded as the most important for PSI 
synthesis and microalgal growth.  
 Generally, specific phylloquinone concentration increased with lower light 
and higher nitrate concentration. It was not correlated with time of day, though it 
was correlated with chlorophyll absorbance at 647 and 664 nm. Phylloquinone titer 
was most strongly influenced by biomass DCW. Biomass DCW was strongly 
correlated with absorbance at 550 nm. Furthermore, biomass productivity could be 
increased by boosting the nitrate concentration and light intensity. By increasing the 
nitrate concentration ten times and doubling the light intensity, it was possible to 
increase the phylloquinone productivity and final titer fourfold, to 22 µg L-1 day-1 
and 161 µg L-1 respectively. On the other hand, increased phosphate concentration 
did not improve the phylloquinone productivity. 
 In addition to determining the effects of different levels of light, nitrate and 
phosphate, spectrophotometric indices were established for the rapid analysis of 
DCW and phylloquinone specific concentration. The DCW was proportional to A550, 
while the specific phylloquinone concentration showed a linear relationship with 
A664/A550. Direct spectrophotometric analysis of the culture can be used to simply and 
rapidly estimate productivity metrics. 
The ability to manipulate the biomass productivity and phylloquinone 
content of A. cylindrica by nutrient variation was successfully achieved. Such results 
demonstrate the potential for biotechnological production of phylloquinone from A. 
cylindrica grown in closed PBRs; future work will focus on both process optimization 
and scale-up. 
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6 Scale-up of Anabaena cylindrica culture in 
photo-bioreactors for vitamin K1 production 
This chapter presents original research on the scale-up of vitamin K1 production 
using A. cylindrica; from the 5 L reactors in the previous chapter to 50 L. A 
comprehensive background on scale-up in bubble column PBRs is provided and the 
most important operating parameters are identified. Methods are given for the 
analysis of the performance of the 50 L PBR and the productivity of vitamin K1. The 
results are discussed in light of the parameters tested. Finally, the key points and 
conclusions of the chapter are summarized. 
6.1 Background 
In order to produce any microalgal product at an industrial scale, the culture system 
must be carefully designed to maximize productivity while minimizing capital and 
operating costs. Key reactor design criteria for maximal productivity include high 
surface to volume ratio, low oxygen accumulation, good mixing, consistent 
temperature, adequate supply of CO2, resistance to contamination, and ease of 
cleaning [170]. Industrial culture systems are generally known as Photo-Bioreactors 
(PBR), however the term PBR is used mainly to refer to closed systems rather than 
open ponds or raceways [170]. Bubble column PBRs are a promising class of culture 
systems as their areal and volumetric productivities are much better than ponds or 
raceways, and similar to flat-panel or tubular designs [275]. They are also estimated 
to be cheaper to build and operate than most other closed PBR designs [275]. 
The column of rising bubbles in bubble column PBRs can simultaneously 
remove excess oxygen and supply CO2; these characteristics are largely independent 
of scale. However, achieving a high surface-to-volume ratio, maximizing mixing and 
minimizing cost of construction in large-scale systems requires a trade-off. Larger 
columns generally have a lower reactor cost per volume [275]; however, increasing 
the column diameter is known to reduce productivity due to increased light 
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limitation near the center of the reactor. The rate of growth is strongly influenced by 
the rate at which photosynthesis can proceed, which is in turn dependent upon the 
intensity of light. For example, it has been shown that the productivity of Chlorella 
sp. declines from 87 mg L-1 h-1 in a 16 mm diameter tube, to 51 mg L-1 h-1 in a 50 mm 
glass tube [416]. It is important to note that the maximum rate of photosynthesis is 
also dependent upon temperature [226], [227], [406], [417], so it is important to 
ensure that microalgae are grown at the optimal temperature [284], [418]. 
To ensure that all cells in a bubble column reactor experience a similar level of light, 
temperature, CO2 and O2, it is essential that mixing is good. Temperature gradients 
can develop in poorly mixed columns. Furthermore, the rate of photosynthesis may 
be negligible in the central “dark zone”, leading to lower CO2 consumption and O2 
generation. Mixing between the dark zone and the outer layer can be improved by 
increasing turbulence in the bubble flow regime [291]. The “churn-turbulent” flow 
regime is characterized by large bubbles (>4 mm diameter for air-in-water systems) 
flowing unsteadily (i.e. with appreciable side-to-side movement) as they rise [274], 
[290], [291]. However, the onset of churn-turbulent flow is generally observed at or 
above 0.2 m column diameter and 5.0 cm s-1 superficial gas velocity [291], [419]. A 
column diameter of 0.2 m is therefore a good trade-off in order to optimize mixing 
and surface-to-volume ratio. 
Pioneering work led by Yusuf Chisti and Emilio Molina Grima at the 
University of Almeria, Spain, has demonstrated that BC-PBRs of 0.2 m diameter and 
2 m height achieve comparable productivities to  tubular PBRs; however, their 
reactor was operated at superficial gas velocities below 5 cm s-1 [275], [420]. They 
hypothesized that increasing bubble size in the dark zone would improve mixing 
without increasing the energy consumption or destructive mechanical stresses [275]. 
In the homogeneous (bubbly) flow regime of air-water systems, increased sparger 
hole diameters (in the 0-2.5 mm range) generate larger bubbles [274]. Increased 
sparger hole diameters [421] and larger bubbles [422], [423] also lead to reduced gas 
holdup. These observations support evidence that directly relates larger holes to the 
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generation of larger bubbles [424]. Larger bubbles are known to reduce the 
superficial gas velocity required to transition to a churn-turbulent bubble flow 
regime [291]. 
As previously mentioned, the main limitation in large-diameter bubble column 
PBRs is mixing between the dark zone and the surface of the reactor. The mixing can 
be quantified by the radial dispersion coefficient (Dr, cm2 s-1), which represents the 
rate at which a concentration of matter is dispersed by advection and diffusion 
throughout the reactor volume. Very little research has been published on radial 
mixing, however increasing the superficial gas velocity (Ug, calculated by dividing 
the volumetric gas flow rate by the cross sectional area of the column) over the range 
0-5.5 cm s-1 generally improves mixing [425]. The group of Chisti and Molina 
measured Dr in their system using an acid tracer method [426]. Increasing Dr was 
shown to increase biomass productivity; however Dr was reasonably constant at 
superficial gas velocities up to 5 cm s-1 [426]. This is unsurprising, as the turbulent 
bubble flow regime (characterized by high radial mixing) usually does not occur at 
superficial velocities below 5 cm s-1. It is likely that superficial gas velocities of at 
least 5 cm s-1 are required in order to improve the radial dispersion coefficient. In a 
20 cm diameter column, this requires an air flow rate of at least 85 L/min, which is 
much higher than the values reported in the literature [278], [283], [420]. 
Another means by which productivity can be improved in PBRs is by using 
continuous (24 hours per day) artificial illumination. This is usually implemented 
indoors, so artificially illuminating BC-PBRs is only feasible when the product is of 
high value and a high degree of cleanliness is required.  This method has been 
successfully used to boost the productivity of astaxanthin (an antioxidant pigment) 
from Haematococcus pluvialis [427]–[429]. Commercially, continuous illumination is 
used to boost the astaxanthin productivity of H. pluvialis grown in bubble column 
reactors, such as at the New Zealand-based company Supreme Health [430]. 
Continuous illumination is not appropriate for all algae as it has been found to 
inhibit growth in some strains [431], [432]. 
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In the present work, A. cylindrica was grown in a 50 L bubble column PBR very 
similar to the system used by the group of Chisti and Molina. The primary aim was 
to determine the feasibility of producing phylloquinone from A. cylindrica at a scale 
reflective of commercial reality. It was predicted that superficial gas velocity above 5 
cm s-1, larger bubble size and longer illumination duration would improve biomass 
(and thus phylloquinone) productivity. Therefore, the secondary aims were to 
investigate the effect of sparger design and air flow rate on biomass and 
phylloquinone productivity; and, the effect of duration of illumination on biomass 
and phylloquinone productivity.  
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6.2 Method and materials 
6.2.1 Flask cultures 
Anabaena cylindrica was grown in flasks to test the effects of different temperatures 
(23 °C, 28 °C, 33 °C, 38 °C) and pH (7.5 and 9.5) on growth rate. Modified ASM-1 
medium (MLA) was prepared as per Bolch and Blackburn [336] without B vitamins 
and selenium. To prepare experimental cultures, fresh medium (100 mL) was added 
to 250 mL Erlenmeyer flasks, then autoclaved and allowed to cool for 24 hours. The 
pH was adjusted by addition of sterile-filtered 1 M sodium carbonate. The flasks 
were inoculated with 10 mL of culture in the exponential growth phase. The algae 
were grown in a temperature-controlled orbital incubator on a LED light pad of 6000 
K color temperature, with a 12-hour light to 12-hour dark cycle. Cultures were 
grown and analyzed in triplicate. Experiments were performed twice (n = 2) to 
ensure reproducibility. 
6.2.2 Photo-bioreactor cultures 
To prepare the inoculum, fresh medium (200 mL) was added to 500 mL Erlenmeyer 
flasks, then autoclaved and allowed to cool for 24 hours. The flasks were inoculated 
with 20 mL of culture in the exponential growth phase. The algae were grown for 1-2 
weeks on a LED light pad of 6000 K color temperature, with a 12-hour light to 12-
hour dark cycle. Subsequently, flask cultures were pooled and 500 mL was used to 
inoculate a 5 L flat-panel PBR (see Section 5.2.1 for details), which was grown for 
another week with LED lights of 6000 K color temperature and approximately 330 
µmol m-2 s-1 PPFD. The culture from the 5 L flat-panel reactor was used to inoculate 
the 50 L reactor. 
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6.2.3 Photobioreactor set-up 
The effect of air flow rate and sparger design on productivity of A. cylindrica was 
investigated in a 50 L custom-made PBR, constructed from clear acrylic tube as 
shown in Figure 6.1 and Figure 6.2. Filtered tap water, MLA nutrient concentrate 
and inoculum were added such that the liquid volume was 50 L, medium 
concentration was 2 × MLA and the initial optical density (at a wavelength of 550 
nm) was approximately 0.12. Tap water was filtered through a wound 
polypropylene depth cartridge with 1 µm pore size (Parker Hannifin Corporation, 
Cleveland, OH, USA) and a carbon filter cartridge with 0.5 µm pore size (Stefani 
Australasia Pty Ltd, Welshpool, WA, Australia). Light was provided by 27 × 9 W 
cool white (6000 K) LED linkable aluminium strip lights (Jaycar). The light intensity 
was measured along the center axis of the column using a Walz ULM-500 series light 
meter equipped with a US-SQS/L spherical sensor. Measurements were made with 
the PBR full of water but without aeration. The mean PPFD was approximately 300 
µmol m-2 s-1 at the centerline of the reactor. 
The temperature was regulated by 28 °C water passing through a 12.5 mm 
diameter U-shaped stainless-steel tube with an approximate surface area of 0.15 m2. 
Air was introduced into the base of the PBR from one of two different types of 
spargers: a 100 mm long arm sparger with 3 rows of 10 × 2 mm diameter holes; or, a 
fused alumina sparger (pore size <0.3 mm [433]) of length 130 mm and diameter 30 
mm (AquaOne cat. #10154, Kong’s Pty Ltd, Ingleburn, NSW, Australia). In all runs, 
the air was enriched with CO2 (food-grade, Coregas, Yennora, NSW, Australia) at 
100 cc min-1. Flow rates for both air and carbon dioxide were measured using RM 
series rotameters (Dwyer Instruments, Michigan City, IN). 
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Figure 6.1: Schematic of the 50 L PBR set-up used in this work. 
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Figure 6.2: Photograph of the 50 L PBR set-up used in this work. 
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Optical density of all cultures was measured as per the method in Section 5.2.2. The 
temperature and pH were measured using an InPro 3250i pH probe (Mettler-Toledo, 
Columbus, OH, United States); dissolved oxygen (DO) was measured using a 
Mettler-Toledo InPro 6850i DO probe. Temperature, pH and DO measurements 
were logged using the M200 Transmitter Configuration Tool software via a Mettler-
Toledo M200 2-channel transmitter. The total volume of medium was kept constant 
by the addition of filtered water into the PBR before sampling.  Samples were 
retained for vitamin K1 concentration analysis (as per method in Section 0) and DCW 
analysis (as per method in Section 5.2.2). All photo-bioreactor experiments were 
performed twice (n = 2). 
6.2.4 Nitrate analysis 
Analysis of dissolved nitrate in the culture medium was based upon the Ultraviolet 
Spectrophotometric Screening Method 4500-NO3- B published by the American Public 
Health Association (APHA) [434]. Briefly, 250 µL of culture was diluted in 4.75 mL 
of reverse-osmosis (RO) water and then shaken vigorously with 100 µL of 1 M HCl. 
The mixture was filtered into a quartz cuvette and the absorption measured at 220 
nm and 275 nm. Based on a calibration curve determined as per the method, the 
concentration of nitrate (in mg L-1) was calculated using the following equation: 
 
 [𝑁𝑁𝑁𝑁3−] = 15.791 × (𝐴𝐴220 − 2𝐴𝐴275) (6.1) 
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6.2.5 Gas holdup and superficial velocity determination 
Assuming a constant cross-sectional area, the total volume (Vtotal) of the 3-phase 
mixture is proportional to the height of the sparged mixture (hsparged), while the 
volume of gas (Vgas) is proportional to the height of the sparged culture mixture 
minus the height of the unsparged mixture (hunsparged). Gas holdup for the mixture of 
culture and air was therefore calculated as follows: 
 
𝜀𝜀𝑔𝑔 = 𝑉𝑉𝑔𝑔𝑔𝑔𝑡𝑡𝑉𝑉𝑡𝑡𝑐𝑐𝑡𝑡𝑔𝑔𝑡𝑡 = ℎ𝑡𝑡𝑠𝑠𝑔𝑔𝑠𝑠𝑔𝑔𝑡𝑡𝑠𝑠 − ℎ𝑢𝑢𝑐𝑐𝑡𝑡𝑠𝑠𝑔𝑔𝑠𝑠𝑔𝑔𝑡𝑡𝑠𝑠ℎ𝑡𝑡𝑠𝑠𝑔𝑔𝑠𝑠𝑔𝑔𝑡𝑡𝑠𝑠  (6.2) 
 
The actual volumetric flow rate of air through the rotameter (Q2) at the calibrated 
temperature (T2 = 294 K) and pressure  (P2 = 14.7 psia = 101 kPa) was calculated by 
adjusting the nominal reading (Q1) for backpressure (P1) and actual temperature (T1) 
as per the manufacturer instructions using the following equation: 
 
𝑄𝑄2 = 𝑄𝑄1�𝑃𝑃1𝑇𝑇2𝑃𝑃2𝑇𝑇1 (6.3) 
 
The superficial gas velocity (Ug) was calculated from the actual volumetric flow rate 
and the cross-sectional are of the reactor (A) using the following equation: 
 
𝑈𝑈𝑔𝑔 = 𝑄𝑄2𝐴𝐴  (6.4) 
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6.3 Results and discussion 
6.3.1 Optimal temperature and pH 
The effect of culture temperature and initial medium pH on specific growth rate was 
analyzed by two-way ANOVA and Dunnett’s multiple comparisons test. There was 
a significant main effect of temperature on growth rate (F(3,8) = 123.1, p < 0.0001), 
while the effect of pH was insignificant (F(1,8) = 0.04118, p = 0.8443). Dunnett’s 
multiple comparisons between pooled values for 23 °C and the other temperatures 
revealed that all were significantly different. The pooled specific growth rates for 28 
°C were greater than all others. Therefore this strain of A. cylindrica was cultured at 
28 °C in the 50 L PBR. However, the growth rate of A. cylindrica was at least 80% of 
this value within the range 23-33 °C. Culture pH in the range 7.5-9.5 does not affect 
the growth rate; therefore, increases in pH over the course of 50 L culture 
experiments should not affect the results. 
 
Figure 6.3: Effect of culture temperature and initial medium pH on specific growth rate of A. cylindrica grown 
in flasks. Values are means of 2 repeats, error bars are SD. Comparison performed using Dunnett’s multiple 
comparisons test, * p < 0.0332, ** p < 0.0021, **** p < 0.0001. 
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6.3.2 Dissolved oxygen, temperature and pH 
The DO, temperature and pH were remarkably stable for all conditions tested. This 
is consistent with the high heat-transfer and mass transfer rates observed in bubble 
columns compared to other reactor designs [274], [275], [290]. Their contributions to 
variation in the results would be negligible. Dissolved oxygen increased to around 
105% when lights were switched on (Figure 6.4), returning to 100% when lights were 
switched off (Figure 6.4a). Temperature also increased slightly when lights were 
switched on, however it remained within ±0.5 °C of 28.0 °C. For cultures subjected to 
24 hour light, temperature and DO were constant at 28 °C and 105 %; no circadian 
variations were observed (Figure 6.4b). In both cyclic and continuously illuminated 
cultures, the pH was constant at approximately 7.5 throughout the batch. 
The phenomenon of increased DO during illumination is due to the 
photosynthetic production of oxygen. Increases in DO of around 20% during 
illumination (“day”) compared to the un-illuminated state (“night”) have been 
observed in similar bubble column systems [278], [283]. The present study supports 
previous data demonstrating that bubble column systems operate in the region of 
100% DO, which is considerably below the inhibitory concentrations of 200-400% 
seen in other culture systems [275], [435].  
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Figure 6.4: Variation of pH, temperature and dissolved oxygen over time for light:dark cycles of (a) 12:12 
hours and (b) 24:00 hours. 
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6.3.3 Effects of air flow rate and sparger design 
The effects of air flow rate and sparger design on phylloquinone productivity were 
tested. Initial batch cultures using the perforated steel tube were grown at nominal 
air flow rates of 0.2, 0.5, 1.0 and 2.0 vvm. The back-pressure varied between 25 and 
35 kPa when changing the sparger design and air-flow rate. Approximately 18 kPa 
of back-pressure was due to the height of the culture medium in the reactor, the 
remainder being due to losses in the tubing and sparger. As Q2 is quite insensitive to 
variations of ±5 kPa in P1 (eqn. (6.3)), actual air flow rates were calculated for P1 = 30 
kPa (Table 6.1 and Figure 6.5). 
 
Table 6.1: Actual and calculated air-flow values for perforated steel tube sparger. Flow rate adjusted based 
upon a back-pressure of 30 kPa as measured at the rotameters. 
Flow rate 
reading (vvm) 
Flow rate 
(L min-1) 
Adjusted flow 
rate (L min-1) 
Superficial gas 
velocity, Ug (cm s-1) 
Gas holdup, 
εg 
0.2 10 11.3 0.66 0.023 
0.5 20 22.5 1.65 0.051 
1.0 50 56.3 3.31 0.086 
2.0 100 112.6 6.61 0.136 
 
 
Figure 6.5: Gas holdup versus superficial velocity for various airflow rates through perforated steel tube 
sparger. Flow regimes based upon likely values [274], [290], [291]. 
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The biomass productivity, nitrate consumption rate and phylloquinone volumetric 
productivity were determined from the slopes of the linear fits of the time-series 
data for DCW, nitrate concentration and phylloquinone titer, respectively. The R-
square value exceeded 0.90 for all linear fits. Although evidence suggested that 
increasing air flow rate to over 5 cm s-1 (1.6 vvm in this system) should improve 
biomass productivity [426], [436], no significant differences in biomass productivity 
(Figure 6.6a), nitrate consumption (Figure 6.6b), phylloquinone specific 
concentration (Figure 6.7a) or phylloquinone titer (Figure 6.7b) were observed. This 
may be due to species-specific effects of shear-stress; for example, cells of Dunaliella 
tertiolecta were found to die at superficial gas velocities above 1 cm s-1 [418], while 
Phaeodactylum tricornutum was found to tolerate velocities up to 5.5 cm s-1 [436]. The 
absence of cell debris and short filaments upon microscopic examination (Figure 6.8) 
indicate that low productivities are not likely due to cell damage. Thus, flow rates of 
0.2 vvm (Ug = 0.66 cm s-1) and 0.5 vvm (Ug = 1.65 cm s-1) were selected to compare the 
effects of aeration from the perforated steel tube (PST) and the ceramic airstone 
(CAS). These airflow rates reflect typical values from previous research, which are in 
the range 0.1-2.0 cm s-1 [278], [279], [283], [287]. 
 
Table 6.2: Summary of test conditions and results for effect of sparger type versus air flow rate. 
Sparg
er 
type 
Air flow 
rate 
(vvm) 
Final DCW 
(g L-1) 
Specific 
final 
phylloquino
ne conc. (µg 
g-1) 
Final 
phylloquinone 
titer (µg L-1) 
Biomass 
productivity 
(mg L-1 d-1) 
Phylloquinone 
productivity 
(µg L-1 d-1) 
CAS 0.2 0.422-0.535 256-264 108-141 52.3-58.5 15.7-18.8 
CAS 0.5 0.425-0.433 280-312 121-133 60.1-61.0 16.3-18.2 
PST 0.2 0.437-0.469 294-319 138-139 61.2-61.9 18.8-19.5 
PST 0.5 0.458-0.458 272-321 124-147 63.1-68.4 19.4-19.6 
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Figure 6.6: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube “PST”) and air flow (0.2, 
0.5, 1.0 and 2.0 vvm) over time on (a) dry cell weight (DCW) and (b) nitrate concentration. 
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Figure 6.7: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube “PST”) and air flow (0.2, 
0.5, 1.0 and 2.0 vvm) over time on phylloquinone (a) specific concentration and (b) titer.  
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Figure 6.8: Micrographs at 10 × magnification of A. cylindrica grown at  (a) 0.2 vvm and (b) 2.0 vvm aeration 
rates. Note long filaments of at least 400 µm (~80 cells) in both images. 
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The 2-way ANOVA of biomass productivity (Figure 6.9a), nitrate consumption rate 
(Figure 6.9b), final specific phylloquinone concentration (Figure 6.10a) and 
phylloquinone final titer (Figure 6.10b) revealed no significant main or interaction 
effects of air flow rate and sparger type. Generally, the DCW increased linearly from 
0.025 to 0.45 g L-1 over 7 days. Medium nitrate concentration decreased linearly from 
approximately 230 to 50 mg L-1. The phylloquinone titer increased linearly from 
approximately 15 to 125 µg L-1. This linear growth behaviour is commonly seen 
during light limitation in large-scale PBR cultures [275], [278], [283], [420]. 
The specific phylloquinone concentration was approximately constant at around 
260 µg g-1; however, a slight drop was observed from day 0 to day 3. The 
concentration gradually increased to return to the initial value by day 7. This 
behaviour is consistent with photoacclimation in response to changing irradiance; 
PSI numbers (and thus phylloquinone concentration) are known to increase under 
low-light (or shaded) conditions. When the inoculum was added to the column at 
the start of each run, it was diluted 10-20 times. Thus, each cell suddenly received 
more light than in the inoculum tank; the numbers of PSI decreased in response. As 
the cells multiplied over time, the culture density gradually increased. Each cell 
received less and less light on average; therefore, the numbers of PSI were increased 
in response. This observation matches the effect of light intensity on phylloquinone 
seen in Chapter 5. The higher phylloquinone concentrations observed in this 50 L 
bubble column system (~260 µg g-1) compared to the 5 L flat panels system (~150 µg 
g-1) probably reflect the increased degree of light limitation in the 50 L bubble 
column. 
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Figure 6.9: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube “PST”) and air flow (0.2 
and 0.5 vvm) on (a) biomass productivity and (b) nitrate consumption rate. Values are mean of n = 2, error bars 
are SD.  
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Figure 6.10: Effect of sparger type (ceramic airstone “CAS” and perforated steel tube “PST”) and air flow (0.2 
and 0.5 vvm) on phylloquinone final (a) specific concentration and (b) titer. 
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DCW productivity was constant at around 60 mg L-1 d-1, which was 40% lower than 
the best productivity achieved in the 5 L flat-panel system in Chapter 5. These 
productivities are also 5-10 times lower than the 0.3 – 0.5 g L-1 d-1 achieved in a very 
similar 60 L system [275], [278], [283]. However, this 60 L system was used outdoors 
where the mean PPFD was 1150 µmol m-2 s-1, almost four times the intensity used 
here. Given the known positive correlation between irradiance and productivity in 
such systems [275], it is likely that outdoor productivities of at least 0.25 g L-1 d-1 
could be achieved in the system presented here. The absence of cell debris and short 
filaments upon microscopic examination (Figure 6.8) indicate that there was no cell 
damage. 
Nitrate consumption was around 28 mg L-1 d-1, which means that 
approximately 0.11 g of nitrogen was incorporated into every 1.0 g of biomass. Based 
on the Kjeldahl method, the biomass would be 69% (6.25 × 11%) protein, which 
agrees closely with the proximate analysis (68.6%) from Section 4.3.2. 
 The phylloquinone mean concentration (Figure 6.10a) and phylloquinone 
volumetric productivity (Figure 6.10b) were calculated for each test condition. There 
were no significant differences between the four different cases as determined by 2-
way ANOVA. The phylloquinone volumetric productivity was 15-20 µg L-1 d-1, 
which was very similar to the optimal value of 22 µg L-1 d-1 achieved in the 5 L flat-
panel system. Despite the lower biomass productivity in the 50 L bubble column, the 
increased specific phylloquinone concentration led to a comparable volumetric 
productivity. 
 The sparger designs and airflow rates tested did not significantly affect 
biomass or phylloquinone productivity. In future, the stainless steel sparger should 
be used because it is cheaper and simpler to construct, operate and maintain. The 
volumetric flow rate of 0.2 vvm should also be used as less energy is consumed 
compared to higher flow rates. 
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6.3.4 Effects of light duration versus medium concentration 
The effects of light duration and medium concentration on phylloquinone 
productivity were tested. Initial batch cultures using 2× MLA medium were grown 
with daily light:dark cycles of 12:12, 16:08, 20:04 and 24:00 hours. Increased light 
duration led to faster biomass growth (Figure 6.11a) and nitrate consumption (Figure 
6.11b), however nitrate limitation may have caused a reduction in phylloquinone 
specific concentration in the fastest-growing cultures (Figure 6.12).  Thus, medium 
concentrations of 2× and 5× MLA, and light:dark cycles of 12:12 and 24:00 hours, 
were selected to compare the effects of medium concentration and light duration on 
phylloquinone productivity. The results are summarized in Table 6.3. 
 
 
Table 6.3: Summary of test conditions and results for effect of daylength versus medium concentration. 
Duration 
of 
daylight 
(h) 
Medium 
conc. 
Final DCW 
(g L-1) 
Final 
phylloquinon
e conc. (µg g-1) 
Final 
phylloquinon
e titer (µg L-1) 
Biomass 
productivity 
(mg L-1 d-1) 
Phylloquino
ne 
productivity 
(µg L-1 d-1) 
12 2 × 0.437-0.469 294-320 138-139 60.1-63.1 18.8-19.5 
12 5 × 0.462-0.510 291-307 134-141 62.6-63.2 17.7-18.6 
24 2 × 0.865-0.902 183-207 139-158 121.2-126.7 22.4-26.5 
24 5 × 0.813-0.876 319-341 270-299 118.5-118.8 39.2-42.0 
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Figure 6.11: Effect of medium concentration (MLA 2× and 5×) and light:dark cycle (12:12, 16:08, 20:04 and 24:00 
hours) over time on (a) dry cell weight (DCW) and (b) nitrate concentration. 
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Figure 6.12: Effect of medium concentration (MLA 2× and 5×) and light:dark cycle (12:12, 16:08, 20:04 and 24:00 
hours) over time on phylloquinone (a) specific concentration (b) titer.  
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The ordinary two-way ANOVA of biomass productivity (Figure 6.13a) showed a 
significant main effect of light duration (F(1,4) = 1405, p < 0.0001). This is a useful 
result, as 24-hour illumination is known to inhibit growth in some species [431], 
[432]. Responses to constant illumination vary considerably between microalgal 
species [437]–[445], even within the same genus or ecological niche, so it is difficult 
to predict the response of a specific strain. The nitrate consumption rates (Figure 
6.13b) were also significantly affected by light duration (F(1,4) = 647.9, p < 0.0001). 
 The two-way ANOVA of final phylloquinone titer (Figure 6.14b) showed 
significant main effects of medium concentration (F(1,4) = 28.2, p = 0.0060) and light 
duration (F(1,4) = 74.75, p = 0.0010). There was also a significant interaction effect 
(F(1,4) = 29, p = 0.0058). Continuously illuminated cultures in both 2× and 5× MLA 
medium grew at the same rate (Figure 6.11a). However, the 2× MLA culture 
exhausted the nitrate content by day 4 (Figure 6.11b), and the specific phylloquinone 
concentration subsequently dropped (Figure 6.12a). This resulted in a final titer of 
approximately 150 µg L-1, which was less than the titer of 300 µg L-1 achieved with 5× 
MLA and 24 h light, but slightly greater than the titer of 140 µg L-1 achieved in both 
12 h light cases (Figure 6.12b). 
 Microscopic inspection on the final day of continuously illuminated cultures 
grown in 2× MLA revealed truncated filaments with the presence of heterocysts 
(Figure 6.15b), consistent with nitrogen limitation [446]. Heterocysts enable 
filamentous cyanobacteria (including A. cylindrica) to fix nitrogen from the 
atmosphere, and thereby continue to grow for a limited time [446]. Microalgae can 
also reallocate nitrogen by breaking down photosynthetic protein complexes during 
nitrogen limitation [386], [447]. Therefore nutrient (probably nitrate) limitation is 
likely responsible for the decrease in phylloquinone concentration despite the 2× 
MLA culture continuing to grow as fast as the 5× MLA culture. This confirms the 
importance of ample nitrogen supply as discussed in Section 5.3.5. 
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Figure 6.13: Effect of medium concentration (MLA 2× and 5×) and light:dark cycle (12:12 and 24:00 hours) on 
(a) biomass productivity and (b) nitrate consumption rate. 
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Figure 6.14: Effect of medium concentration (2× and 5× MLA) and light:dark cycle (12:12 and 24:00 hours) on 
phylloquinone final (a) specific concentration and (b) titer. 
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Figure 6.15: Light micrographs (40x magnification) of A. cylindrica after 7 days of growth in: (a) 5x MLA; and, 
(b) 2x MLA. Note the heterocysts (enlarged cells induced by nitrogen limitation) indicated by arrows in (b). 
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6.4 Conclusions 
Anabaena cylindrica was grown in a 50 L bubble column PBR. The scale-up was 
successful when compared to the 5 L system from Chapter 5, where the best biomass 
productivity was around 100 mg d-1, the best phylloquinone productivity was 22 µg 
L-1 d-1, and the highest final titer was 161 µg L-1. Here, the base case test conditions of 
0.2 vvm aeration, 1% CO2 enrichment, 2× MLA medium concentration, and a 12:12 
hour light:dark cycle yielded a biomass productivity of approximately 60 mg L-1 d-1 
and a phylloquinone productivity of approximately 18 µg L-1 d-1, with a final titer of 
approximately 135 µg L-1. Increasing the aeration rate and reducing the pore size of 
the sparger did not significantly influence the biomass and phylloquinone 
productivities of the system. By boosting the medium concentration and subjecting 
the culture to 24 hour light, the biomass productivity, phylloquinone productivity 
and final titer were doubled to approximately 120 mg L-1 d-1, 40 µg L-1 d-1 and 285 µg 
L-1 respectively. However, phylloquinone specific concentration declined after 
nitrogen depletion, so an adequate supply of nitrogen in the medium is essential to 
ensure phylloquinone productivity. 
In summary, the scale-up was successful. The biomass productivity of the 
system appears to be proportional to the cumulative irradiance received. In nitrogen 
replete cultures, phylloquinone concentration varied little and the phylloquinone 
productivity was directly proportional to the biomass productivity. Maximizing 
cumulative irradiance and ensuring nitrogen repletion are the most important 
factors in maximizing the phylloquinone productivity of this system. 
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7 Conclusions and future work 
7.1 Conclusions  
The objective of the research presented in this thesis was to develop a 
biotechnological process for the production of vitamin K1 for human and animal 
health. Vitamin K1 is the most common form of vitamin K in the diets of humans 
[34], [157]–[161]. It is also the only form used as a drug to correct vitamin K 
deficiency bleeding [197]. Natural food additives are becoming increasingly popular 
as consumer demand increases for “natural” products. For example, a type of 
vitamin K2 (menaquinone-7) is commercially produced by fermentation and has 
become very popular in recent years [203]. Although vitamin K1 is naturally 
occurring in food, currently it is only produced by chemical synthesis for use in 
supplements and drugs [197]. There is obvious demand for “natural” vitamin K1, 
made by biotechnological means, that also has the potential to improve the 
sustainability of vitamin K1 production. 
 Since the synthetic vitamin K analogs were banned due to toxicity in 1963 
[18], vitamin K1 has become the most widely used type of vitamin K in human 
nutrition and health. In the intervening years, numerous randomized controlled 
trials (RCTs) [60], [61] and cross-sectional studies [56]–[59] have demonstrated the 
health benefits of high vitamin K intake. Given the essentiality of vitamin K and the 
similarity between vitamin K-dependent proteins in vertebrates [113], it is probable 
that vitamin K1 would also be superior in animal nutrition and health. However, 
vitamin K analogs such as menadione bisulfite are still the only forms used in animal 
nutrition [448]. Animal nutrition, especially the chicken industry, is the biggest user 
of vitamin K supplements [181]. Converting livestock industries to using vitamin K1 
has the potential to improve animal welfare and represents an enormous 
opportunity. 
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7.1.1 Effectiveness of vitamin K1 for boosting vitamin K status in 
chickens 
One of the key problems in the chicken industry is that there is no perceived benefit 
of natural vitamin K compared to analogs. However, there is ample evidence that 
demonstrates that vitamin K analogs are toxic [13], [14], [449]–[452] and ineffective 
[9], [10], [12], [77]. There is also some evidence to show that vitamin K1 is the main 
form of vitamin K in the wild diets of Gallus gallus [39], [191]–[193]. However, there 
is little evidence to show that vitamin K, including vitamin K1, is superior to analogs 
for the health of chickens. This was a gap worth investigating prior to the 
development of a new biotechnological process for the production of vitamin K1. 
Previous research by Talbot et al. has demonstrated the potential benefits of 
vitamin K1 for improving bone density in chickens [453]. Bone fracture is a common 
problem in both egg laying and broiler (meat) chickens due to fast growth, lack of 
exercise and inadequate nutrition [454], [455]. For example, almost one-third of 
laying hens have fractures at the end of their laying life [456]. As chicken production 
intensifies [6], these problems will continue to plague the chicken industry. Another 
emerging area of vitamin K research is in the prevention of immune disorders [25], 
[26]. It is well established that nutrition is a powerful modulator of the immune 
system in chickens [7] but there is no evidence about the effects of any K vitamers or 
analogs on the immune responses of chickens. Nevertheless, analysis of the chicken 
blood confirmed that vitamin K1 was the best form to achieve boosted vitamin K 
levels. This is known to translate to higher tissue and egg levels of vitamin K in 
chickens [453], [457]. Therefore, vitamin K1 is the most effective nutritional form of 
vitamin K for improving vitamin K status in chickens. 
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7.1.2 Identification of a microorganism that is naturally rich in 
vitamin K1 
The first step in the development of the biotechnological process was to identify an 
organism that could produce phylloquinone in high concentrations. Phylloquinone 
is biosynthesized by photosynthetic organisms for use in electron transport [214], so 
plant leaves seem a logical place to begin. However, plant cell culture is very 
difficult and phylloquinone is found at low concentrations (<10 µg g-1) in terrestrial 
plants. Many algae are known to contain much higher levels of phylloquinone (10-
750 µg g-1) [157], [208], and algal microorganisms (“microalgae”) are much easier to 
culture than plant cells [238]. The identification and characterization of a strain of 
microalgae that is rich in phylloquinone was an essential step in the research. 
A review of the literature and industry best-practice suggests that microalgae 
are the best organisms for biotechnological production of vitamin K1. After screening 
seven common microalgae, one clearly superior strain was identified. At 200 µg g-1 
dry mass, A. cylindrica (CS-172) was found to contain a significantly higher 
concentration of phylloquinone than the other strains, being six-times richer than 
good dietary sources such as parsley [34], [159]. Vitamin K1 content was confirmed 
by APCI-LC-MS/MS and independent laboratory verification. A toxicology bioassay 
demonstrated the absence of acute toxicity, as would be expected from cyanotoxin-
producing strains. The high concentration of authentic vitamin K1 and the apparent 
absence of cyanotoxins demonstrates the potential of using A. cylindrica for the safe 
and efficient biotechnological production of phylloquinone. 
7.1.3 Importance of light intensity and medium nitrogen for the 
production of vitamin K1 
The second step in the development of the biotechnological process was to 
determine the optimal culture conditions to maximize productivity of 
phylloquinone. They key inputs for microalgal growth are generally recognized as 
light, nitrogen and phosphorus [170]. Light is especially important, as it is known to 
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strongly affect growth rate and photosynthetic electron transport [220]. Nitrogen is 
important because it is essential for protein synthesis, and proteins make up all of 
the cellular machinery. Phosphorus is important because it is essential for DNA 
synthesis, building cell membranes, energy storage, and carbon fixation. Although 
carbon is required for all biological molecules, microalgae can capture it from 
atmospheric CO2, so it is usually a cheap and plentiful input. Optimizing the levels 
of light, nitrogen and phosphorus was necessary to maximize phylloquinone 
productivity. 
A. cylindrica was grown in 5 L flat panel PBRs, and the effects of key nutrient 
levels were tested. Low light (PPFD ~170 µmol m-2 s-1) and high nitrogen (1700 mg L-
1) boosted phylloquinone specific concentration, while high light (PPFD ~330 µmol 
m-2 s-1) and high nitrogen boosted biomass productivity. Overall, high light and 
nitrogen maximized phylloquinone productivity. It was also found that 
phylloquinone and biomass concentrations can be estimated by spectrophotometry, 
which is useful for industrial processes. These results are essential for the success of 
industrial scale cultures, as volumetric productivity is the main limitation of 
microalgal processes. 
7.1.4 Robustness of vitamin K1 production in A. cylindrica against 
variations due to scale-up 
The third step in the development of the biotechnological process was to test the 
technical feasibility of producing phylloquinone using microalgae in a pilot-scale 
bubble-column PBR. Scale-up of any process to an industrial size almost always 
entails some loss of productivity. In the case of microalgal culture, this is usually due 
to light limitation [170]. As a rule of thumb, the culture depth should be no more 
than 5 cm thick in order to prevent self-shading [170].  Thinner cultures favor higher 
productivities. Conversely, it is much cheaper to scale-up a cylindrical culture vessel 
by increasing vessel diameter (volume is proportional to the square of diameter) 
than by increasing length (volume is proportional to length). This means that 
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industrial culture vessels will have a central “dark” zone where cells cannot 
photosynthesize. Therefore, it is important to develop strategies that improve the 
cumulative irradiance of cultures in large reactors. Ensuring fast and even mixing of 
the cells between the light and dark zones in large culture vessels is essential. In 
bubble column reactors, mixing is dependent upon the bubble flow regime, so this 
was the most important aspect of scale-up. If mixing cannot be further improved, 
increasing the cumulative irradiance is another possibility. Developing these 
strategies was essential for efficient scale-up. 
A. cylindrica was grown in a 50 liter bubble-column PBR. The most important 
operating conditions (air flow rate, sparger design, cumulative irradiance, nutrient 
repletion) were tested. Air flow rate (Ug in the range 0.62 to 6.2 cm s-1) and sparger 
design (2 mm holes versus <300 µm pores) had no significant effect on biomass or 
phylloquinone productivity. At a similar light intensity (PPFD ~300 µmol m-2 s-1), the 
phylloquinone productivity was very similar in the 50 L PBR to the 5 L PBR (~20 µg 
L-1 d-1). This was despite lower biomass productivity in the 50 L PBR. These 
phenomena are probably due to light-limitation, inducing PSI synthesis and slower 
growth. As lower light intensity appears to favor phylloquinone synthesis, the effect 
of self-shading has some benefit. An adequate concentration of nitrogen in the 
medium is essential for maximizing phylloquinone specific concentration; N-replete 
biomass contained more than 260 µg g-1, compared to N-limited biomass with less 
than 200 µg g-1. It appears that this strain of A. cylindrica is a very robust organism 
and that production of phylloquinone is not greatly affected by variations in 
temperature, pH and light availability due to self-shading.  
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7.2 Future work 
The research presented here lays the foundation for development of a microalgal 
process for production of vitamin K1. Naturally, there is much left to do in order to 
realize this opportunity. Furthermore, many questions have arisen from the research 
that bear further investigation. Ideally, these limitations and unanswered questions 
of the present study would be investigated in future work. 
7.2.1 Benefits of vitamin K1 for chicken welfare and productivity 
Foremost among the unanswered is the question: does natural vitamin K, especially 
vitamin K1, confer immune benefits upon chickens? This question is of both intense 
scientific and commercial interest. Our immunological assays did not reveal any 
differences between vitamin K1, vitamin K2 and menadione. Our experiment was 
powered to observe an expected effect size of approximately 50%. Similar effect sizes 
were observed in previous studies of the immunomodulatory effects of vitamin K 
[130], [309], [310], however these studies were in vitro and used doses that were 
much higher than the blood concentrations observed in our study. Therefore, it is 
likely that either higher doses or a more statistically powerful study design would be 
required in order to observe immune benefits. As the doses used here reflect the 
industry standard, a more statistically powerful experiment is the better option. A 
large (n > 1000 per group) observational study would satisfy this criterion. 
Furthermore, observational studies can use metrics that are more relevant to the 
poultry industry, such as feed conversion, laying efficiency and attrition rate. These 
metrics are easily interpreted by farmers and others in the industry, and form a more 
compelling case for the use of one treatment over another. 
7.2.2 Safety of health products from cyanobacteria for repeated long-
term use 
An important aspect of human and animal nutrition is product safety. The strain of 
A. cylindrica used here was categorized by ANACC as non-toxic. The results 
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presented here support the absence of acute toxicity of A. cylindrica. However, these 
results provide no data on the long-term effects of repeated doses (e.g. the potential 
neurodegenerative effects of amino acids such as BMAA [458]). As A. cylindrica is a 
novel food organism, more comprehensive animal testing is required to demonstrate 
safety [459], [460]. The OECD Test no. 408 for oral toxicity [461] is typically used for 
testing potential sub-chronic toxicity of novel foods (including GM organisms) [462], 
[463]. This test standard stipulates that at least 20 animals (10 male and 10 female) 
should be used per diet group, and that the feed study should last at least 90 days. 
Such a study is an essential future step in the application of this strain to health 
products for human and animal consumption. 
The strain of A. cylindrica used here may be only one of many that are rich in 
vitamin K1; there are tens of thousands of microalgal species waiting to be tested and 
exploited for their valuable products [213], [464]. According to the literature, it is 
probable that other cyanobacteria and some rhodophytes (red algae) are also very 
rich sources of phylloquinone [354], [378], [384]. The fact that the cyanobacteria 
tested (A. cylindrica and Spirulina sp.) contained the highest and second-highest 
concentrations of vitamin K1 lend credence to this hypothesis. Testing of other 
genera and families would potentially reveal alternative organisms for the 
biotechnological production of phylloquinone under industrially useful conditions, 
such as extreme pH (>9), salinity (>30 g L-1) and temperature (>30 °C). Analysis of 
existing genomic data may be able to suggest non-toxic candidates with similar traits 
to A. cylindrica. Creation of super-productive and non-toxic strains may even be 
possible, thanks to the burgeoning field of metabolic engineering [256], [257], [465]. 
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7.2.3 Optimization of nutrient inputs for an industrial scale process 
Light was, as expected, identified as the most important input to the production of 
vitamin K1. Nitrogen was also very important. Medium nitrogen is often supplied as 
urea or ammonium, which are cheaper than nitrate, and these are all utilized at 
different rates [170]. The effect of nitrogen source on cell growth should be tested. 
Iron may also have an appreciable effect on vitamin K1 productivity. Iron is essential 
for PSI [221], so it would make sense to test the effects of different concentrations 
and oxidation states on productivity. The aim of these studies is to maximize 
productivity while minimizing the cost of mineral inputs, because laboratory culture 
medium is expensive to make. It would be of industrial relevance to test alternative, 
nutrient-rich water sources, such as waste water from hydroponics and aquaculture. 
One particularly puzzling aspect of vitamin K1 biosynthesis had to do with 
nitrogen limitation. There is a putative role for PSI in nitrogen fixation [221], and PSI 
function is usually preserved during nitrogen limitation [386]–[388], [447]. Why is it, 
then, that medium nitrogen limitation appeared to strongly decrease phylloquinone 
content? The ability to grow A. cylindrica in nitrogen-fixing mode is beneficial 
because it eliminates the cost of medium nitrogen (such as nitrate) and prevents fast-
growing, non-nitrogen fixing microalgae (such as Chlorella sp.) from contaminating 
the culture. Genomic and proteomic analyses of A. cylindrica under different culture 
conditions could help to explain why it has such a high phylloquinone 
concentration, and further elucidate the mechanisms influencing phylloquinone 
concentration. Electron microscopy of the thylakoid membranes may also reveal 
useful information about the cellular influences on PSI and phylloquinone 
concentration. These results could be used to develop a method for producing 
vitamin K1 by growing A. cylindrica in a nitrogen-free medium [466]. 
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7.2.4 Optimization of irradiance in a pilot-scale photo-bioreactor 
Maximizing the cumulative irradiance (the integral of light intensity over time) is 
clearly preferable. Whether this is best achieved by increasing irradiance duration or 
intensity (or a combination of both) is not immediately obvious. The effect of 
continuous light was to double the biomass and vitamin K1 productivity of the 
system, compared to a 12:12 hour light:dark cycle. Therefore, it is hypothesized that 
any increase in cumulative irradiance will improve productivity. However, due to 
the constraints of the indoor system, light intensities tested were approximately one-
quarter of actual mean daylight intensities. It remains to be seen whether: (a) 
maximum daylight intensities are actually inhibitory; and, (b) whether continuous 
light at maximum daylight intensity would also boost productivity. It may be that 
the effects of mixing become much more important at these high light intensities. In 
that case, methods should be tested for improving radial mixing in bubble-columns, 
such as baffles, draft tubes and large-bubble generators. 
7.2.5 Advanced tools for monitoring of microalgal culture 
Many aspects of microalgal growth, including nutrient uptake, toxin production and 
light response, can be monitored using so-called “omics” techniques [467]. The 
influence of genetic and environmental factors on microalgal behavior can be 
observed in changes to the proteome and metabolome [468]–[470]. Although 
research has focused mainly on the synthesis and storage of lipids for biofuel 
production [469], [470], these techniques can be applied to other aspects of algal 
metabolism. For example, the development of high-throughput mass-spectrometric 
and label-based methods has enabled the analysis of protein response to changes in 
light exposure [469]. Likewise, advances in chromatography and mass-spectrometry 
have enabled the analysis of the toxicity of a range of cyanobacterial metabolites 
[471]. These tools could be used to monitor proteins and other compounds that 
indicate positive (e.g. phylloquinone synthesis) and negative (e.g. toxin BMAA) 
characteristics of A. cylindrica cultures. 
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7.2.6 Optimization of downstream processing 
The vitamin K-rich biomass of A. cylindrica can be incorporated into animal feed (as 
demonstrated in this thesis) and, possibly, cosmetics and nutritional products for 
human consumption. Mature dewatering technologies (gravity sedimentation, 
centrifugation and filtration) and drying technologies (freeze-drying or spray-
drying) are adequate for the preparation of biomass for these purposes [264], [472]. 
However, to produce a pure vitamin K1 product, it is necessary to perform 
downstream processing on the biomass. 
Unit operations in the downstream processing of algal biomass would include 
cell disruption, debris removal and primary isolation, product enrichment and final 
isolation [45]. Although there are also mature technologies for each of these unit 
operations [45], substantial innovation is possible by combining or eliminating 
operations. For example, super-critical CO2 extraction can replace traditional cell 
disruption (milling or homogenization), debris removal (filtration) and primary 
isolation (solvent extraction). Alternatively, disruption and primary isolation could 
be performed in the algae culture vessel by increasing the medium osmolarity and 
adding a non-polar solvent phase. Future research could investigate these or similar 
advances in downstream processing of algal biomass. 
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7.3 Final remarks 
Biotechnological processes, such as the proposed microalgal process for vitamin K1, 
have many benefits over chemical syntheses. Of course, there are also drawbacks to 
biotechnological processes. In the long-run, however, it is likely that the advantages 
will far outweigh the disadvantages. 
Biotechnological processes currently face obstacles in the form of biology and 
ethics, and microalgal biotechnology is no exception. Wild-type organisms often do 
not make chemicals efficiently enough for industrial purposes. With genetic 
manipulation, it is often possible to make these organisms fit for industrial use. 
However, gene technologies are controversial and tightly regulated. Despite these 
obstacles, it is important to persevere with research in microalgal biotechnology. 
Resource scarcity and environmental degradation are causing a host of social, 
economic and environmental problems. Ignoring these problems could be 
catastrophic. Microalgae do not consume scarce resources such as arable land and 
fresh food. Instead, they consume plentiful “resources” such as sunlight and carbon 
dioxide. The production of vitamin K1 is just one example of the way in which 
microalgal biotechnology could change human industry for the better. Though it 
may take many years to realize this vision, it is a worthwhile and essential endeavor. 
 
 
  
Chapter 8: References 
162 
 
8 References 
 
[1] C. K. Roberts and R. J. Barnard, “Effects of exercise and diet on chronic disease,” 
Journal of Applied Physiology, vol. 98, no. 1, pp. 3–30, Jan. 2005. 
[2] Australian Institute of Health and Welfare, “Australia’s health 2016,” no. 15, 2016. 
[3] A. Trichopoulou, T. Costacou, C. Bamia, and D. Trichopoulos, “Adherence to a 
Mediterranean Diet and Survival in a Greek Population,” New England Journal of 
Medicine, vol. 348, no. 26, pp. 2599–2608, Jun. 2003. 
[4] Y. Yamori, A. Miura, and K. Taira, “Implications from and for food cultures for 
cardiovascular diseases: Japanese food, particularly Okinawan diets,” Asia Pacific 
Journal of Clinical Nutrition, vol. 10, no. 2, pp. 144–145, Jun. 2001. 
[5] D. C. Willcox, G. Scapagnini, and B. J. Willcox, “Healthy aging diets other than the 
Mediterranean: A focus on the Okinawan diet,” Mechanisms of Ageing and 
Development, vol. 136–137, pp. 148–162, Mar. 2014. 
[6] P. K. Thornton, “Livestock production: recent trends, future prospects,” Philosophical 
Transactions of the Royal Society B: Biological Sciences, vol. 365, no. 1554, pp. 
2853–2867, Sep. 2010. 
[7] K. C. Klasing, “Nutrition and the immune system,” British Poultry Science, vol. 48, 
no. 5, pp. 525–537, Oct. 2007. 
[8] C. C. Whitehead, “Nutrition and poultry welfare,” World&#39;s Poultry Science 
Journal, vol. 58, no. 3, pp. 349–356, Sep. 2002. 
[9] J. A. Sadowski, C. T. Esmon, and J. W. Suttie, “Vitamin K-dependent carboxylase. 
Requirements of the rat liver microsomal enzyme system.,” J. Biol. Chem., vol. 251, 
no. 9, pp. 2770–2776, May 1976. 
[10] H. C. Buitenhuis, B. A. M. Soute, and C. Vermeer, “Comparison of the vitamins K1, 
K2 and K3 as cofactors for the hepatic vitamin K-dependent carboxylase,” Biochimica 
et Biophysica Acta (BBA) - General Subjects, vol. 1034, no. 2, pp. 170–175, May 
1990. 
[11] K. Nakagawa et al., “Identification of UBIAD1 as a novel human menaquinone-4 
biosynthetic enzyme,” Nature, vol. 468, no. 7320, pp. 117–121, Nov. 2010. 
[12] D. O. Mack, M. Wolfensberger, J. M. Girardot, J. A. Miller, and B. C. Johnson, “The 
carboxylation activity of vitamin K analogs with substitutions at position 2, 3, or 5.,” J. 
Biol. Chem., vol. 254, no. 8, pp. 2656–2664, Apr. 1979. 
[13] H. Thor, M. T. Smith, P. Hartzell, G. Bellomo, S. A. Jewell, and S. Orrenius, “The 
metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A 
study of the implications of oxidative stress in intact cells.,” J. Biol. Chem., vol. 257, 
no. 20, pp. 12419–12425, Oct. 1982. 
[14] D. Di Monte, G. Bellomo, H. Thor, P. Nicotera, and S. Orrenius, “Menadione-induced 
cytotoxicity is associated with protein thiol oxidation and alteration in intracellular 
Ca2+ homeostasis,” Archives of Biochemistry and Biophysics, vol. 235, no. 2, pp. 343–
350, Dec. 1984. 
[15] F. Mirabelli, A. Salis, M. Perotti, F. Taddei, G. Bellomo, and S. Orrenius, “Alterations 
of surface morphology caused by the metabolism of menadione in mammalian cells are 
associated with the oxidation of critical sulfhydryl groups in cytoskeletal proteins,” 
Biochemical Pharmacology, vol. 37, no. 18, pp. 3423–3427, Sep. 1988. 
[16] G. Bellomo, F. Mirabelli, M. Vairetti, F. Iosi, and W. Malorni, “Cytoskeleton as a 
target in menadione-induced oxidative stress in cultured mammalian cells. I. 
Chapter 8: References 
163 
 
Biochemical and immunocytochemical features,” J. Cell. Physiol., vol. 143, no. 1, pp. 
118–128, Apr. 1990. 
[17] P. C. Brown, D. M. Dulik, and T. W. Jones§, “The toxicity of menadione (2-methyl-
1,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial 
cells,” Archives of Biochemistry and Biophysics, vol. 285, no. 1, pp. 187–196, Feb. 
1991. 
[18] “FDA bans use of viamin K3, denies danger (March 29, 1963),” Chicago Tribune, p. 
14, 29-Mar-1963. 
[19] R. M. Russell and P. M. Suter, “Vitamin and Trace Mineral Deficiency and Excess,” in 
Harrison’s Principles of Internal Medicine, 19th ed., D. Kasper, A. Fauci, S. Hauser, 
D. Longo, J. L. Jameson, and J. Loscalzo, Eds. New York, NY: McGraw-Hill 
Education, 2015. 
[20] J. L. Zehnder, “Drugs Used in Disorders of Coagulation,” in Basic & Clinical 
Pharmacology, 13th ed., New York, NY: McGraw-Hill Education, 2015. 
[21] T. Lissauer and G. Clayden, Eds., Illustrated Textbook of Paediatrics, 4th ed. London, 
UK: Elsevier Health Sciences, 2011. 
[22] A. Palermo et al., “Vitamin K and osteoporosis: Myth or reality?,” Metabolism, vol. 
70, pp. 57–71, May 2017. 
[23] G. Hao et al., “Vitamin K intake and the risk of fractures,” Medicine (Baltimore), vol. 
96, no. 17, Apr. 2017. 
[24] M. K. Shea and R. M. Holden, “Vitamin K Status and Vascular Calcification: 
Evidence from Observational and Clinical Studies,” Adv Nutr, vol. 3, no. 2, pp. 158–
165, Mar. 2012. 
[25] S. G. Harshman and M. K. Shea, “The Role of Vitamin K in Chronic Aging Diseases: 
Inflammation, Cardiovascular Disease, and Osteoarthritis,” Curr Nutr Rep, vol. 5, no. 
2, pp. 90–98, Jun. 2016. 
[26] M. K. Shea, M. Cushman, S. L. Booth, G. L. Burke, H. Chen, and S. B. Kritchevsky, 
“Associations between vitamin K status and haemostatic and inflammatory biomarkers 
in community-dwelling adults: The Multi-Ethnic Study of Atherosclerosis,” Thromb 
Haemost, vol. 112, no. 3, pp. 438–444, Sep. 2014. 
[27] N. Presse et al., “Vitamin K status and cognitive function in healthy older adults,” 
Neurobiology of Aging, vol. 34, no. 12, pp. 2777–2783, Dec. 2013. 
[28] S. Tamadon-Nejad, “Warfarin-induced vitamin K deficiency is associated with 
cognitive and behavioral perturbations, and alterations in brain sphingolipids in rats,” 
M.S. thesis, University of Montreal, Montreal, Canada, 2012. 
[29] C. Annweiler, G. Ferland, P. Barberger-Gateau, A. Brangier, Y. Rolland, and O. 
Beauchet, “Vitamin K Antagonists and Cognitive Impairment: Results From a Cross-
Sectional Pilot Study Among Geriatric Patients,” J Gerontol A Biol Sci Med Sci, vol. 
70, no. 1, pp. 97–101, Jan. 2015. 
[30] M. Nour, Z. Sui, A. Grech, A. Rangan, K. McGeechan, and M. Allman-Farinelli, “The 
fruit and vegetable intake of young Australian adults: a population perspective,” Public 
Health Nutrition, vol. 20, no. 14, pp. 2499–2512, Oct. 2017. 
[31] G. F. Combs Jr, The Vitamins, 4th ed. Saint Louis: Elsevier Science, 2012. 
[32] “Vitamin B - Better Health Channel.” [Online]. Available: 
https://www.betterhealth.vic.gov.au/health/healthyliving/vitamin-b. [Accessed: 19-
Feb-2018]. 
[33] “Vitamin Stability - Vitamin basics - Compendium - DSM.” [Online]. Available: 
https://www.dsm.com/markets/anh/en_US/Compendium/vitamin_basics/vitamin_stabil
ity.html. [Accessed: 19-Feb-2018]. 
Chapter 8: References 
164 
 
[34] M. J. Shearer and  et al, “Chemistry, nutritional sources, tissue distribution and 
metabolism of vitamin K with special reference to bone health,” The Journal of 
Nutrition, vol. 126, no. 4S, p. 1181S, Apr. 1996. 
[35] Healthdirect, “Vitamin A.” [Online]. Available: 
https://www.healthdirect.gov.au/vitamin-a. [Accessed: 19-Feb-2018]. 
[36] Healthdirect, “Vitamin E.” [Online]. Available: 
https://www.healthdirect.gov.au/vitamin-e. [Accessed: 19-Feb-2018]. 
[37] Healthdirect, “Vitamin C.” [Online]. Available: 
https://www.healthdirect.gov.au/vitamin-c. [Accessed: 19-Feb-2018]. 
[38] L. R. McDowell, “Reevaluation of the metabolic essentiality of the vitamins - 
review.,” Asian-Australasian Journal of Animal Sciences, vol. 13, no. 1, pp. 115–125, 
2000. 
[39] Nutrient Requirements of Poultry: Ninth Revised Edition, 1994. Washington, D.C.: 
National Academies Press, 1994. 
[40] K. M. Fairfield and R. H. Fletcher, “Vitamins for Chronic Disease Prevention in 
Adults: Scientific Review,” JAMA, vol. 287, no. 23, pp. 3116–3126, Jun. 2002. 
[41] Rodrigo Ramón, Guichard Cristián, and Charles Roberto, “Clinical pharmacology and 
therapeutic use of antioxidant vitamins,” Fundamental & Clinical Pharmacology, vol. 
21, no. 2, pp. 111–127, Jan. 2007. 
[42] FSANZ, “Policy Guideline: Fortification of Food with Vitamins and Minerals,” Jun-
2016. [Online]. Available: 
http://www.foodstandards.gov.au/consumer/nutrition/vitaminadded/documents/Fortific
ation%20of%20vitamins%20and%20minerals%20-
%20amended%20Oct%202009.pdf. [Accessed: 20-Feb-2018]. 
[43] “Vitamins and minerals added to food.” [Online]. Available: 
http://www.foodstandards.gov.au/consumer/nutrition/vitaminadded/Pages/default.aspx. 
[Accessed: 23-May-2017]. 
[44] E. J. Vandamme, “Production of vitamins, coenzymes and related biochemicals by 
biotechnological processes,” J. Chem. Technol. Biotechnol., vol. 53, no. 4, pp. 313–
327, Jan. 1992. 
[45] P. M. Doran, Bioprocess Engineering Principles. San Diego: Elsevier Science & 
Technology, 2012. 
[46] “Vitamin Ingredients Market: Production Volume to Reach 63,512.4 tons by 2025, 
Reports TMR,” PRNewswire, New York, NY, Mar. 2017. 
[47] “Vitamins Market - Growth, Share, Opportunities & Competitive Analysis, 2015 - 
2022,” Credence Research, San Jose, CA, 57709-12–15, Dec. 2015. 
[48] “Three Things that are Influencing Growth in the Vitamin Ingredients Market,” 
Technavio, London, UK, Jun. 2015. 
[49] J.-P. Lange, “Fuels and Chemicals Manufacturing; Guidelines for Understanding and 
Minimizing the Production Costs,” CATTECH, vol. 5, no. 2, pp. 82–95, Aug. 2001. 
[50] W. Bonrath and T. Netscher, “Catalytic processes in vitamins synthesis and 
production,” Applied Catalysis A: General, vol. 280, no. 1, pp. 55–73, Feb. 2005. 
[51] C. Vermeer, “Vitamin K: the effect on health beyond coagulation – an overview,” 
Food & Nutrition Research, vol. 56, no. 1, p. 5329, 2012. 
[52] S. L. Booth, “Roles for Vitamin K Beyond Coagulation,” Annual Review of Nutrition, 
vol. 29, no. 1, pp. 89–110, 2009. 
[53] G. Ferland, “Vitamin K and the Nervous System: An Overview of its Actions,” Adv 
Nutr, vol. 3, no. 2, pp. 204–212, Mar. 2012. 
Chapter 8: References 
165 
 
[54] M. Shiraki, N. Tsugawa, and T. Okano, “Recent advances in vitamin K-dependent Gla-
containing proteins and vitamin K nutrition,” Osteoporosis and Sarcopenia, vol. 1, no. 
1, pp. 22–38, Sep. 2015. 
[55] B. A. G. Willems, C. Vermeer, C. P. M. Reutelingsperger, and L. J. Schurgers, “The 
realm of vitamin K dependent proteins: Shifting from coagulation toward 
calcification,” Mol. Nutr. Food Res., vol. 58, no. 8, pp. 1620–1635, Aug. 2014. 
[56] D. Feskanich, P. Weber, W. C. Willett, H. Rockett, S. L. Booth, and G. A. Colditz, 
“Vitamin K intake and hip fractures in women: a prospective study,” Am J Clin Nutr, 
vol. 69, no. 1, pp. 74–79, Jan. 1999. 
[57] S. L. Booth et al., “Dietary vitamin K intakes are associated with hip fracture but not 
with bone mineral density in elderly men and women,” Am J Clin Nutr, vol. 71, no. 5, 
pp. 1201–1208, May 2000. 
[58] Y. Yaegashi, T. Onoda, K. Tanno, T. Kuribayashi, K. Sakata, and H. Orimo, 
“Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, 
and vitamin K,” Eur J Epidemiol, vol. 23, no. 3, pp. 219–225, Mar. 2008. 
[59] E. M. Apalset, C. G. Gjesdal, G. E. Eide, and G. S. Tell, “Intake of vitamin K1 and K2 
and risk of hip fractures: The Hordaland Health Study,” Bone, vol. 49, no. 5, pp. 990–
995, Nov. 2011. 
[60] A. M. Cheung et al., “Vitamin K Supplementation in Postmenopausal Women with 
Osteopenia (ECKO Trial): A Randomized Controlled Trial,” PLOS Medicine, vol. 5, 
no. 10, p. e196, Oct. 2008. 
[61] M. H. J. Knapen, N. E. Drummen, E. Smit, C. Vermeer, and E. Theuwissen, “Three-
year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy 
postmenopausal women,” Osteoporos Int, vol. 24, no. 9, pp. 2499–2507, Sep. 2013. 
[62] R. Chan, J. Leung, and J. Woo, “No Association between Dietary Vitamin K Intake 
and Fracture Risk in Chinese Community-Dwelling Older Men and Women: A 
Prospective Study,” Calcif Tissue Int, vol. 90, no. 5, pp. 396–403, May 2012. 
[63] L. Rejnmark et al., “No effect of vitamin K1 intake on bone mineral density and 
fracture risk in perimenopausal women,” Osteoporos Int, vol. 17, no. 8, pp. 1122–
1132, Aug. 2006. 
[64] Y. Kasukawa et al., “Effects of risedronate alone or combined with vitamin K2 on 
serum undercarboxylated osteocalcin and osteocalcin levels in postmenopausal 
osteoporosis,” J Bone Miner Metab, vol. 32, no. 3, pp. 290–297, May 2014. 
[65] S. Cockayne, J. Adamson, S. Lanham-New, M. J. Shearer, S. Gilbody, and D. J. 
Torgerson, “Vitamin K and the Prevention of Fractures: Systematic Review and Meta-
analysis of Randomized Controlled Trials,” Arch Intern Med, vol. 166, no. 12, pp. 
1256–1261, Jun. 2006. 
[66] Y. Fang, C. Hu, X. Tao, Y. Wan, and F. Tao, “Effect of vitamin K on bone mineral 
density: a meta-analysis of randomized controlled trials,” J Bone Miner Metab, vol. 30, 
no. 1, pp. 60–68, Jan. 2012. 
[67] D. W. MacCorquodale, S. B. Binkley, S. A. Thayer, and E. A. Doisy, “On the 
constitution of vitamin K1,” J. Am. Chem. Soc., vol. 61, no. 7, pp. 1928–1929, Jul. 
1939. 
[68] L. F. Fieser, “Synthesis of Vitamin K1,” J. Am. Chem. Soc., vol. 61, no. 12, pp. 3467–
3475, Dec. 1939. 
[69] R. W. McKee, S. B. Binkley, S. A. Thayer, D. W. MacCorquodale, and E. A. Doisy, 
“The isolation of vitamin K2,” Journal of Biological Chemistry, vol. 131, pp. 327–344, 
1939. 
[70] L. F. Fieser, W. P. Campbell, and E. M. Fry, “Synthesis of Quinones Related to 
Vitamins K1 and K2,” J. Am. Chem. Soc., vol. 61, no. 8, pp. 2206–2218, Aug. 1939. 
Chapter 8: References 
166 
 
[71] B. K. Jacobsen and H. Dam, “Vitamin K in bacteria,” Biochimica et Biophysica Acta, 
vol. 40, pp. 211–216, Jan. 1960. 
[72] S. Ansbacher and E. Fernholz, “Simple compounds with vitamin K activity,” J. Am. 
Chem. Soc., vol. 61, no. 7, pp. 1924–1925, Jul. 1939. 
[73] L. F. Fieser et al., “Quinones having vitamin K activity,” J. Am. Chem. Soc., vol. 61, 
no. 7, pp. 1925–1926, Jul. 1939. 
[74] H. J. Almquist and A. A. Klose, “Synthetic and natural antihemorrhagic compounds,” 
J. Am. Chem. Soc., vol. 61, no. 9, pp. 2557–2558, Sep. 1939. 
[75] J. M. Macfie, A. L. Bacharach, and M. R. A. Chance, “A Vitamin K Analogue in 
Obstructive Jaundice,” British Medical Journal, vol. 2, no. 4120, p. 1220, Dec. 1939. 
[76] Anderson ER, Karabin JE, Udesky H, and Seed L, “Parenteral administration of a 
watersoluble compound with vitamin k activity: 4-amino-2-methyl-1-naphthol 
hydrochloride,” Arch Surg, vol. 41, no. 5, pp. 1244–1250, Nov. 1940. 
[77] J. P. Jones, A. Fausto, R. M. Houser, E. J. Gardner, and R. E. Olson, “Effect of vitamin 
K homologues on the conversion of preprothrombin to prothrombin in rat liver 
microsomes,” Biochemical and Biophysical Research Communications, vol. 72, no. 2, 
pp. 589–597, Sep. 1976. 
[78] T. J. Monks, R. P. Hanzlik, G. M. Cohen, D. Ross, and D. G. Graham, “Quinone 
chemistry and toxicity,” Toxicology and Applied Pharmacology, vol. 112, no. 1, pp. 2–
16, Jan. 1992. 
[79] “Menadione,” The Merck Index Online, 2013. [Online]. Available: 
https://www.rsc.org/Merck-
Index/monograph/m7169/menadione%20derivative%20sodium%20bisulfite?q=authori
ze. [Accessed: 08-Aug-2017]. 
[80] “Menaquinones,” The Merck Index Online, 2013. [Online]. Available: 
https://www.rsc.org/Merck-
Index/monograph/m7171/menaquinones%20derivative%20menaquinone%20?q=autho
rize. [Accessed: 08-Aug-2017]. 
[81] “Phylloquinone,” The Merck Index Online, 2013. [Online]. Available: 
https://www.rsc.org/Merck-Index/monograph/m8762/phylloquinone?q=authorize. 
[Accessed: 08-Aug-2017]. 
[82] P. Sommer and M. Kofler, “Physicochemical Properties and Methods of Analysis of 
Phylloquinones, Menaquinones, Ubiquinones, Plastoquinones, Menadione, and 
Related Compounds,” Vitamins & Hormones, vol. 24, pp. 349–399, Jan. 1967. 
[83] J. F. Pennock, “Occurrence of Vitamins K and Related Quinones,” in Vitamins & 
Hormones, vol. 24, I. G. W. Robert S. Harris John A. Loraine, G. F. Marrian and 
Kenneth V. Thimann, Ed. Cambridge, MA: Academic Press, 1967, pp. 307–329. 
[84] F. R. Whatley, M. B. Allen, and D. I. Arnon, “Photosynthesis by isolated chloroplasts: 
VII. Vitamin K and riboflavin phosphate as cofactors of cyclic photophosphorylation,” 
Biochimica et Biophysica Acta, vol. 32, pp. 32–46, Jan. 1959. 
[85] A. Ben-Shem, F. Frolow, and N. Nelson, “Crystal structure of plant photosystem I,” 
Nature, vol. 426, no. 6967, pp. 630–635, Dec. 2003. 
[86] M. D. Collins and D. Jones, “Distribution of isoprenoid quinone structural types in 
bacteria and their taxonomic implication.,” Microbiological Reviews, vol. 45, no. 2, p. 
316, Jun. 1981. 
[87] B. Nowicka and J. Kruk, “Occurrence, biosynthesis and function of isoprenoid 
quinones,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1797, no. 9, pp. 
1587–1605, Sep. 2010. 
[88] B. Furie, B. A. Bouchard, and B. C. Furie, “Vitamin K-Dependent Biosynthesis of γ-
Carboxyglutamic Acid,” Blood, vol. 93, no. 6, pp. 1798–1808, Mar. 1999. 
Chapter 8: References 
167 
 
[89] E. L. Ulrich, M. E. Girvin, W. A. Cramer, and J. L. Markley, “Location and mobility 
of ubiquinones of different chain lengths in artificial membrane vesicles,” 
Biochemistry, vol. 24, no. 10, pp. 2501–2508, May 1985. 
[90] Y. Roche, P. Peretti, and S. Bernard, “Influence of the chain length of ubiquinones on 
their interaction with DPPC in mixed monolayers,” Biochimica et Biophysica Acta 
(BBA) - Biomembranes, vol. 1758, no. 4, pp. 468–478, Apr. 2006. 
[91] L. Rossi, G. A. Moore, S. Orrenius, and P. J. O’Brien, “Quinone toxicity in 
hepatocytes without oxidative stress,” Archives of Biochemistry and Biophysics, vol. 
251, no. 1, pp. 25–35, Nov. 1986. 
[92] P. J. O’Brien, “Molecular mechanisms of quinone cytotoxicity,” Chemico-Biological 
Interactions, vol. 80, no. 1, pp. 1–41, 1991. 
[93] D. Ross, H. Thor, S. Orrenius, and P. Moldeus, “Interaction of menadione (2-methyl-
1,4-naphthoquinone) with glutathione,” Chemico-Biological Interactions, vol. 55, pp. 
177–184, Jan. 1985. 
[94] “Henrik Dam - Nobel Lecture: The Discovery of Vitamin K, Its Biological Functions 
and Therapeutical Application,” 2014. [Online]. Available: 
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1943/dam-lecture.html. 
[Accessed: 15-May-2018]. 
[95] C. T. Esmon, J. A. Sadowski, and J. W. Suttie, “A new carboxylation reaction. The 
vitamin K-dependent incorporation of H-14-CO3- into prothrombin.,” J. Biol. Chem., 
vol. 250, no. 12, pp. 4744–4748, Jun. 1975. 
[96] P. A. Friedman and M. Shia, “Some characteristics of a vitamin K-dependent 
carboxylating system from rat liver microsomes,” Biochemical and Biophysical 
Research Communications, vol. 70, no. 2, pp. 647–654, May 1976. 
[97] G. L. Nelsestuen and J. W. Suttie, “Mode of action of vitamin K. Calcium binding 
properties of bovine prothrombin,” Biochemistry, vol. 11, no. 26, pp. 4961–4964, Dec. 
1972. 
[98] P. V. Hauschka, J. B. Lian, and P. M. Gallop, “Direct identification of the calcium-
binding amino acid, gamma-carboxyglutamate, in mineralized tissue,” PNAS, vol. 72, 
no. 10, pp. 3925–3929, Oct. 1975. 
[99] J. V. Ratcliffe, B. Furie, and B. C. Furie, “The importance of specific gamma-
carboxyglutamic acid residues in prothrombin. Evaluation by site-specific 
mutagenesis.,” J. Biol. Chem., vol. 268, no. 32, pp. 24339–24345, Nov. 1993. 
[100] T. Sakai, T. Lund-Hansen, L. Thim, and W. Kisiel, “The gamma-carboxyglutamic acid 
domain of human factor VIIa is essential for its interaction with cell surface tissue 
factor.,” J. Biol. Chem., vol. 265, no. 4, pp. 1890–1894, Feb. 1990. 
[101] G. L. Nelsestuen, M. Broderius, and G. Martin, “Role of gamma-carboxyglutamic 
acid. Cation specificity of prothrombin and factor X-phospholipid binding.,” J. Biol. 
Chem., vol. 251, no. 22, pp. 6886–6893, Nov. 1976. 
[102] R. Rawala-Sheikh, S. S. Ahmad, D. M. Monroe, H. R. Roberts, and P. N. Walsh, “Role 
of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and 
in factor-X activation,” Blood, vol. 79, no. 2, pp. 398–405, Jan. 1992. 
[103] L. Zhang, A. Jhingan, and F. J. Castellino, “Role of individual gamma-
carboxyglutamic acid residues of activated human protein C in defining its in vitro 
anticoagulant activity,” Blood, vol. 80, no. 4, pp. 942–952, Aug. 1992. 
[104] T. Sugo, B. Dahlbäck, A. Holmgren, and J. Stenflo, “Calcium binding of bovine 
protein S. Effect of thrombin cleavage and removal of the gamma-carboxyglutamic 
acid-containing region.,” J. Biol. Chem., vol. 261, no. 11, pp. 5116–5120, Apr. 1986. 
Chapter 8: References 
168 
 
[105] P. V. Hauschka and F. H. Wians, “Osteocalcin-hydroxyapatite interaction in the 
extracellular organic matrix of bone,” Anat. Rec., vol. 224, no. 2, pp. 180–188, Jun. 
1989. 
[106] L. J. Schurgers et al., “Post-translational modifications regulate matrix Gla protein 
function: importance for inhibition of vascular smooth muscle cell calcification,” 
Journal of Thrombosis and Haemostasis, vol. 5, no. 12, pp. 2503–2511, Dec. 2007. 
[107] T. Nakano, K. Kawamoto, J. Kishino, K. Nomura, K. Higashino, and H. Arita, 
“Requirement of γ-carboxyglutamic acid residues for the biological activity of Gas6: 
contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells,” 
Biochemical Journal, vol. 323, no. 2, pp. 387–392, Apr. 1997. 
[108] I. Hasanbasic, I. Rajotte, and M. Blostein, “The role of γ-carboxylation in the anti-
apoptotic function of gas6,” Journal of Thrombosis and Haemostasis, vol. 3, no. 12, 
pp. 2790–2797, Dec. 2005. 
[109] M. J. Shearer and P. Newman, “Recent trends in the metabolism and cell biology of 
vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis,” J. 
Lipid Res., vol. 55, no. 3, pp. 345–362, Mar. 2014. 
[110] C. Vermeer, “Gamma-carboxyglutamate-containing proteins and the vitamin K-
dependent carboxylase.,” Biochemical Journal, vol. 266, no. 3, p. 625, Mar. 1990. 
[111] G. Ferland, “The Vitamin K-dependent Proteins: an Update,” Nutrition Reviews, vol. 
56, no. 8, pp. 223–230, Aug. 1998. 
[112] G. L. Nelsestuen, A. M. Shah, and S. B. Harvey, “Vitamin K-dependent proteins,” 
Vitamins & Hormones, vol. 58, pp. 355–389, 2000. 
[113] European Bioinformatics Institute, “Expression Atlas.” [Online]. Available: 
http://www.ebi.ac.uk/gxa/home. 
[114] H. Dam, F. Schønheyder, and E. Tage-Hansen, “Studies on the mode of action of 
vitamin K,” Biochemical Journal, vol. 30, no. 6, p. 1075, Jun. 1936. 
[115] G. L. Nelsestuen and J. W. Suttie, “The Mode of Action of Vitamin K. Isolation of a 
Peptide Containing the Vitamin K-Dependent Portion of Prothrombin,” PNAS, vol. 70, 
no. 12, pp. 3366–3370, Dec. 1973. 
[116] S. Magnusson, L. Sottrup-jensen, and T. E. Petersen, “Primary structure of the vitamin 
K-dependent part of prothrombin,” FEBS Letters, vol. 44, no. 2, pp. 189–193, Aug. 
1974. 
[117] G. L. Nelsestuen, T. H. Zytkovicz, and J. B. Howard, “The Mode of Action of Vitamin 
K identification of γ-carboxyglutamic acid as a component of prothrombin,” J. Biol. 
Chem., vol. 249, no. 19, pp. 6347–6350, Oct. 1974. 
[118] D. V. Shah and J. W. Suttie, “The vitamin K dependent, in vitro production of 
prothrombin,” Biochemical and Biophysical Research Communications, vol. 60, no. 4, 
pp. 1397–1402, Oct. 1974. 
[119] J. Stenflo, P. Fernlund, W. Egan, and P. Roepstorff, “Vitamin K Dependent 
Modifications of Glutamic Acid Residues in Prothrombin,” PNAS, vol. 71, no. 7, pp. 
2730–2733, Jul. 1974. 
[120] W. Kisiel and E. W. Davie, “Isolation and characterization of bovine factor VII,” 
Biochemistry, vol. 14, no. 22, pp. 4928–4934, Nov. 1975. 
[121] D. Bucher, E. Nebelin, J. Thomsen, and J. Stenflo, “Identification of γ-
carboxyglutamic acid residues in bovine factors IX and X, and in a new vitamin K-
dependent protein,” FEBS Letters, vol. 68, no. 2, pp. 293–296, Oct. 1976. 
[122] C. V. Prowse and M. P. Esnouf, “The Isolation of a New Warfarin-Sensitive Protein 
from Bovine Plasma,” Biochemical Society Transactions, vol. 5, no. 1, pp. 255–256, 
Feb. 1977. 
Chapter 8: References 
169 
 
[123] J. Stenflo and M. Jönsson, “Protein S, a new vitamin K-dependent protein from bovine 
plasma,” FEBS Letters, vol. 101, no. 2, pp. 377–381, May 1979. 
[124] M. J. Shearer, “Vitamin K deficiency bleeding (VKDB) in early infancy,” Blood 
Reviews, vol. 23, no. 2, pp. 49–59, Mar. 2009. 
[125] A. H. Sutor, R. von Kries, E. A. Cornelissen, A. W. McNinch, and M. Andrew, 
“Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal 
Subcommittee. International Society on Thrombosis and Haemostasis,” Thromb. 
Haemost., vol. 81, no. 3, pp. 456–461, Mar. 1999. 
[126] P. A. Price, A. A. Otsuka, J. W. Poser, J. Kristaponis, and N. Raman, “Characterization 
of a gamma-carboxyglutamic acid-containing protein from bone,” PNAS, vol. 73, no. 
5, pp. 1447–1451, May 1976. 
[127] J. K. D. Villa, M. A. N. Diaz, V. R. Pizziolo, and H. S. D. Martino, “Effect of vitamin 
K in bone metabolism and vascular calcification: a review of mechanisms of action 
and evidences,” Critical Reviews in Food Science and Nutrition, pp. 00–00, Jul. 2016. 
[128] T. N. Stitt et al., “The anticoagulation factor protein S and its relative, Gas6, are 
ligands for the Tyro 3/Axl family of receptor tyrosine kinases,” Cell, vol. 80, no. 4, pp. 
661–670, Feb. 1995. 
[129] C. V. Rothlin, S. Ghosh, E. I. Zuniga, M. B. A. Oldstone, and G. Lemke, “TAM 
Receptors Are Pleiotropic Inhibitors of the Innate Immune Response,” Cell, vol. 131, 
no. 6, pp. 1124–1136, Dec. 2007. 
[130] F. Alciato, P. P. Sainaghi, D. Sola, L. Castello, and G. C. Avanzi, “TNF-alpha, IL-6, 
and IL-1 expression is inhibited by GAS6 in monocytes/macrophages.,” J Leukoc Biol, 
vol. 87, no. 5, pp. 869–875, May 2010. 
[131] J. H. M. van der Meer, T. van der Poll, and C. van ‘t Veer, “TAM receptors, Gas6, and 
protein S: roles in inflammation and hemostasis,” Blood, vol. 123, no. 16, pp. 2460–
2469, Apr. 2014. 
[132] J. D. Kulman, J. E. Harris, B. A. Haldeman, and E. W. Davie, “Primary structure and 
tissue distribution of two novel proline-rich γ-carboxyglutamic acid proteins,” PNAS, 
vol. 94, no. 17, pp. 9058–9062, Aug. 1997. 
[133] J. D. Kulman, J. E. Harris, L. Xie, and E. W. Davie, “Identification of two novel 
transmembrane γ-carboxyglutamic acid proteins expressed broadly in fetal and adult 
tissues,” PNAS, vol. 98, no. 4, pp. 1370–1375, Feb. 2001. 
[134] J. D. Kulman, J. E. Harris, L. Xie, and E. W. Davie, “Proline-rich Gla protein 2 is a 
cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator 
Yes-associated protein,” PNAS, vol. 104, no. 21, pp. 8767–8772, May 2007. 
[135] D. F. Mosher, M. W. Johansson, M. E. Gillis, and D. S. Annis, “Periostin and TGF-β-
induced protein: Two peas in a pod?,” Critical Reviews in Biochemistry and Molecular 
Biology, vol. 50, no. 5, pp. 427–439, Sep. 2015. 
[136] D. S. Annis et al., “Absence of Vitamin K-Dependent γ-Carboxylation in Human 
Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to 
Optimize γ-Carboxylation,” PLOS ONE, vol. 10, no. 8, p. e0135374, Aug. 2015. 
[137] D. L. Coutu, J. H. Wu, A. Monette, G.-É. Rivard, M. D. Blostein, and J. Galipeau, 
“Periostin, a Member of a Novel Family of Vitamin K-dependent Proteins, Is 
Expressed by Mesenchymal Stromal Cells,” J. Biol. Chem., vol. 283, no. 26, pp. 
17991–18001, Jun. 2008. 
[138] M. Lev and A. F. Milford, “Vitamin K stimulation of sphingolipid synthesis,” 
Biochemical and Biophysical Research Communications, vol. 45, no. 2, pp. 358–362, 
Oct. 1971. 
[139] N. A. Denisova and S. L. Booth, “Vitamin K and Sphingolipid Metabolism: Evidence 
to Date,” Nutrition Reviews, vol. 63, no. 4, pp. 111–121, Apr. 2005. 
Chapter 8: References 
170 
 
[140] J. Li et al., “Novel Role of Vitamin K in Preventing Oxidative Injury to Developing 
Oligodendrocytes and Neurons,” J. Neurosci., vol. 23, no. 13, pp. 5816–5826, Jul. 
2003. 
[141] T. Ichikawa, K. Horie-Inoue, K. Ikeda, B. Blumberg, and S. Inoue, “Vitamin K2 
induces phosphorylation of protein kinase A and expression of novel target genes in 
osteoblastic cells,” J Mol Endocrinol, vol. 39, no. 4, pp. 239–247, Oct. 2007. 
[142] M. Vos et al., “Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 
Deficiency,” Science, vol. 336, no. 6086, pp. 1306–1310, Jun. 2012. 
[143] T. Okano et al., “Conversion of Phylloquinone (Vitamin K1) into Menaquinone-4 
(Vitamin K2) in Mice,” J. Biol. Chem., vol. 283, no. 17, pp. 11270–11279, Apr. 2008. 
[144] K. Ramotar, J. M. Conly, H. Chubb, and T. J. Louie, “Production of Menaquinones by 
Intestinal Anaerobes,” J Infect Dis., vol. 150, no. 2, pp. 213–218, Aug. 1984. 
[145] F. Fernandez and M. D. Collins, “Vitamin K composition of anaerobic gut bacteria,” 
FEMS Microbiology Letters, vol. 41, no. 2, pp. 175–180, Apr. 1987. 
[146] J. C. Mathers, F. Fernandez, M. J. Hill, P. T. McCarthy, M. J. Shearer, and A. Oxley, 
“Dietary modification of potential vitamin K supply from enteric bacterial 
menaquinones in rats,” British Journal of Nutrition, vol. 63, no. 03, pp. 639–652, May 
1990. 
[147] J. M. Conly, K. Stein, L. Worobetz, and S. Rutledge-Harding, “The contribution of 
vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional 
requirements for vitamin K,” Am. J. Gastroenterol., vol. 89, no. 6, pp. 915–923, Jun. 
1994. 
[148] Ichihashi T, Takagishi Y, Uchida K, and Yamada H, “Colonic absorption of 
menaquinone-4 and menaquinone-9 in rats.,” J Nutr, vol. 122, no. 3, pp. 506–512, 
Mar. 1992. 
[149] D. Hollander, E. Rim, and R. Pe, “Vitamin K2 colonic and ileal in vivo absorption: 
bile, fatty acids, and pH effects on transport,” American Journal of Physiology - 
Gastrointestinal and Liver Physiology, vol. 233, no. 2, pp. G124–G129, Aug. 1977. 
[150] Kindberg C, Suttie J, Uchida K, Hirauchi K, and Nakao H, “Menaquinone production 
and utilization in germ-free rats after inoculation with specific organisms.,” J Nutr, vol. 
117, no. 6, pp. 1032–1035, Jun. 1987. 
[151] J. Conly and K. Stein, “Reduction of vitamin K2 concentrations in human liver 
associated with the use of broad spectrum antimicrobials,” Clinical and Investigative 
Medicine, vol. 17, no. 6, pp. 531–9, Dec. 1994. 
[152] J. P. Karl et al., “Changes in Fecal Vitamin K Content are Associated with the Gut 
Microbiota,” FASEB J, vol. 29, no. 1 Supplement, p. 262.1, Apr. 2015. 
[153] J. W. Suttie, “The Importance of Menaquinones in Human Nutrition,” Annual Review 
of Nutrition, vol. 15, no. 1, pp. 399–417, 1995. 
[154] M. J. Shearer, “Vitamin K in Parenteral Nutrition,” Gastroenterology, vol. 137, no. 5, 
pp. S105–S118, Nov. 2009. 
[155] Institute of Medicine (US) Panel on Micronutrients, Dietary Reference Intakes for 
Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, 
Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National 
Academies Press (US), 2001. 
[156] N. and A. (NDA) EFSA Panel on Dietetic Products et al., “Dietary reference values for 
vitamin K,” EFSA Journal, vol. 15, no. 5, p. n/a-n/a, May 2017. 
[157] M. Kamao et al., “Vitamin K Content of Foods and Dietary Vitamin K Intake in 
Japanese Young Women,” Journal of Nutritional Science and Vitaminology, vol. 53, 
no. 6, pp. 464–470, 2007. 
Chapter 8: References 
171 
 
[158] L. J. Schurgers and C. Vermeer, “Determination of Phylloquinone and Menaquinones 
in Food,” Pathophysiology of Haemostasis and Thrombosis, vol. 30, no. 6, pp. 298–
307, May 2001. 
[159] T. J. Koivu, V. I. Piironen, S. K. Henttonen, and P. H. Mattila, “Determination of 
Phylloquinone in Vegetables, Fruits, and Berries by High-Performance Liquid 
Chromatography with Electrochemical Detection,” J. Agric. Food Chem., vol. 45, no. 
12, pp. 4644–4649, Dec. 1997. 
[160] S. L. Booth, J. A. Sadowski, and J. A. T. Pennington, “Phylloquinone (Vitamin K1) 
Content of Foods in the U.S. Food and Drug Administration’s Total Diet Study,” J. 
Agric. Food Chem., vol. 43, no. 6, pp. 1574–1579, Jun. 1995. 
[161] C. Bolton-Smith, R. J. G. Price, S. T. Fenton, D. J. Harrington, and M. J. Shearer, 
“Compilation of a provisional UK database for the phylloquinone (vitamin K1) content 
of foods,” British Journal of Nutrition, vol. 83, no. 04, pp. 389–399, Apr. 2000. 
[162] V. Piironen, T. Koivu, O. Tammisalo, and P. Mattila, “Determination of phylloquinone 
in oils, margarines and butter by high-performance liquid chromatography with 
electrochemical detection,” Food Chemistry, vol. 59, no. 3, pp. 473–480, Jul. 1997. 
[163] G. Ferland and J. A. Sadowski, “Vitamin K1 (phylloquinone) content of edible oils:  
effects of heating and light exposure,” J. Agric. Food Chem., vol. 40, no. 10, pp. 1869–
1873, Oct. 1992. 
[164] L. J. Schurgers et al., “Nutritional Intake of Vitamins K1 (Phylloquinone) and K2 
(Menaquinone) in The Netherlands,” Journal of Nutritional & Environmental 
Medicine, vol. 9, no. 2, pp. 115–122, Jan. 1999. 
[165] H. Sumi, “Accumulation of Vitamin K (Menaquinone-7) in Plasma after Ingestion of 
Natto and Natto Bacilli (B. subtilis natto),” Food Science and Technology Research, 
vol. 5, no. 1, pp. 48–50, 1999. 
[166] K. Hojo, R. Watanabe, T. Mori, and N. Taketomo, “Quantitative Measurement of 
Tetrahydromenaquinone-9 in Cheese Fermented by Propionibacteria,” Journal of 
Dairy Science, vol. 90, no. 9, pp. 4078–4083, Sep. 2007. 
[167] T. J. Koivu-Tikkanen, V. Ollilainen, and V. I. Piironen, “Determination of 
Phylloquinone and Menaquinones in Animal Products with Fluorescence Detection 
after Postcolumn Reduction with Metallic Zinc,” J. Agric. Food Chem., vol. 48, no. 12, 
pp. 6325–6331, Dec. 2000. 
[168] K. Hirauchi et al., “Measurement of k vitamins in animal tissues by high-performance 
liquid chromatography with fluorimetric detection,” Journal of Chromatography B: 
Biomedical Sciences and Applications, vol. 497, pp. 131–137, Jan. 1989. 
[169] S. J. Elder, D. B. Haytowitz, J. Howe, J. W. Peterson, and S. L. Booth, “Vitamin K 
Contents of Meat, Dairy, and Fast Food in the U.S. Diet,” J. Agric. Food Chem., vol. 
54, no. 2, pp. 463–467, Jan. 2006. 
[170] A. Richmond, Handbook of Microalgal Culture: Biotechnology and Applied 
Phycology. Oxford, UK: Blackwell Science Ltd, 2004. 
[171] P. C. (Philip C. Withers, Comparative animal physiology. Orlando, Florida: Saunders 
College Pub., 1992. 
[172] D. Randall, W. Burggren, and K. French, Eckert animal physiology: mechanisms and 
adaptations., 4th ed. New York, N.Y., United States: W.H. Freeman and Co., 1997. 
[173] R. M. Akers and D. M. Denbow, Anatomy and Physiology of Domestic Animals, 2nd 
ed. Somerset: Wiley, 2013. 
[174] R. F. Evert, “Cell Wall,” in Esau’s Plant Anatomy, John Wiley & Sons, Inc., 2006, pp. 
65–101. 
[175] H. H. Erickson, J. P. Goff, W. O. Reece, and E. E. Uemura, Dukes’ Physiology of 
Domestic Animals, 13th ed. Somerset: Wiley, 2015. 
Chapter 8: References 
172 
 
[176] B. L. M. G. Gijsbers, K.-S. G. Jie, and C. Vermeer, “Effect of food composition on 
vitamin K absorption in human volunteers,” British Journal of Nutrition, vol. 76, no. 
02, pp. 223–229, Aug. 1996. 
[177] A. K. Garber, N. C. Binkley, D. C. Krueger, and J. W. Suttie, “Comparison of 
Phylloquinone Bioavailability from Food Sources or a Supplement in Human 
Subjects,” J. Nutr., vol. 129, no. 6, pp. 1201–1203, Jun. 1999. 
[178] C. Hotz and R. S. Gibson, “Traditional Food-Processing and Preparation Practices to 
Enhance the Bioavailability of Micronutrients in Plant-Based Diets,” J. Nutr., vol. 137, 
no. 4, pp. 1097–1100, Apr. 2007. 
[179] S. L. Booth, A. H. Lichtenstein, and G. E. Dallal, “Phylloquinone Absorption from 
Phylloquinone-Fortified Oil Is Greater than from a Vegetable in Younger and Older 
Men and Women,” J. Nutr., vol. 132, no. 9, pp. 2609–2612, Sep. 2002. 
[180] K. M. M. D. Brinkhous, H. P. M. D. Smith, and E. D. M. D. Warner, “Prothrombin 
deficiency and the bleeding tendency in obstructuve jaundice and in biliary fistula 
effect of feeding bile and alfalfa (vitamin K),” Journal of the Medical Sciences, vol. 
196, no. 1, pp. 50–56, Jul. 1938. 
[181] E. M. Research, “Global Animal Feed Additives Market to witness a CAGR of 5.1% 
during 2017-2023: Energias market Research Pvt. Ltd.,” GlobeNewswire News Room, 
02-Feb-2018. [Online]. Available: http://globenewswire.com/news-
release/2018/02/02/1332186/0/en/Global-Animal-Feed-Additives-Market-to-witness-a-
CAGR-of-5-1-during-2017-2023-Energias-market-Research-Pvt-Ltd.html. [Accessed: 
24-Apr-2018]. 
[182] H. J. Almquist and E. L. R. Stokstad, “Factors Influencing the Incidence of Dietary 
Hemorrhagic Disease in Chicks: Two Figures,” The Journal of Nutrition, vol. 12, no. 
4, pp. 329–335, 1936. 
[183] H. Almquist and E. Stokstad, “Dietary haemorrhagic disease in chicks,” Nature, vol. 
136, no. July 6, p. 31, 1935. 
[184] Reportlinker, “Animal Feed Additives Market by Types (Antibiotics, Vitamins, 
Antioxidants, Amino Acids,Feed enzymes), Livestock (Swine, Poultry, Cattle, 
Aquaculture, Others) & Geography - Trends & Forecasts (2011 - 2018).” [Online]. 
Available: https://www.prnewswire.com/news-releases/animal-feed-additives-market-
by-types-antibiotics-vitamins-antioxidants-amino-acidsfeed-enzymes-livestock-swine-
poultry-cattle-aquaculture-others--geography---trends--forecasts-2011---2018-
255675691.html. [Accessed: 24-Apr-2018]. 
[185] H. Dam and E. Søndergaard, “Comparison of the Action of Vitamin K1, Menadione 
and Synkavit administered Intravenously to Vitamin K Deficient Chicks.,” Acta 
Pharmacologica et Toxicologica, vol. 9, no. 2, pp. 131–136, Apr. 1953. 
[186] D. V. Frost and H. C. Spruth, “Control of Hemorrhagic Condition in Chickens with 
Menadione Sodium Bisulfite,” Poultry Science, vol. 34, no. 1, pp. 56–64, Jan. 1955. 
[187] H. S. Perdue, H. C. Spruth, and D. V. Frost, “Comparison of Vitamin K Activities of 
Vitamin K1 and Klotogen (Menadione Sodium Bisulfite Complex),” Poultry Science, 
vol. 36, no. 3, pp. 633–635, May 1957. 
[188] T. S. Nelson and L. C. Norris, “Studies on the vitamin K requirement of the chick. I. 
Requirements of the chick for vitamin K1, menadione and menadione sodium 
bisulfite,” The Journal Of Nutrition, vol. 72, pp. 137–144, Oct. 1960. 
[189] T. S. NELSON and L. C. NORRIS, “Studies on the vitamin K requirement of the 
chick. 2. Effect of sulfaquinoxaline on the quantitative requirements of the chick for 
vitamin K1, menadione and menadione sodium bisulfite.,” Journal of Nutrition, vol. 
73, pp. 135–142, 1961. 
Chapter 8: References 
173 
 
[190] P. Griminger, “Relative Vitamin K Potency of Two Water-Soluble Menadione 
Analogues,” Poultry Science, vol. 44, no. 1, pp. 210–213, Jan. 1965. 
[191] G. McBride, I. P. Parer, and F. Foenander, “The Social Organization and Behaviour of 
the Feral Domestic Fowl,” Animal Behaviour Monographs, vol. 2, pp. 125–181, Jan. 
1969. 
[192] C. J. Savory, D. G. M. Wood-Gush, and I. J. H. Duncan, “Feeding behaviour in a 
population of domestic fowls in the wild,” Applied Animal Ethology, vol. 4, no. 1, pp. 
13–27, Mar. 1978. 
[193] Muhammad Arshad, Mohamed Zakaria, Ahmad S. Sajap, and Ahmad Ismail, “Food 
and Feeding Habits of Red Junglefowl,” Pakistan Journal of Biological Sciences, vol. 
3, no. 6, pp. 1024–1026, Jun. 2000. 
[194] “Vitamin K Substances,” in IARC Monograph on the Carcinogenic Risks to Humans, 
vol. 76 Some Antiviral and Antineoplastic Drugs, and other Pharmaceutical Agents, 
Lyon, France: IARC Press, 2000, pp. 417–86. 
[195] A. M. Daines, R. J. Payne, M. E. Humphries, and A. D. Abell, “The Synthesis of 
Naturally Occurring Vitamin K and Vitamin K Analogues,” Current Organic 
Chemistry, vol. 7, no. 16, pp. 1625–1634, Nov. 2003. 
[196] A. Berenjian, R. Mahanama, J. Kavanagh, and F. Dehghani, “Vitamin K series: current 
status and future prospects,” Critical Reviews in Biotechnology, vol. 35, no. 2, pp. 
199–208, Apr. 2015. 
[197] S. D. Van Arnum, “Vitamin K,” in Kirk-Othmer Encyclopedia of Chemical 
Technology, 4th ed., New York, NY: John Wiley & Sons, Inc., 2000. 
[198] S. M. Coman, V. I. Parvulescu, S. Wuttke, and E. Kemnitz, “Synthesis of Vitamin K1 
and K1-Chromanol by Friedel–Crafts Alkylation in Heterogeneous Catalysis,” 
ChemCatChem, vol. 2, no. 1, pp. 92–97, Jan. 2010. 
[199] K. Doebel and O. Isler, “Synthesis of vitamin K1 using boron trifluoride catalysts,” 
US2683176 A, 06-Jul-1954. 
[200] R. Hirschmann, R. Miller, and N. L. Wendler, “The Synthesis of Vitamin K1,” J. Am. 
Chem. Soc., vol. 76, no. 18, pp. 4592–4594, Sep. 1954. 
[201] B. R. Baker, T. H. Davies, L. McElroy, and G. H. Carlson, “The Antihemorrhagic 
Activity of Sulfonated Derivatives of 2-Methylnaphthalene,” J. Am. Chem. Soc., vol. 
64, no. 5, pp. 1096–1101, May 1942. 
[202] J.-H. Tien, C.-Y. Pang, and N.-H. Hsu, “Method of making vitamin K1,” World 
Intellectual Property Organization Patent WO2016060670 A1, 21-Apr-2016. 
[203] NattoPharma, “MenaQ7 Varieties,” 2015. [Online]. Available: 
http://menaq7.com/why-menaq7/varieties/. [Accessed: 06-Nov-2017]. 
[204] Sungen Bioscience, “Technology & Characteristics of Natto K2TM,” 2016. [Online]. 
Available: 
http://www.sungenbio.com/?page=p560b871c859a7&lang=437&ContentID=15. 
[Accessed: 06-Nov-2017]. 
[205] R. Bentley and R. Meganathan, “Biosynthesis of vitamin K (menaquinone) in 
bacteria.,” Microbiol. Rev., vol. 46, no. 3, pp. 241–280, Sep. 1982. 
[206] J. W. Seeger and R. Bentley, “Phylloquinone (Vitamin K1) biosynthesis in Euglena 
gracilis strain Z,” Phytochemistry, vol. 30, no. 11, pp. 3585–3589, Jan. 1991. 
[207] Agricultural Research Service, United States Department of Agriculture, “Basic 
Report:  11445, Seaweed, kelp, raw,” 2017. [Online]. Available: 
https://ndb.nal.usda.gov/ndb/foods/show/3158?fgcd=&manu=&lfacet=&format=Abrid
ged&count=&max=35&offset=&sort=&qlookup=seaweed. [Accessed: 15-Mar-2017]. 
[208] Y. D. Roeck-Holtzhauer, I. Quere, and C. Claire, “Vitamin analysis of five planktonic 
microalgae and one macroalga,” J Appl Phycol, vol. 3, no. 3, pp. 259–264, 1991. 
Chapter 8: References 
174 
 
[209] A. L. Demain and J. L. Adrio, “Contributions of Microorganisms to Industrial 
Biology,” Mol Biotechnol, vol. 38, no. 1, p. 41, Jan. 2008. 
[210] M. A. Borowitzka, “High-value products from microalgae—their development and 
commercialisation,” J Appl Phycol, vol. 25, no. 3, pp. 743–756, Jan. 2013. 
[211] P. Spolaore, C. Joannis-Cassan, E. Duran, and A. Isambert, “Commercial applications 
of microalgae,” Journal of Bioscience and Bioengineering, vol. 101, no. 2, pp. 87–96, 
Feb. 2006. 
[212] P. Lee and C. Schmidt-Dannert, “Metabolic engineering towards biotechnological 
production of carotenoids in microorganisms,” Appl Microbiol Biotechnol, vol. 60, no. 
1–2, pp. 1–11, Oct. 2002. 
[213] J. A. Gimpel, V. Henríquez, and S. P. Mayfield, “In Metabolic Engineering of 
Eukaryotic Microalgae: Potential and Challenges Come with Great Diversity,” Front 
Microbiol, vol. 6, p. 1376, Dec. 2015. 
[214] Basset G, Latimer S, Fatihi A, Soubeyrand E, and Block A, “Phylloquinone (Vitamin 
K1): Occurrence, Biosynthesis and Functions.,” Mini Rev Med Chem, vol. 17(12), pp. 
1028–1038, Jun. 2016. 
[215] K. Brettel, P. Sétif, and P. Mathis, “Flash-induced absorption changes in photosystem I 
at low temperature: evidence that the electron acceptor A1 is vitamin K1,” FEBS 
Letters, vol. 203, no. 2, pp. 220–224, Jul. 1986. 
[216] P. Jordan, P. Fromme, H. T. Witt, O. Klukas, W. Saenger, and N. Krauß, “Three-
dimensional structure of cyanobacterial photosystem I at 2.5 |[angst]| resolution,” 
Nature, vol. 411, no. 6840, pp. 909–917, Jun. 2001. 
[217] A. K. Singh, M. Bhattacharyya-Pakrasi, and H. B. Pakrasi, “Identification of an 
Atypical Membrane Protein Involved in the Formation of Protein Disulfide Bonds in 
Oxygenic Photosynthetic Organisms,” J. Biol. Chem., vol. 283, no. 23, pp. 15762–
15770, Jun. 2008. 
[218] F. Furt, C. van Oostende, J. R. Widhalm, M. A. Dale, J. Wertz, and G. J. C. Basset, “A 
bimodular oxidoreductase mediates the specific reduction of phylloquinone (vitamin 
K1) in chloroplasts,” The Plant Journal, vol. 64, no. 1, pp. 38–46, Oct. 2010. 
[219] R. Verpoorte, R. van der Heijden, H. J. G. ten Hoopen, and J. Memelink, “Metabolic 
engineering of plant secondary metabolite pathways for the production of fine 
chemicals,” Biotechnology Letters, vol. 21, no. 6, pp. 467–479, Jun. 1999. 
[220] J. M. Anderson, W. S. Chow, and Y.-I. Park, “The grand design of photosynthesis: 
Acclimation of the photosynthetic apparatus to environmental cues,” Photosynth Res, 
vol. 46, no. 1–2, pp. 129–139, Nov. 1995. 
[221] P. R. Chitnis, “Photosystem I: Function and Physiology,” Annual Review of Plant 
Physiology and Plant Molecular Biology, vol. 52, no. 1, pp. 593–626, 2001. 
[222] J. A. González and J. Calbó, “Modelled and measured ratio of PAR to global radiation 
under cloudless skies,” Agricultural and Forest Meteorology, vol. 110, no. 4, pp. 319–
325, Feb. 2002. 
[223] Z. Dubinsky and N. Stambler, “Photoacclimation processes in phytoplankton: 
mechanisms, consequences, and applications,” Aquatic Microbial Ecology, vol. 56, no. 
2–3, pp. 163–176, Sep. 2009. 
[224] H. L. MacIntyre, T. M. Kana, T. Anning, and R. J. Geider, “Photoacclimation of 
Photosynthesis Irradiance Response Curves and Photosynthetic Pigments in 
Microalgae and Cyanobacteria1,” Journal of Phycology, vol. 38, no. 1, pp. 17–38, Feb. 
2002. 
[225] R. Goss and T. Jakob, “Regulation and function of xanthophyll cycle-dependent 
photoprotection in algae,” Photosynth Res, vol. 106, no. 1–2, pp. 103–122, Nov. 2010. 
Chapter 8: References 
175 
 
[226] I. R. Davison, “Environmental Effects on Algal Photosynthesis: Temperature,” Journal 
of Phycology, vol. 27, no. 1, pp. 2–8, Feb. 1991. 
[227] P. Claquin, I. Probert, S. Lefebvre, and B. Veron, “Effects of temperature on 
photosynthetic parameters and TEP production in eight species of marine microalgae,” 
Aquatic Microbial Ecology, vol. 51, no. 1, pp. 1–11, Apr. 2008. 
[228] R. J. Geider, H. L. MacIntyre, and T. M. Kana, “Dynamic model of phytoplankton 
growth and acclimation: responses of the balanced growth rate and the chlorophyll a: 
carbon ratio to light, nutrient-limitation and temperature,” Marine Ecology Progress 
Series, vol. 148, no. 1/3, pp. 187–200, 1997. 
[229] M. Lürling, F. Eshetu, E. J. Faassen, S. Kosten, and V. L. M. Huszar, “Comparison of 
cyanobacterial and green algal growth rates at different temperatures,” Freshwater 
Biology, vol. 58, no. 3, pp. 552–559, Mar. 2013. 
[230] C. Butterwick, S. I. Heaney, and J. F. Talling, “Diversity in the influence of 
temperature on the growth rates of freshwater algae, and its ecological relevance,” 
Freshwater Biology, vol. 50, no. 2, pp. 291–300, Feb. 2005. 
[231] R. E. Hecky and P. Kilham, “Nutrient limitation of phytoplankton in freshwater and 
marine environments: A review of recent evidence on the effects of enrichment1,” 
Limnol. Oceanogr., vol. 33, no. 4part2, pp. 796–822, Jul. 1988. 
[232] R. J. Geider and J. L. Roche, “The role of iron in phytoplankton photosynthesis, and 
the potential for iron-limitation of primary productivity in the sea,” Photosynth Res, 
vol. 39, no. 3, pp. 275–301, Mar. 1994. 
[233] D. H. Turpin, “Effects of Inorganic N Availability on Algal Photosynthesis and Carbon 
Metabolism,” Journal of Phycology, vol. 27, no. 1, pp. 14–20, Feb. 1991. 
[234] M. T. Auer, M. S. Kieser, and R. P. Canale, “Identification of Critical Nutrient Levels 
through Field Verification of Models for Phosphorus and Phytoplankton Growth,” 
Can. J. Fish. Aquat. Sci., vol. 43, no. 2, pp. 379–388, Feb. 1986. 
[235] J. J. Elser, E. R. Marzolf, and C. R. Goldman, “Phosphorus and Nitrogen Limitation of 
Phytoplankton Growth in the Freshwaters of North America: A Review and Critique of 
Experimental Enrichments,” Can. J. Fish. Aquat. Sci., vol. 47, no. 7, pp. 1468–1477, 
Jul. 1990. 
[236] J. J. Elser et al., “Global analysis of nitrogen and phosphorus limitation of primary 
producers in freshwater, marine and terrestrial ecosystems,” Ecology Letters, vol. 10, 
no. 12, pp. 1135–1142, Dec. 2007. 
[237] I. Berman-Frank, P. Lundgren, and P. Falkowski, “Nitrogen fixation and 
photosynthetic oxygen evolution in cyanobacteria,” Research in Microbiology, vol. 
154, no. 3, pp. 157–164, Apr. 2003. 
[238] S. C. Roberts, “Production and engineering of terpenoids in plant cell culture,” Nat 
Chem Biol, vol. 3, no. 7, pp. 387–395, Jul. 2007. 
[239] J. Gross, J. Meurer, and D. Bhattacharya, “Evidence of a chimeric genome in the 
cyanobacterial ancestor of plastids,” BMC Evolutionary Biology, vol. 8, p. 117, 2008. 
[240] M. Rohmer, M. Knani, P. Simonin, B. Sutter, and H. Sahm, “Isoprenoid biosynthesis 
in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate,” 
Biochemical Journal, vol. 295, no. 2, pp. 517–524, Oct. 1993. 
[241] A. Disch, J. Schwender, C. Müller, H. K. Lichtenthaler, and M. Rohmer, “Distribution 
of the mevalonate and glyceraldehyde phosphate/pyruvate pathways for isoprenoid 
biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714,” 
Biochemical Journal, vol. 333, no. 2, pp. 381–388, Jul. 1998. 
[242] W. Eisenreich, A. Bacher, D. Arigoni, and F. Rohdich, “Biosynthesis of isoprenoids 
via the non-mevalonate pathway,” CMLS, Cell. Mol. Life Sci., vol. 61, no. 12, pp. 
1401–1426, Jun. 2004. 
Chapter 8: References 
176 
 
[243] G. Beck et al., “Characterization of the GGPP synthase gene family in Arabidopsis 
thaliana,” Plant Mol Biol, vol. 82, no. 4–5, pp. 393–416, Jul. 2013. 
[244] Y. Keller, F. Bouvier, A. d’Harlingue, and B. Camara, “Metabolic compartmentation 
of plastid prenyllipid biosynthesis,” European Journal of Biochemistry, vol. 251, no. 
1–2, pp. 413–417, Jan. 1998. 
[245] R. Meganathan, “Biosynthesis of menaquinone (vitamin K2) and ubiquinone 
(coenzyme Q): A perspective on enzymatic mechanisms,” in Cofactor Biosynthesis, 
vol. 61, Gerald Litwack and Tadhg Begley, Eds. Cambridge, MA: Academic Press, 
2001, pp. 173–218. 
[246] T. W. Johnson et al., “Recruitment of a foreign quinone into the A(1) site of 
photosystem I. I. Genetic and physiological characterization of phylloquinone 
biosynthetic pathway mutants in Synechocystis sp. pcc 6803.,” J. Biol. Chem., vol. 
275, no. 12, pp. 8523–8530, Mar. 2000. 
[247] J. Gross et al., “A Plant Locus Essential for Phylloquinone (Vitamin K1) Biosynthesis 
Originated from a Fusion of Four Eubacterial Genes,” J. Biol. Chem., vol. 281, no. 25, 
pp. 17189–17196, Jun. 2006. 
[248] M. Jiang, Y. Cao, Z.-F. Guo, M. Chen, X. Chen, and Z. Guo, “Menaquinone 
Biosynthesis in Escherichia coli:  Identification of 2-Succinyl-5-enolpyruvyl-6-
hydroxy-3-cyclohexene-1-carboxylate as a Novel Intermediate and Re-Evaluation of 
MenD Activity,” Biochemistry, vol. 46, no. 38, pp. 10979–10989, Sep. 2007. 
[249] M. Jiang, X. Chen, Z.-F. Guo, Y. Cao, M. Chen, and Z. Guo, “Identification and 
Characterization of (1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate 
Synthase in the Menaquinone Biosynthesis of Escherichia coli,” Biochemistry, vol. 47, 
no. 11, pp. 3426–3434, Mar. 2008. 
[250] J. R. Widhalm, C. van Oostende, F. Furt, and G. J. C. Basset, “A dedicated thioesterase 
of the Hotdog-fold family is required for the biosynthesis of the naphthoquinone ring 
of vitamin K1,” PNAS, vol. 106, no. 14, pp. 5599–5603, Apr. 2009. 
[251] A. Fatihi et al., “A Dedicated Type II NADPH Dehydrogenase Performs the 
Penultimate Step in the Biosynthesis of Vitamin K1 in Synechocystis and 
Arabidopsis,” The Plant Cell, vol. 27, no. 6, pp. 1730–1741, Jun. 2015. 
[252] A. Lohmann et al., “Deficiency in Phylloquinone (Vitamin K1) Methylation Affects 
Prenyl Quinone Distribution, Photosystem I Abundance, and Anthocyanin 
Accumulation in the Arabidopsis AtmenG Mutant,” J. Biol. Chem., vol. 281, no. 52, 
pp. 40461–40472, Dec. 2006. 
[253] C. P. Cluis, A. M. Burja, and V. J. J. Martin, “Current prospects for the production of 
coenzyme Q10 in microbes,” Trends in Biotechnology, vol. 25, no. 11, pp. 514–521, 
Nov. 2007. 
[254] J. K. Kim, E. J. Kim, and H. Y. Jung, “Vitamin Q10 : Property, Production and 
Application,” in Industrial Biotechnology of Vitamins, Biopigments, and Antioxidants, 
E. J. Vandamme and J. L. Revuelta, Eds. Weinheim, Germany: Wiley-VCH Verlag 
GmbH & Co. KGaA, 2016, pp. 321–365. 
[255] M. K. Kong and P. C. Lee, “Metabolic engineering of menaquinone-8 pathway of 
Escherichia coli as a microbial platform for vitamin K production,” Biotechnol. 
Bioeng., vol. 108, no. 8, pp. 1997–2002, Aug. 2011. 
[256] N. J. Oliver, C. A. Rabinovitch-Deere, A. L. Carroll, N. E. Nozzi, A. E. Case, and S. 
Atsumi, “Cyanobacterial metabolic engineering for biofuel and chemical production,” 
Current Opinion in Chemical Biology, vol. 35, pp. 43–50, Dec. 2016. 
[257] M. A. Gomaa, L. Al-Haj, and R. M. M. Abed, “Metabolic engineering of 
Cyanobacteria and microalgae for enhanced production of biofuels and high-value 
products,” J Appl Microbiol, vol. 121, no. 4, pp. 919–931, Oct. 2016. 
Chapter 8: References 
177 
 
[258] B. M. Berla, R. Saha, C. M. Immethun, C. D. Maranas, T. S. Moon, and H. B. Pakrasi, 
“Synthetic biology of cyanobacteria: unique challenges and opportunities,” Front 
Microbiol, vol. 4, p. 246, Aug. 2013. 
[259] S. Qin, H. Lin, and P. Jiang, “Advances in genetic engineering of marine algae,” 
Biotechnology Advances, vol. 30, no. 6, pp. 1602–1613, Nov. 2012. 
[260] R. León-Bañares, D. González-Ballester, A. Galván, and E. Fernández, “Transgenic 
microalgae as green cell-factories,” Trends in Biotechnology, vol. 22, no. 1, pp. 45–52, 
Jan. 2004. 
[261] J. Ni, F. Tao, Y. Wang, F. Yao, and P. Xu, “A photoautotrophic platform for the 
sustainable production of valuable plant natural products from CO 2,” Green 
Chemistry, vol. 18, no. 12, pp. 3537–3548, 2016. 
[262] Y. Wang, F. Tao, J. Ni, C. Li, and P. Xu, “Production of C3 platform chemicals from 
CO 2 by genetically engineered cyanobacteria,” Green Chemistry, vol. 17, no. 5, pp. 
3100–3110, 2015. 
[263] M. A. Borowitzka, “Commercial production of microalgae: ponds, tanks, tubes and 
fermenters,” Journal of Biotechnology, vol. 70, no. 1–3, pp. 313–321, Apr. 1999. 
[264] R. Harun, M. Singh, G. M. Forde, and M. K. Danquah, “Bioprocess engineering of 
microalgae to produce a variety of consumer products,” Renewable and Sustainable 
Energy Reviews, vol. 14, no. 3, pp. 1037–1047, Apr. 2010. 
[265] A. C. Apel and D. Weuster-Botz, “Engineering solutions for open microalgae mass 
cultivation and realistic indoor simulation of outdoor environments,” Bioprocess 
Biosyst Eng, vol. 38, no. 6, pp. 995–1008, Jan. 2015. 
[266] S. Aaronson and Z. Dubinsky, “Mass production of microalgae,” Experientia, vol. 38, 
no. 1, pp. 36–40, Jan. 1982. 
[267] C. U. Ugwu, H. Aoyagi, and H. Uchiyama, “Photobioreactors for mass cultivation of 
algae,” Bioresource technology, vol. 99, no. 10, pp. 4021–4028, 2008. 
[268] Y. Chisti, “Large-Scale Production of Algal Biomass: Raceway Ponds,” in Algae 
Biotechnology, F. Bux and Y. Chisti, Eds. Cham: Springer International Publishing, 
2016, pp. 21–40. 
[269] R. Davis, J. Markham, C. Kinchin, N. Grundl, E. C. D. Tan, and D. Humbird, “Process 
Design and Economics for the Production of Algal Biomass: Algal Biomass 
Production in Open Pond Systems and Processing Through Dewatering for 
Downstream Conversion,” NREL (National Renewable Energy Laboratory (NREL), 
Golden, CO (United States)), NREL/TP--5100-64772, Feb. 2016. 
[270] F. G. Acién et al., “Photobioreactors for the production of microalgae,” Rev Environ 
Sci Biotechnol, vol. 12, pp. 131–151, 2013. 
[271] J. H. de Vree, R. Bosma, M. Janssen, M. J. Barbosa, and R. H. Wijffels, “Comparison 
of four outdoor pilot-scale photobioreactors,” Biotechnology for Biofuels, vol. 8, no. 1, 
Dec. 2015. 
[272] E. Sierra, F. G. Acién, J. M. Fernández, J. L. García, C. González, and E. Molina, 
“Characterization of a flat plate photobioreactor for the production of microalgae,” 
Chemical Engineering Journal, vol. 138, no. 1–3, pp. 136–147, 2008. 
[273] G. Torzillo and G. C. Zittelli, “Tubular photobioreactors,” in Algal biorefineries, 
Springer, 2015, pp. 187–212. 
[274] N. Kantarci, F. Borak, and K. O. Ulgen, “Bubble column reactors,” Process 
Biochemistry, vol. 40, no. 7, pp. 2263–2283, Jun. 2005. 
[275] A. Sánchez Mirón, A. Contreras Gómez, F. Garcı́a Camacho, E. Molina Grima, and Y. 
Chisti, “Comparative evaluation of compact photobioreactors for large-scale 
monoculture of microalgae,” Journal of Biotechnology, vol. 70, no. 1–3, pp. 249–270, 
Apr. 1999. 
Chapter 8: References 
178 
 
[276] E. Kojima and K. Zhang, “Growth and hydrocarbon production of microalga 
Botryococcus braunii in bubble column photobioreactors,” Journal of Bioscience and 
Bioengineering, vol. 87, no. 6, pp. 811–815, Jun. 1999. 
[277] Huang Yao‐ming and Rorrer Gregory L., “Optimal temperature and photoperiod for 
the cultivation of Agardhiella subulata microplantlets in a bubble‐column 
photobioreactor,” Biotechnology and Bioengineering, vol. 79, no. 2, pp. 135–144, May 
2002. 
[278] A. Sánchez Mirón, M.-C. Cerón Garcı́a, F. Garcı́a Camacho, E. Molina Grima, and Y. 
Chisti, “Growth and biochemical characterization of microalgal biomass produced in 
bubble column and airlift photobioreactors: studies in fed-batch culture,” Enzyme and 
Microbial Technology, vol. 31, no. 7, pp. 1015–1023, Dec. 2002. 
[279] S.-L. Choi, I. S. Suh, and C.-G. Lee, “Lumostatic operation of bubble column 
photobioreactors for Haematococcus pluvialis cultures using a specific light uptake 
rate as a control parameter,” Enzyme and Microbial Technology, vol. 33, no. 4, pp. 
403–409, Sep. 2003. 
[280] R. Ranjbar, R. Inoue, H. Shiraishi, T. Katsuda, and S. Katoh, “High efficiency 
production of astaxanthin by autotrophic cultivation of Haematococcus pluvialis in a 
bubble column photobioreactor,” Biochemical Engineering Journal, vol. 39, no. 3, pp. 
575–580, May 2008. 
[281] J. H. Yoon, J.-H. Shin, and T. H. Park, “Characterization of factors influencing the 
growth of Anabaena variabilis in a bubble column reactor,” Bioresource Technology, 
vol. 99, no. 5, pp. 1204–1210, Mar. 2008. 
[282] E. Jacob-Lopes, L. M. Cacia Ferreira Lacerda, and T. T. Franco, “Biomass production 
and carbon dioxide fixation by Aphanothece microscopica Nägeli in a bubble column 
photobioreactor,” Biochemical Engineering Journal, vol. 40, no. 1, pp. 27–34, May 
2008. 
[283] Sevilla J. M. Fernández, Cerón García M. C., Sánchez Mirón A., Belarbi El Hassan, 
Camacho F. García, and Grima E. Molina, “Pilot‐Plant‐Scale Outdoor Mixotrophic 
Cultures of Phaeodactylum tricornutum Using Glycerol in Vertical Bubble Column 
and Airlift Photobioreactors: Studies in Fed‐Batch Mode,” Biotechnology Progress, 
vol. 20, no. 3, pp. 728–736, Sep. 2008. 
[284] J. F. Sánchez, J. M. Fernández, F. G. Acién, A. Rueda, J. Pérez-Parra, and E. Molina, 
“Influence of culture conditions on the productivity and lutein content of the new strain 
Scenedesmus almeriensis,” Process Biochemistry, vol. 43, no. 4, pp. 398–405, Apr. 
2008. 
[285] C. V. González López, F. G. Acién Fernández, J. M. Fernández Sevilla, J. F. Sánchez 
Fernández, M. C. Cerón García, and E. Molina Grima, “Utilization of the 
cyanobacteria Anabaena sp. ATCC 33047 in CO2 removal processes,” Bioresource 
Technology, vol. 100, no. 23, pp. 5904–5910, Dec. 2009. 
[286] S. Rasoul-Amini, N. Montazeri-Najafabady, M. A. Mobasher, S. Hoseini-Alhashemi, 
and Y. Ghasemi, “Chlorella sp.: A new strain with highly saturated fatty acids for 
biodiesel production in bubble-column photobioreactor,” Applied Energy, vol. 88, no. 
10, pp. 3354–3356, Oct. 2011. 
[287] F. J. Valdés, M. R. Hernández, L. Catalá, and A. Marcilla, “Estimation of CO2 
stripping/CO2 microalgae consumption ratios in a bubble column photobioreactor 
using the analysis of the pH profiles. Application to Nannochloropsis oculata 
microalgae culture,” Bioresource Technology, vol. 119, pp. 1–6, Sep. 2012. 
[288] K. Kumar and D. Das, “Growth characteristics of Chlorella sorokiniana in airlift and 
bubble column photobioreactors,” Bioresource Technology, vol. 116, pp. 307–313, Jul. 
2012. 
Chapter 8: References 
179 
 
[289] Z. Li, M. Sun, Q. Li, A. Li, and C. Zhang, “Profiling of carotenoids in six microalgae 
(Eustigmatophyceae) and assessment of their β-carotene productions in bubble column 
photobioreactor,” Biotechnol Lett, vol. 34, no. 11, pp. 2049–2053, Nov. 2012. 
[290] W.-D. Deckwer and A. Schumpe, “Improved tools for bubble column reactor design 
and scale-up,” Chemical Engineering Science, vol. 48, no. 5, pp. 889–911, Jan. 1993. 
[291] Shah Y. T., Kelkar B. G., Godbole S. P., and Deckwer W.‐D., “Design parameters 
estimations for bubble column reactors,” AIChE Journal, vol. 28, no. 3, pp. 353–379, 
May 1982. 
[292] J. P. Bitog et al., “Application of computational fluid dynamics for modeling and 
designing photobioreactors for microalgae production: A review,” Computers and 
Electronics in Agriculture, vol. 76, no. 2, pp. 131–147, May 2011. 
[293] V. B. Agbor, N. Cicek, R. Sparling, A. Berlin, and D. B. Levin, “Biomass 
pretreatment: Fundamentals toward application,” Biotechnology Advances, vol. 29, no. 
6, pp. 675–685, Nov. 2011. 
[294] E. Günerken, E. D’Hondt, M. H. M. Eppink, L. Garcia-Gonzalez, K. Elst, and R. H. 
Wijffels, “Cell disruption for microalgae biorefineries,” Biotechnology Advances, vol. 
33, no. 2, pp. 243–260, Mar. 2015. 
[295] D. Gutzeit, G. Baleanu, P. Winterhalter, and G. Jerz, “Determination of Processing 
Effects and of Storage Stability on Vitamin K1 (Phylloquinone) in Sea Buckthorn 
Berries (Hippophaë rhamnoides L. ssp. rhamnoides) and Related Products,” Journal of 
Food Science, vol. 72, no. 9, pp. C491–C497, Nov. 2007. 
[296] K. Kurihara and Y. Takagi, “Concentration and Purification of Vitamin K1,” Japanese 
Patent JPS61249947 (A), 07-Nov-1986. 
[297] K. Kurihara and Y. Takagi, “Production of Vitamin K1 Concentrate,” Japanese Patent 
JPS62265245 (A), 18-Nov-1987. 
[298] Y. Isobe et al., “Production of Natural Vitamin K Condensate,” Japanese Patent 
JPH05155803 (A), 22-Jun-1993. 
[299] P. T. Anastas and J. C. Warner, Green chemistry: theory and practice. Oxford: Oxford 
University Press, 1998. 
[300] F. Chemat, M. A. Vian, and G. Cravotto, “Green Extraction of Natural Products: 
Concept and Principles,” International Journal of Molecular Sciences, vol. 13, no. 7, 
pp. 8615–8627, Jul. 2012. 
[301] E. Ibañez, M. Herrero, J. A. Mendiola, and M. Castro-Puyana, “Extraction and 
Characterization of Bioactive Compounds with Health Benefits from Marine 
Resources: Macro and Micro Algae, Cyanobacteria, and Invertebrates,” in Marine 
Bioactive Compounds, M. Hayes, Ed. Boston, MA: Springer US, 2012, pp. 55–98. 
[302] F. M. Kerton, Y. Liu, K. W. Omari, and K. Hawboldt, “Green chemistry and the 
ocean-based biorefinery,” Green Chemistry, vol. 15, no. 4, pp. 860–871, 2013. 
[303] J. F. Pennock, “The biosynthesis of chloroplastidic terpenoid quinones and 
chromanols,” Biochemical Society Transactions, vol. 11, no. 5, pp. 504–510, Oct. 
1983. 
[304] R. Casani, “Vitamin E,” in Kirk-Othmer Encyclopedia of Chemical Technology, 4th 
ed., New York, NY: John Wiley & Sons, Inc., 2000. 
[305] R. Bruni, A. Guerrini, S. Scalia, C. Romagnoli, and G. Sacchetti, “Rapid techniques 
for the extraction of vitamin E isomers from Amaranthus caudatus seeds: ultrasonic 
and supercritical fluid extraction,” Phytochem. Anal., vol. 13, no. 5, pp. 257–261, Sep. 
2002. 
[306] Y. Ge, Y. Ni, H. Yan, Y. Chen, and T. Cai, “Optimization of the Supercritical Fluid 
Extraction of Natural Vitamin E from Wheat Germ Using Response Surface 
Methodology,” Journal of Food Science, vol. 67, no. 1, pp. 239–243, Jan. 2002. 
Chapter 8: References 
180 
 
[307] M. F. Mendes, F. L. P. Pessoa, and A. M. C. Uller, “An economic evaluation based on 
an experimental study of the vitamin E concentration present in deodorizer distillate of 
soybean oil using supercritical CO2,” The Journal of Supercritical Fluids, vol. 23, no. 
3, pp. 257–265, Aug. 2002. 
[308] J. A. Mendiola et al., “Enrichment of vitamin E from Spirulina platensis microalga by 
SFE,” The Journal of Supercritical Fluids, vol. 43, no. 3, pp. 484–489, Jan. 2008. 
[309] R. Checker et al., “Vitamin K3 suppressed inflammatory and immune responses in a 
redox-dependent manner,” Free Radical Research, vol. 45, no. 8, pp. 975–985, Aug. 
2011. 
[310] H. Hatanaka et al., “Effects of vitamin K3 and K5 on proliferation, cytokine 
production, and regulatory T cell-frequency in human peripheral-blood mononuclear 
cells,” Life Sciences, vol. 99, no. 1–2, pp. 61–68, Mar. 2014. 
[311] M. Ogawa et al., “Vitamins K2, K3 and K5 exert antitumor effects on established 
colorectal cancer in mice by inducing apoptotic death of tumor cells,” Int. J. Oncol., 
vol. 31, no. 2, pp. 323–331, Aug. 2007. 
[312] M. Ishibashi, M. Arai, S. Tanaka, K. Onda, and T. Hirano, “Antiproliferative and 
Apoptosis-Inducing Effects of Lipophilic Vitamins on Human Melanoma A375 Cells 
in Vitro,” Biological and Pharmaceutical Bulletin, vol. 35, no. 1, pp. 10–17, Jan. 2012. 
[313] M. H. Maxwell, “Avian blood leucocyte responses to stress,” World’s Poultry Science 
Journal, vol. 49, no. 1, pp. 34–43, Mar. 1993. 
[314] S. M. Peighambari, R. J. Julian, J. P. Vaillancourt, and C. L. Gyles, “Escherichia coli 
cellulitis: experimental infections in broiler chickens,” Avian Dis., vol. 39, no. 1, pp. 
125–134, Mar. 1995. 
[315] K. S. Latimer, K. N. Tang, M. A. Goodwin, W. L. Steffens, and J. Brown, “Leukocyte 
changes associated with acute inflammation in chickens,” Avian Dis., vol. 32, no. 4, 
pp. 760–772, Dec. 1988. 
[316] C. G. Scanes, Sturkie’s Avian Physiology, 6th ed. Saint Louis: Elsevier Science, 2014. 
[317] S. D. Boever, S. Croubels, K. Demeyere, B. Lambrecht, P. D. Backer, and E. Meyer, 
“Flow cytometric differentiation of avian leukocytes and analysis of their intracellular 
cytokine expression,” Avian Pathology, vol. 39, no. 1, pp. 41–46, Feb. 2010. 
[318] R. L. Bohls, R. Smith, P. J. Ferro, N. J. Silvy, Z. Li, and E. W. Collisson, “The use of 
flow cytometry to discriminate avian lymphocytes from contaminating thrombocytes,” 
Developmental & Comparative Immunology, vol. 30, no. 9, pp. 843–850, 2006. 
[319] S.-C. Chow, J. Shao, H. Wang, and Y. Lokhnygina, Eds., Sample size calculations in 
clinical research, Third edition. Boca Raton: Taylor & Francis, 2017. 
[320] W. Bh, U. Y, and S. Jw, “Comparative metabolism and requirement of vitamin K in 
chicks and rats.,” J Nutr, vol. 122, no. 12, pp. 2354–2360, Dec. 1992. 
[321] Becton Dickinson and Company, “BD Accuri C6 Software User Guide.” 2012. 
[322] E. Karsten, E. Breen, and B. R. Herbert, “Red blood cells are dynamic reservoirs of 
cytokines,” Scientific Reports, vol. 8, no. 1, p. 3101, Feb. 2018. 
[323] E. Karsten, C. J. Hill, and B. R. Herbert, “Red blood cells: The primary reservoir of 
macrophage migration inhibitory factor in whole blood,” Cytokine, vol. 102, pp. 34–
40, Feb. 2018. 
[324] Marion G. Macey, Ed., Flow cytometry: principles and applications. Totowa, N.J: 
Humana Press, 2007. 
[325] Biotium, “CFTM488A Dye,” Biotium. [Online]. Available: 
https://biotium.com/technology/cf-dyes/cf488a-dye/. [Accessed: 23-May-2017]. 
[326] N. C. Rath, G. R. Huff, J. M. Balog, and W. E. Huff, “Fluorescein isothiocyanate 
staining and characterization of avian heterophils1,” Veterinary Immunology and 
Immunopathology, vol. 64, no. 1, pp. 83–95, Jun. 1998. 
Chapter 8: References 
181 
 
[327] M. Guillaumont, H. Weiser, L. Sann, B. Vignal, M. Leclercq, and A. Frederich, 
“Hepatic concentration of vitamin K active compounds after application of 
phylloquinone to chickens on a vitamin K deficient or adequate diet.,” Int J Vitam Nutr 
Res, vol. 62, no. 1, pp. 15–20, 1992. 
[328] G. H. Dialameh, W. V. Taggart, J. T. Matschiner, and R. E. Olson, “Isolation and 
characterization of menaquinone-4 as a product of menadione metabolism in chicks 
and rats.,” International Journal for Vitamin and Nutrition Research, vol. 41, no. 3, pp. 
391–400, 1971. 
[329] N. L. Thomson, G. S. Howarth, K.-L. Currie, D. N. Duong, and D. A. J. Stone, 
“Impact of Vitamin K1 on Tissue Vitamin K Levels, Immunity, and Survival of 
Greenlip Abalone, Haliotis laevigata, at Summer Water Temperatures,” Journal of 
Shellfish Research, vol. 37, no. 1, pp. 181–190, Apr. 2018. 
[330] H. Dam and J. Glavind, “Vitamin K in the plant,” Biochemical Journal, vol. 32, no. 3, 
p. 485, Mar. 1938. 
[331] G. Ferland and J. A. Sadowski, “Vitamin K1 (phylloquinone) content of green 
vegetables:  effects of plant maturation and geographical growth location,” J. Agric. 
Food Chem., vol. 40, no. 10, pp. 1874–1877, Oct. 1992. 
[332] L. Lefebvre-Legendre et al., “Loss of Phylloquinone in Chlamydomonas Affects 
Plastoquinone Pool Size and Photosystem II Synthesis,” J. Biol. Chem., vol. 282, no. 
18, pp. 13250–13263, May 2007. 
[333] M. Mimuro et al., “The secondary electron acceptor of photosystem I in Gloeobacter 
violaceus PCC 7421 is menaquinone-4 that is synthesized by a unique but unknown 
pathway,” FEBS Letters, vol. 579, no. 17, pp. 3493–3496. 
[334] E. Yoshida, A. Nakamura, and T. Watanabe, “Reversed-phase HPLC Determination of 
Chlorophyll a′ and Naphthoquinones in Photosystem I of Red Algae: Existence of Two 
Menaquinone-4 Molecules in Photosystem I of Cyanidium caldarium,” Analytical 
Sciences, vol. 19, no. 7, pp. 1001–1005, 2003. 
[335] J. Ruiz et al., “Towards industrial products from microalgae,” Energy Environ. Sci., 
vol. 9, no. 10, pp. 3036–3043, 2016. 
[336] C. J. S. Bolch and S. I. Blackburn, “Isolation and purification of Australian isolates of 
the toxic cyanobacteriumMicrocystis aeruginosa Kütz,” J Appl Phycol, vol. 8, no. 1, 
pp. 5–13, Jan. 1996. 
[337] R. W. Castenholz, “[3] Culturing methods for cyanobacteria,” in Methods in 
Enzymology, vol. 167, Academic Press, 1988, pp. 68–93. 
[338] R. Rippka, “[1] Isolation and purification of cyanobacteria,” in Methods in 
Enzymology, vol. 167, Academic Press, 1988, pp. 3–27. 
[339] R. R. L. Guillard and J. H. Ryther, “Studies of Marine Planktonic Diatoms: I. 
Cyclotella Nana Hustedt, and Detonula Confervacea (cleve) Gran.,” Can. J. 
Microbiol., vol. 8, no. 2, pp. 229–239, Apr. 1962. 
[340] CSIRO, “Australian National Algae Supply Service.” [Online]. Available: 
http://www.csiro.au/en/Research/Collections/ANACC/Australian-National-Algae-
Supply-service. [Accessed: 02-Nov-2016]. 
[341] G. Breuer et al., “Analysis of Fatty Acid Content and Composition in Microalgae,” J 
Vis Exp, no. 80, Oct. 2013. 
[342] “AOAC Official Method 999.15 Vitamin K in Milk and Infant Formulas Liquid 
Chromatographic Method,” J. AOAC Int., vol. 83, no. 121, 2000. 
[343] Y. Suhara, M. Kamao, N. Tsugawa, and T. Okano, “Method for the Determination of 
Vitamin K Homologues in Human Plasma Using High-Performance Liquid 
Chromatography-Tandem Mass Spectrometry,” Anal. Chem., vol. 77, no. 3, pp. 757–
763, Feb. 2005. 
Chapter 8: References 
182 
 
[344] W. W. Carmichael, “Cyanobacteria secondary metabolites—the cyanotoxins,” Journal 
of Applied Bacteriology, vol. 72, no. 6, pp. 445–459, Jun. 1992. 
[345] “Method 959.08,” in Official Methods of Analysis, 17th ed., Gaithersburg, MD: AOAC 
INTERNATIONAL, 2000. 
[346] W. W. Carmichael, C. Drapeau, and D. M. Anderson, “Harvesting of Aphanizomenon 
flos-aquae Ralfs ex Born. &amp; Flah. var. flos-aquae (Cyanobacteria) from Klamath 
Lake for human dietary use,” Journal of Applied Phycology, vol. 12, no. 6, pp. 585–
595. 
[347] L. Pearson, T. Mihali, M. Moffitt, R. Kellmann, and B. Neilan, “On the Chemistry, 
Toxicology and Genetics of the Cyanobacterial Toxins, Microcystin, Nodularin, 
Saxitoxin and Cylindrospermopsin,” Marine Drugs, vol. 8, no. 5, pp. 1650–1680, May 
2010. 
[348] E. Funari and E. Testai, “Human Health Risk Assessment Related to Cyanotoxins 
Exposure,” Critical Reviews in Toxicology, vol. 38, no. 2, pp. 97–125, Jan. 2008. 
[349] E. Bonos et al., “Spirulina as a functional ingredient in broiler chicken diets,” South 
African Journal of Animal Science, vol. 46, no. 1, pp. 94–102, 2016. 
[350] P. G. Peiretti and G. Meineri, “Effects of diets with increasing levels of Spirulina 
platensis on the performance and apparent digestibility in growing rabbits,” Livestock 
Science, vol. 118, no. 1–2, pp. 173–177, Oct. 2008. 
[351] E. Ross and W. Dominy, “The Nutritional Value of Dehydrated, Blue-Green Algae 
(Spirulina plantensis) for Poultry,” Poultry Science, vol. 69, no. 5, pp. 794–800, May 
1990. 
[352] T. W. Campbell, R. W. Allison, M. A. Thrall, and G. Weiser, Veterinary Hematology 
and Clinical Chemistry, vol. 2nd ed. Hoboken: Wiley-Blackwell, 2012. 
[353] A. Melis and J. S. Brown, “Stoichiometry of system I and system II reaction centers 
and of plastoquinone in different photosynthetic membranes,” PNAS, vol. 77, no. 8, pp. 
4712–4716, Aug. 1980. 
[354] A. Melis, “Spectroscopic Methods in Photosynthesis: Photosystem Stoichiometry and 
Chlorophyll Antenna Size,” Philosophical Transactions of the Royal Society B: 
Biological Sciences, vol. 323, no. 1216, pp. 397–409, Apr. 1989. 
[355] Y. Ikeda et al., “Photosystem I complexes associated with fucoxanthin-chlorophyll-
binding proteins from a marine centric diatom, Chaetoceros gracilis,” Biochimica et 
Biophysica Acta (BBA) - Bioenergetics, vol. 1777, no. 4, pp. 351–361, Apr. 2008. 
[356] United States Department of Agriculture and Agricultural Research Service, “Basic 
Report:  11667, Seaweed, spirulina, dried.” [Online]. Available: 
https://ndb.nal.usda.gov/ndb/foods/show/3306?manu=&fgcd=. 
[357] E. W. Becker, “Microalgae for Human and Animal Nutrition,” 2013. 
[358] J. J. Abelilla, Y. Liu, and H. H. Stein, “Digestible indispensable amino acid score 
(DIAAS) and protein digestibility corrected amino acid score (PDCAAS) in oat protein 
concentrate measured in 20- to 30-kilogram pigs,” Journal of the Science of Food and 
Agriculture, vol. 98, no. 1, pp. 410–414, Jan. 2018. 
[359] D. J. Millward, “Amino acid scoring patterns for protein quality assessment,” British 
Journal of Nutrition, vol. 108, no. S2, pp. S31–S43, Aug. 2012. 
[360] E. W. Becker, “Micro-algae as a source of protein,” Biotechnology Advances, vol. 25, 
no. 2, pp. 207–210, Mar. 2007. 
[361] National Health and Medical Research Council, “Nutrient Reference Values for 
Australia and New Zealand Including Recommended Dietary Intakes,” 11-Nov-2009. 
[Online]. Available: https://www.nhmrc.gov.au/guidelines-publications/n35-n36-n37. 
Chapter 8: References 
183 
 
[362] G. P. Otto et al., “Clinical Chemistry Reference Intervals for C57BL/6J, C57BL/6N, 
and C3HeB/FeJ Mice (Mus musculus),” J Am Assoc Lab Anim Sci, vol. 55, no. 4, pp. 
375–386, Jul. 2016. 
[363] C. Mazzaccara et al., “Age-Related Reference Intervals of the Main Biochemical and 
Hematological Parameters in C57BL/6J, 129SV/EV and C3H/HeJ Mouse Strains,” 
PLOS ONE, vol. 3, no. 11, p. e3772, Nov. 2008. 
[364] I. Fernández, A. Peña, N. D. Teso, V. Pérez, and J. Rodríguez-Cuesta, “Clinical 
Biochemistry Parameters in C57BL/6J Mice after Blood Collection from the 
Submandibular Vein and Retroorbital Plexus,” J Am Assoc Lab Anim Sci, vol. 49, no. 
2, pp. 202–206, Mar. 2010. 
[365] J. Zaias, M. Mineau, C. Cray, D. Yoon, and N. H. Altman, “Reference Values for 
Serum Proteins of Common Laboratory Rodent Strains,” J Am Assoc Lab Anim Sci, 
vol. 48, no. 4, pp. 387–390, Jul. 2009. 
[366] E. G. Giannini, R. Testa, and V. Savarino, “Liver enzyme alteration: a guide for 
clinicians,” Canadian Medical Association Journal, vol. 172, no. 3, pp. 367–379, Feb. 
2005. 
[367] X. Pan et al., “Mouse toxicity of Anabaena flos-aquae from Lake Dianchi, China,” 
Environ. Toxicol., vol. 24, no. 1, pp. 10–18, Feb. 2009. 
[368] M. Fraga et al., “Multi-detection method for five common microalgal toxins based on 
the use of microspheres coupled to a flow-cytometry system,” Analytica Chimica Acta, 
vol. 850, pp. 57–64, Nov. 2014. 
[369] P. Kos, G. Gorzo, G. Suranyi, and G. Borbely, “Simple and Efficient Method for 
Isolation and Measurement of Cyanobacterial Hepatotoxins by Plant Tests (Sinapis 
alba L.),” Analytical Biochemistry, vol. 225, no. 1, pp. 49–53, Feb. 1995. 
[370] A. Kaminski, B. Bober, Z. Lechowski, and J. Bialczyk, “Determination of anatoxin-a 
stability under certain abiotic factors,” Harmful Algae, vol. 28, pp. 83–87, Aug. 2013. 
[371] R. Aranda‐Rodriguez, A. Tillmanns, F. M. Benoit, F. R. Pick, J. Harvie, and L. 
Solenaia, “Pressurized liquid extraction of toxins from cyanobacterial cells,” 
Environmental Toxicology, vol. 20, no. 3, pp. 390–396. 
[372] T. R. Baker, G. J. Doucette, C. L. Powell, G. L. Boyer, and F. G. Plumley, “GTX4 
imposters: characterization of fluorescent compounds synthesized by Pseudomonas 
stutzeri SF/PS and Pseudomonas/Alteromonas PTB-1, symbionts of saxitoxin-
producing Alexandrium spp.,” Toxicon, vol. 41, no. 3, pp. 339–347, Mar. 2003. 
[373] M. Karamoko, S. Cline, K. Redding, N. Ruiz, and P. P. Hamel, “Lumen Thiol 
Oxidoreductase1, a Disulfide Bond-Forming Catalyst, Is Required for the Assembly of 
Photosystem II in Arabidopsis,” The Plant Cell, vol. 23, no. 12, pp. 4462–4475, Dec. 
2011. 
[374] S. Purton et al., “Site-Directed Mutagenesis of PsaA Residue W693 Affects 
Phylloquinone Binding and Function in the Photosystem I Reaction Center of 
Chlamydomonas reinhardtii,” Biochemistry, vol. 40, no. 7, pp. 2167–2175, Feb. 2001. 
[375] H. Shimada et al., “Inactivation and deficiency of core proteins of photosystems I and 
II caused by genetical phylloquinone and plastoquinone deficiency but retained 
lamellar structure in a T-DNA mutant of Arabidopsis,” The Plant Journal, vol. 41, no. 
4, pp. 627–637. 
[376] Y. Hihara, K. Sonoike, and M. Ikeuchi, “A Novel Gene, pmgA, Specifically Regulates 
Photosystem Stoichiometry in the Cyanobacterium Synechocystis Species PCC 6803 
in Response to High Light,” Plant Physiology, vol. 117, no. 4, pp. 1205–1216, 1998. 
[377] A. Murakami and Y. Fujita, “Regulation of Photosystem Stoichiometry in the 
Photosynthetic System of the Cyanophyte Synechocystis PCC 6714 in Response to 
Light-Intensity,” Plant Cell Physiol, vol. 32, no. 2, pp. 223–230, Mar. 1991. 
Chapter 8: References 
184 
 
[378] Y. Fujita and A. Murakami, “Regulation of Electron Transport Composition in 
Cyanobacterial Photosynthetic System: Stoichiometry among Photosystem I and II 
Complexes and Their Light-Harvesting Antennae and Cytochrome b6/fComplex,” 
Plant Cell Physiol, vol. 28, no. 8, pp. 1547–1553, Dec. 1987. 
[379] A. Murakami, S.-J. Kim, and Y. Fujita, “Changes in Photosystem Stoichiometry in 
Response to Environmental Conditions for Cell Growth Observed with the Cyanophyte 
Synechocystis PCC 6714,” Plant Cell Physiol, vol. 38, no. 4, pp. 392–397, Jan. 1997. 
[380] J. Kopečná, J. Komenda, L. Bučinská, and R. Sobotka, “Long-Term Acclimation of the 
Cyanobacterium Synechocystis sp. PCC 6803 to High Light Is Accompanied by an 
Enhanced Production of Chlorophyll That Is Preferentially Channeled to Trimeric 
Photosystem I,” Plant Physiology, vol. 160, no. 4, pp. 2239–2250, Dec. 2012. 
[381] J. Kopečná, R. Sobotka, and J. Komenda, “Inhibition of chlorophyll biosynthesis at the 
protochlorophyllide reduction step results in the parallel depletion of Photosystem I 
and Photosystem II in the cyanobacterium Synechocystis PCC 6803,” Planta, vol. 237, 
no. 2, pp. 497–508, Feb. 2013. 
[382] M. Muramatsu, K. Sonoike, and Y. Hihara, “Mechanism of downregulation of 
photosystem I content under high-light conditions in the cyanobacterium 
Synechocystis sp. PCC 6803,” Microbiology, vol. 155, no. 3, pp. 989–996, 2009. 
[383] Y. Hihara and M. Ikeuchi, “Toward the Elucidation of Physiological Significance of 
pmgA-mediated High-Light Acclimation to Adjust Photosystem Stoichiometry: 
Effects of the Prolonged High-Light Treatment on pmgA Mutants,” in Photosynthesis: 
Mechanisms and Effects, Springer, Dordrecht, 1998, pp. 2929–2932. 
[384] A. Murakami and Y. Fujita, “Regulation of Stoichiometry between PSI and PSII in 
Response to Light Regime for Photosynthesis Observed with Synechocystis PCC 
6714: Relationship between Redox State of Cyt b6-f Complex and Regulation of PSI 
Formation,” Plant Cell Physiol, vol. 34, no. 8, pp. 1175–1180, Dec. 1993. 
[385] J. H. Ryther and W. M. Dunstan, “Nitrogen, Phosphorus, and Eutrophication in the 
Coastal Marine Environment,” Science, vol. 171, no. 3975, pp. 1008–1013, 1971. 
[386] J. A. Berges, D. O. Charlebois, D. C. Mauzerall, and P. G. Falkowski, “Differential 
Effects of Nitrogen Limitation on Photosynthetic Efficiency of Photosystems I and II 
in Microalgae,” Plant Physiology, vol. 110, no. 2, pp. 689–696, Feb. 1996. 
[387] E. Salomon, L. Bar-Eyal, S. Sharon, and N. Keren, “Balancing photosynthetic electron 
flow is critical for cyanobacterial acclimation to nitrogen limitation,” Biochimica et 
Biophysica Acta (BBA) - Bioenergetics, vol. 1827, no. 3, pp. 340–347, Mar. 2013. 
[388] V. Krasikov, E. Aguirre von Wobeser, H. L. Dekker, J. Huisman, and H. C. P. 
Matthijs, “Time-series resolution of gradual nitrogen starvation and its impact on 
photosynthesis in the cyanobacterium Synechocystis PCC 6803,” Physiologia 
Plantarum, vol. 145, no. 3, pp. 426–439, Jul. 2012. 
[389] A. P. Srivastava, D. B. Knaff, and P. Sétif, “Kinetic Studies of a Ferredoxin-Dependent 
Cyanobacterial Nitrate Reductase,” Biochemistry, vol. 53, no. 31, pp. 5092–5101, Aug. 
2014. 
[390] I. Sherameti, S. K. Sopory, A. Trebicka, T. Pfannschmidt, and R. Oelmüller, 
“Photosynthetic Electron Transport Determines Nitrate Reductase Gene Expression 
and Activity in Higher Plants,” J. Biol. Chem., vol. 277, no. 48, pp. 46594–46600, 
Nov. 2002. 
[391] V. H. Smith, “Low Nitrogen to Phosphorus Ratios Favor Dominance by Blue-Green 
Algae in Lake Phytoplankton,” Science, vol. 221, no. 4611, pp. 669–671, 1983. 
[392] H C Huppe and  and D. H. Turpin, “Integration of Carbon and Nitrogen Metabolism in 
Plant and Algal Cells,” Annual Review of Plant Physiology and Plant Molecular 
Biology, vol. 45, no. 1, pp. 577–607, 1994. 
Chapter 8: References 
185 
 
[393] G.-Y. Rhee and I. J. Gotham, “Optimum N:P Ratios and Coexistence of Planktonic 
Algae,” Journal of Phycology, vol. 16, no. 4, pp. 486–489, Dec. 1980. 
[394] Rhee G‐Yull, “Effects of N:P atomic ratios and nitrate limitation on algal growth, cell 
composition, and nitrate uptake,” Limnology and Oceanography, vol. 23, no. 1, pp. 
10–25, Jan. 1978. 
[395] C. A. Raines, “The Calvin cycle revisited,” Photosynthesis Research, vol. 75, no. 1, 
pp. 1–10, Jan. 2003. 
[396] S. Scherer, H. Almon, and P. Böger, “Interaction of photosynthesis, respiration and 
nitrogen fixation in cyanobacteria,” Photosynthesis Research, vol. 15, no. 2, pp. 95–
114, Feb. 1988. 
[397] R. E. Lee, Phycology, 4th ed. Cambridge: Cambridge University Press, 2008. 
[398] D. D. McClure, A. Luiz, B. Gerber, G. W. Barton, and J. M. Kavanagh, “An 
investigation into the effect of culture conditions on fucoxanthin production using the 
marine microalgae Phaeodactylum tricornutum,” Algal Research, vol. 29, pp. 41–48, 
Jan. 2018. 
[399] J. A. Myers, B. S. Curtis, and W. R. Curtis, “Improving accuracy of cell and 
chromophore concentration measurements using optical density,” BMC Biophysics, 
vol. 6, p. 4, 2013. 
[400] D. Millie, O. Schofield, G. Kirkpatrick, G. Johnsen, and T. Evens, “Using absorbance 
and fluorescence spectra to discriminate microalgae,” European Journal of Phycology, 
vol. 37, no. 3, pp. 313–322, Sep. 2002. 
[401] R. J. Porra, “The chequered history of the development and use of simultaneous 
equations for the accurate determination of chlorophylls a and b,” in Discoveries in 
Photosynthesis, Govindjee, J. T. Beatty, H. Gest, and J. F. Allen, Eds. Springer 
Netherlands, 2005, pp. 633–640. 
[402] C. J. Zhu and Y. K. Lee, “Determination of biomass dry weight of marine microalgae,” 
Journal of Applied Phycology, vol. 9, no. 2, pp. 189–194, Apr. 1997. 
[403] R. J. Porra, W. A. Thompson, and P. E. Kriedemann, “Determination of accurate 
extinction coefficients and simultaneous equations for assaying chlorophylls a and b 
extracted with four different solvents: verification of the concentration of chlorophyll 
standards by atomic absorption spectroscopy,” Biochimica et Biophysica Acta (BBA) - 
Bioenergetics, vol. 975, no. 3, pp. 384–394, Aug. 1989. 
[404] S. Bailey, R. G. Walters, S. Jansson, and P. Horton, “Acclimation of Arabidopsis 
thaliana to the light environment: the existence of separate low light and high light 
responses,” Planta, vol. 213, no. 5, pp. 794–801, Sep. 2001. 
[405] W. A. Kratz and J. Myers, “Nutrition and Growth of Several Blue-Green Algae,” 
American Journal of Botany, vol. 42, no. 3, pp. 282–287, 1955. 
[406] R. D. Robarts and T. Zohary, “Temperature effects on photosynthetic capacity, 
respiration, and growth rates of bloom‐forming cyanobacteria,” New Zealand Journal 
of Marine and Freshwater Research, vol. 21, no. 3, pp. 391–399, Sep. 1987. 
[407] L. Mendez, A. Mahdy, M. Ballesteros, and C. González-Fernández, “Chlorella vulgaris 
vs cyanobacterial biomasses: Comparison in terms of biomass productivity and biogas 
yield,” Energy Conversion and Management, vol. 92, no. Supplement C, pp. 137–142, 
Mar. 2015. 
[408] J. C. Goldman, “Outdoor algal mass cultures—II. Photosynthetic yield limitations,” 
Water Research, vol. 13, no. 2, pp. 119–136, 1979. 
[409] T. Hase, P. Schürmann, and D. B. Knaff, “The Interaction of Ferredoxin with 
Ferredoxin-Dependent Enzymes,” in Photosystem I, Springer, Dordrecht, 2006, pp. 
477–498. 
Chapter 8: References 
186 
 
[410] A. Suzuki and D. B. Knaff, “Glutamate synthase: structural, mechanistic and 
regulatory properties, and role in the amino acid metabolism,” Photosynthesis 
Research, vol. 83, pp. 191–217, Feb. 2005. 
[411] N. Kloft and K. Forchhammer, “Signal Transduction Protein PII Phosphatase PphA Is 
Required for Light-Dependent Control of Nitrate Utilization in Synechocystis sp. 
Strain PCC 6803,” J. Bacteriol., vol. 187, no. 19, pp. 6683–6690, Oct. 2005. 
[412] C. Lillo, U. S. Lea, and P. Ruoff, “Nutrient depletion as a key factor for manipulating 
gene expression and product formation in different branches of the flavonoid 
pathway,” Plant, Cell & Environment, vol. 31, no. 5, pp. 587–601, May 2008. 
[413] J. Gershenzon, “Metabolic costs of terpenoid accumulation in higher plants,” J Chem 
Ecol, vol. 20, no. 6, pp. 1281–1328, Jun. 1994. 
[414] C. A. Klausmeier, E. Litchman, T. Daufresne, and S. A. Levin, “Optimal nitrogen-to-
phosphorus stoichiometry of phytoplankton,” Nature, vol. 429, no. 6988, pp. 171–174, 
May 2004. 
[415] L. Xin, H. Hong-ying, G. Ke, and S. Ying-xue, “Effects of different nitrogen and 
phosphorus concentrations on the growth, nutrient uptake, and lipid accumulation of a 
freshwater microalga Scenedesmus sp.,” Bioresource Technology, vol. 101, no. 14, pp. 
5494–5500, Jul. 2010. 
[416] K. Kobayashi and K. Fujita, “Tube Diameter on Tubular Photobioreactor for 
Microalgal Culture and Its Biomass Productivity,” Journal of Chemical Engineering of 
Japan, vol. 30, no. 2, pp. 339–341, 1997. 
[417] J. A. Raven and R. J. Geider, “Temperature and algal growth,” New Phytologist, vol. 
110, no. 4, pp. 441–461, Dec. 1988. 
[418] T. Suzuki, T. Matsuo, K. Ohtaguchi, and K. Koide, “Gas-Sparged bioreactors for CO2 
fixation by Dunaliella tertiolecta,” Journal of Chemical Technology & Biotechnology, 
vol. 62, no. 4, pp. 351–358. 
[419] W.-D. Deckwer, Y. Louisi, A. Zaidi, and M. Ralek, “Hydrodynamic Properties of the 
Fischer-Tropsch Slurry Process,” Industrial & Engineering Chemistry Process Design 
and Development, vol. 19, no. 4, pp. 699–708, Oct. 1980. 
[420] M. C. G.-M. López et al., “Comparative analysis of the outdoor culture of 
Haematococcus pluvialis in tubular and bubble column photobioreactors,” Journal of 
Biotechnology, vol. 123, no. 3, pp. 329–342, May 2006. 
[421] S. Degaleesan, M. Dudukovic, and Y. Pan, “Experimental study of gas-induced liquid-
flow structures in bubble columns,” AIChE Journal, vol. 47, no. 9, pp. 1913–1931. 
[422] S. C. Saxena, N. S. Rao, and A. C. Saxena, “Heat-Transfer and Gas-Holdup Studies in 
a Bubble Column: Air-Water-Glass Bead System,” Chemical Engineering 
Communications, vol. 96, no. 1, pp. 31–55, Oct. 1990. 
[423] C. L. Hyndman, F. Larachi, and C. Guy, “Understanding gas-phase hydrodynamics in 
bubble columns: a convective model based on kinetic theory,” Chemical Engineering 
Science, vol. 52, no. 1, pp. 63–77, Jan. 1997. 
[424] M. Bouaifi, G. Hebrard, D. Bastoul, and M. Roustan, “A comparative study of gas 
hold-up, bubble size, interfacial area and mass transfer coefficients in stirred gas–
liquid reactors and bubble columns,” Chemical Engineering and Processing: Process 
Intensification, vol. 40, no. 2, pp. 97–111, Feb. 2001. 
[425] Sánchez Mirón Asterio, García Camacho Francisco, Contreras Gómez Antonio, Grima 
Emilio Molina, and Chisti Yusuf, “Bubble‐column and airlift photobioreactors for 
algal culture,” AIChE Journal, vol. 46, no. 9, pp. 1872–1887, Apr. 2004. 
[426] F. Camacho Rubio, A. Sánchez Mirón, M. C. Cerón García, F. García Camacho, E. 
Molina Grima, and Y. Chisti, “Mixing in bubble columns: a new approach for 
Chapter 8: References 
187 
 
characterizing dispersion coefficients,” Chemical Engineering Science, vol. 59, no. 20, 
pp. 4369–4376, Oct. 2004. 
[427] J. Fábregas, A. Otero, A. Maseda, and A. Domínguez, “Two-stage cultures for the 
production of Astaxanthin from Haematococcus pluvialis,” Journal of Biotechnology, 
vol. 89, no. 1, pp. 65–71, Jul. 2001. 
[428] C. Aflalo, Y. Meshulam, A. Zarka, and S. Boussiba, “On the relative efficiency of two- 
vs. one-stage production of astaxanthin by the green alga Haematococcus pluvialis,” 
Biotechnology and Bioengineering, vol. 98, no. 1, pp. 300–305. 
[429] M. Kobayashi, T. Kakizono, N. Nishio, and S. Nagai, “Effects of light intensity, light 
quality, and illumination cycle on astaxanthin formation in a green alga, 
Haematococcus pluvialis,” Journal of Fermentation and Bioengineering, vol. 74, no. 1, 
pp. 61–63, Jan. 1992. 
[430] “Our Story,” Supreme Health. [Online]. Available: 
https://www.supremehealth.co.nz/our-story_1518. [Accessed: 12-Jun-2018]. 
[431] L. Suzuki and C. H. Johnson, “Algae Know the Time of Day: Circadian and 
Photoperiodic Programs,” Journal of Phycology, vol. 37, no. 6, pp. 933–942. 
[432] R. A. Hut and D. G. M. Beersma, “Evolution of time-keeping mechanisms: early 
emergence and adaptation to photoperiod,” Philosophical Transactions of the Royal 
Society of London B: Biological Sciences, vol. 366, no. 1574, pp. 2141–2154, Jul. 
2011. 
[433] J. Mueller, W. C. Boyle, and I. H. J. Popel, Aeration: Principles and Practice. CRC 
Press, 2002. 
[434] E. W. Rice and American Public Health Association, Eds., Standard methods for the 
examination of water and wastewater, 22. ed. Washington, DC: American Public 
Health Association, 2012. 
[435] E. Molina, J. Fernández, F. G. Acién, and Y. Chisti, “Tubular photobioreactor design 
for algal cultures,” Journal of Biotechnology, vol. 92, no. 2, pp. 113–131, Dec. 2001. 
[436] A. Contreras, F. García, E. Molina, and J. C. Merchuk, “Interaction between CO2-
mass transfer, light availability, and hydrodynamic stress in the growth of 
Phaeodactylum tricornutum in a concentric tube airlift photobioreactor,” 
Biotechnology and Bioengineering, vol. 60, no. 3, pp. 317–325, 1998. 
[437] I. Krzemińska, B. Pawlik-Skowrońska, M. Trzcińska, and J. Tys, “Influence of 
photoperiods on the growth rate and biomass productivity of green microalgae,” 
Bioprocess Biosyst Eng, vol. 37, no. 4, pp. 735–741, Apr. 2014. 
[438] S. Wahidin, A. Idris, and S. R. M. Shaleh, “The influence of light intensity and 
photoperiod on the growth and lipid content of microalgae Nannochloropsis sp.,” 
Bioresource Technology, vol. 129, pp. 7–11, Feb. 2013. 
[439] E. Paasche, “Marine Plankton Algae Grown with Light-Dark Cycles.,” Physiologia 
Plantarum, vol. 21, no. 1, pp. 66–77. 
[440] K. Lee and C.-G. Lee, “Effect of light/dark cycles on wastewater treatments by 
microalgae,” Biotechnol. Bioprocess Eng., vol. 6, no. 3, pp. 194–199, Jun. 2001. 
[441] E. Jacob-Lopes, C. H. G. Scoparo, L. M. C. F. Lacerda, and T. T. Franco, “Effect of 
light cycles (night/day) on CO2 fixation and biomass production by microalgae in 
photobioreactors,” Chemical Engineering and Processing: Process Intensification, vol. 
48, no. 1, pp. 306–310, Jan. 2009. 
[442] R. Bouterfas, M. Belkoura, and A. Dauta, “The effects of irradiance and photoperiod 
on the growth rate of three freshwater green algae isolated from a eutrophic lake,” 
Limnética, vol. 25, no. 3, pp. 647–656, 2006. 
Chapter 8: References 
188 
 
[443] B. Rost, U. Riebesell, and D. Sültemeyer, “Carbon acquisition of marine 
phytoplankton: Effect of photoperiod length,” Limnology and Oceanography, vol. 51, 
no. 1, pp. 12–20. 
[444] D. M. Arias, E. Uggetti, M. J. García-Galán, and J. García, “Production of 
polyhydroxybutyrates and carbohydrates in a mixed cyanobacterial culture: Effect of 
nutrients limitation and photoperiods,” New Biotechnology, vol. 42, pp. 1–11, May 
2018. 
[445] M. M. Maroneze et al., “The role of photoperiods on photobioreactors – A potential 
strategy to reduce costs,” Bioresource Technology, vol. 219, pp. 493–499, Nov. 2016. 
[446] N. M. Weare and J. R. Benemann, “Nitrogen fixation by Anabaena cylindrica,” Archiv. 
Mikrobiol., vol. 93, no. 2, pp. 101–112, Jun. 1973. 
[447] J. D. Ownby, M. Shannahan, and E. Hood, “Protein Synthesis and Degradation in 
Anabaena During Nitrogen Starvation,” Microbiology, vol. 110, no. 2, pp. 255–261, 
1979. 
[448] Office of the Federal Register, “Part 573—Food Additives Permitted in Feed and 
Drinking Water of Animals,” in Code of Federal Regulations, vol. 64, US Government 
Publishing Office, 1999, p. 46840. 
[449] H. E. M. G. Haenen, P. Rogmans, J. H. M. Temmink, and P. J. van Bladeren, 
“Differential detoxification of two thioether conjugates of menadione in confluent 
monolayers of rat renal proximal tubular cells,” Toxicology in Vitro, vol. 8, no. 2, pp. 
207–214, Apr. 1994. 
[450] F. A. Redegeld, G. A. Hofman, P. G. van de Loo, A. S. Koster, and J. Noordhoek, 
“Nephrotoxicity of the glutathione conjugate of menadione (2-methyl-1, 4-
naphthoquinone) in the isolated perfused rat kidney. Role of metabolism by gamma-
glutamyltranspeptidase and probenecid-sensitive transport.,” J Pharmacol Exp Ther, 
vol. 256, no. 2, pp. 665–669, Feb. 1991. 
[451] O. Broberger, L. Ernster, and R. Zetterström, “Oxidation of Human Hæmoglobin by 
Vitamin K3,” Nature, vol. 188, pp. 316–317, Oct. 1960. 
[452] Smith A, Jr., and Custer R, “Toxicity of vitamin k: Induced hypoprothrombinemia and 
altered liver function,” JAMA, vol. 173, no. 5, pp. 502–504, Jun. 1960. 
[453] Andrea Talbot, “Vitamin K enriched eggs: benefits for the consumer, the farmer and 
the hen,” in APSS 2018 Proceedings, Sydney, NSW, Australia, 2018, p. 254. 
[454] I. C. D. Jong and D. Guémené, “Major welfare issues in broiler breeders,” World’s 
Poultry Science Journal, vol. 67, no. 1, pp. 73–82, Mar. 2011. 
[455] I. J. H. Duncan, “Animal Welfare Issues in the Poultry Industry: Is There a Lesson to 
Be Learned?,” Journal of Applied Animal Welfare Science, vol. 4, no. 3, pp. 207–221, 
Jul. 2001. 
[456] N. G. Gregory and L. J. Wilkins, “Broken bones in domestic fowl: Handling and 
processing damage in end‐of‐lay battery hens,” British poultry science, vol. 30, no. 3, 
pp. 555–562, 1989. 
[457] Y. Suzuki and M. Okamoto, “Production of hen’s eggs rich in vitamin K,” Nutrition 
Research, vol. 17, no. 10, pp. 1607–1615, Oct. 1997. 
[458] W. Holtcamp, “The Emerging Science of BMAA: Do Cyanobacteria Contribute to 
Neurodegenerative Disease?,” Environ Health Perspect, vol. 120, no. 3, pp. a110–
a116, Mar. 2012. 
[459] M. van der Spiegel, M. y. Noordam, and H. j. van der Fels-Klerx, “Safety of Novel 
Protein Sources (Insects, Microalgae, Seaweed, Duckweed, and Rapeseed) and 
Legislative Aspects for Their Application in Food and Feed Production,” 
Comprehensive Reviews in Food Science and Food Safety, vol. 12, no. 6, pp. 662–678, 
Nov. 2013. 
Chapter 8: References 
189 
 
[460] A. Constable et al., “History of safe use as applied to the safety assessment of novel 
foods and foods derived from genetically modified organisms,” Food and Chemical 
Toxicology, vol. 45, no. 12, pp. 2513–2525, Dec. 2007. 
[461] Organisation for Economic Co-operation and Development, Test no. 408: repeated 
dose 90-day oral toxicity study in rodents. Paris: OECD Pub., 1998. 
[462] C. Snell et al., “Assessment of the health impact of GM plant diets in long-term and 
multigenerational animal feeding trials: A literature review,” Food and Chemical 
Toxicology, vol. 50, no. 3, pp. 1134–1148, Mar. 2012. 
[463] J. L. Domingo and J. Giné Bordonaba, “A literature review on the safety assessment of 
genetically modified plants,” Environment International, vol. 37, no. 4, pp. 734–742, 
May 2011. 
[464] V. Ebenezer, L. K. Medlin, and J.-S. Ki, “Molecular Detection, Quantification, and 
Diversity Evaluation of Microalgae,” Mar Biotechnol, vol. 14, no. 2, pp. 129–142, 
Apr. 2012. 
[465] B. A. Neilan et al., “The genetics and genomics of cyanobacterial toxicity,” pp. 417–
452, 2008. 
[466] A. G. Fontes, M. Angeles Vargas, J. Moreno, M. G. Guerrero, and M. Losada, “Factors 
affecting the production of biomass by a nitrogen-fixing blue-green alga in outdoor 
culture,” Biomass, vol. 13, no. 1, pp. 33–43, Jan. 1987. 
[467] M. T. Guarnieri and P. T. Pienkos, “Algal omics: unlocking bioproduct diversity in 
algae cell factories,” Photosynthesis research, vol. 123, no. 3, pp. 255–263, 2015. 
[468] J.-P. Cadoret, M. Garnier, and B. Saint-Jean, “Microalgae, functional genomics and 
biotechnology,” in Advances in Botanical Research, vol. 64, Elsevier, 2012, pp. 285–
341. 
[469] V. Anand, P. K. Singh, C. Banerjee, and P. Shukla, “Proteomic approaches in 
microalgae: perspectives and applications,” 3 Biotech, vol. 7, no. 3, p. 197, 2017. 
[470] G. De Bhowmick, L. Koduru, and R. Sen, “Metabolic pathway engineering towards 
enhancing microalgal lipid biosynthesis for biofuel application—a review,” Renewable 
and Sustainable Energy Reviews, vol. 50, pp. 1239–1253, 2015. 
[471] B. Marie et al., “Global metabolomic characterizations of Microcystis spp. highlights 
clonal diversity in natural bloom-forming populations and expands metabolite 
structural diversity,” bioRxiv, p. 407189, 2018. 
[472] L. Brennan and P. Owende, “Biofuels from microalgae—A review of technologies for 
production, processing, and extractions of biofuels and co-products,” Renewable and 
Sustainable Energy Reviews, vol. 14, no. 2, pp. 557–577, Feb. 2010. 
 

Appendix A: AEC approval letter for project 2015/769 
A-1 
 
Appendix A: AEC approval letter for project 
2015/769 
  
Appendix A: AEC approval letter for project 2015/769 
A-2 
 
 
  
Appendix A: AEC approval letter for project 2015/769 
A-3 
 
 
  
Appendix A: AEC approval letter for project 2015/769 
A-4 
 
 
  
Appendix A: AEC approval letter for project 2015/769 
A-5 
 
 
 
  
Appendix B: AEC approval letter for project 2017/1243 
B-6 
 
 
 
Appendix B: AEC approval letter for project 
2017/1243 
  
Appendix B: AEC approval letter for project 2017/1243 
B-7 
 
 
  
Appendix B: AEC approval letter for project 2017/1243 
B-8 
 
 
  
Appendix B: AEC approval letter for project 2017/1243 
B-9 
 
 
  
Appendix B: AEC approval letter for project 2017/1243 
B-10 
 
 
  
Appendix C: Diet formulation sheet for dough premix SF14-156 
C-11 
 
Appendix C: Diet formulation sheet for dough 
premix SF14-156 
 
  
Appendix C: Diet formulation sheet for dough premix SF14-156 
C-12 
 
 
  
Appendix C: Diet formulation sheet for dough premix SF14-156 
C-13 
 
 
  
Appendix C: Diet formulation sheet for dough premix SF14-156 
C-14 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-15 
 
 
 
Appendix D: Reports of analysis for 
nutritional content of A. cylindrica 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-16 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-17 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-18 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-19 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-20 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-21 
 
 
  
Appendix D: Reports of analysis for nutritional content of A. cylindrica 
D-22 
 
 
 
 
